id,pmid,year,seq,MAP,name,cter,nter,lyn_cyc,ldmix,non_nat,len,nature,activity,source,origin,exp_str,non_hem,dssp,smiles
1025,18081258,2008,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},Katala B1,Free,Free,Cyclic,L,None,29,Anti-HIV,HD50 = 11.7 µM,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA,CCCCCSSHHHHCCCCCSSCCCCSSCCSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
1027,18081258,2008,GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN,GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN{cyc:N-C},Cycloviolacin Y1,Free,Free,Cyclic,L,None,33,Anti-HIV,Poor hemolytic,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
1028,18081258,2008,GVPCGESCVFIPCITGVIGCSCSSNVCYLN,GVPCGESCVFIPCITGVIGCSCSSNVCYLN{cyc:N-C},Cycloviolacin Y4,Free,Free,Cyclic,L,None,30,Anti-HIV,HD50 = 9.3 µM,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA,CCSSSSCCCCCCSSSSBTTBCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O
1029,18081258,2008,GIPCAESCVWIPCTVTALVGCSCSDKVCYN,GIPCAESCVWIPCTVTALVGCSCSDKVCYN{cyc:N-C},Cycloviolacin Y5,Free,Free,Cyclic,L,None,30,Anti-HIV,HD50 = 8.7 µM,Human,Cyclotides (Chinese herb from the Violaceae family Viola yedoensis),NA,NA,CCBTTTBCCCCSCCCTTCCCCSTTCCCSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C
1031,18243710,2008,DAACAAHCLWR,DAACAAHCLWR{cyc:N-C}{ct:Amid},DHWRox,Amidation,Free,Cyclic,L,None,11,Antimicrobial,HC50 >200 μg/ml,Human,"α-helical domain of Tenecin 1,an insect defensin",α-helix,NA,CCSSSCCTTC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1033,18243710,2008,DAACAAKCLWR,DAACAAKCLWR{cyc:N-C}{ct:Amid},DKWRox,Amidation,Free,Cyclic,L,None,11,Antimicrobial,HC50 >200 μg/ml,Human,"α-helical domain of Tenecin 1,an insect defensin",α-helix,NA,CTTTTTTSTTC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1035,18243710,2008,KAACAAHCLWR,KAACAAHCLWR{cyc:N-C}{ct:Amid},KHWRox,Amidation,Free,Cyclic,L,None,11,Antimicrobial,HC50 >200 μg/ml,Human,"α-helical domain of Tenecin 1,an insect defensin",α-helix,NA,CCTTSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1037,18243710,2008,KAACAAKCLWR,KAACAAKCLWR{cyc:N-C}{ct:Amid},KKWRox,Amidation,Free,Cyclic,L,None,11,Antimicrobial,HC50 >200 μg/ml,Human,"α-helical domain of Tenecin 1,an insect defensin",α-helix,NA,CBTTBSSSSCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1091,17212422,2007,APC-L-ACPC-K-ACPC-L-APC-L-ACPC-K-ACPC-L-APC-L-ACPC,{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 1,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 3.1 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1092,17212422,2007,APC-L-ACPC-L-APC-L-ACPC-K-ACPC-L-ACPC-K-ACPC-L-APC,{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 2,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 1.6 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1093,17212422,2007,ACPC-L-APC-K-APC-L-ACPC-K-APC-L-ACPC-L-ACPC-L-ACPC,{nnr:ACPC}-L-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 3,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1094,17212422,2007,APC-L-APC-L-ACPC-K-ACPC-L-ACPC-L-APC-L-ACPC-K-ACPC,{nnr:APC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 4,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1095,17212422,2007,APC-L-ACPC-L-APC-L-ACPC-L-APC-L-ACPC-K-ACPC-L-APC,{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 5,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 1.6 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1096,17212422,2007,APC-F-ACPC-L-APC-L-ACPC-F-APC-F-ACPC-K-ACPC-L-APC,{nnr:APC}-F-{nnr:ACPC}-L-{nnr:APC}-L-{nnr:ACPC}-F-{nnr:APC}-F-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 6,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 1.6 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1097,17212422,2007,APC-L-ACPC-K-ACPC-A-APC-A-ACPC-K-ACPC-A-APC-L-ACPC,{nnr:APC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 7,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at >400 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1098,17212422,2007,APC-L-ACPC-A-APC-A-ACPC-K-ACPC-L-ACPC-K-ACPC-A-APC,{nnr:APC}-L-{nnr:ACPC}-A-{nnr:APC}-A-{nnr:ACPC}-K-{nnr:ACPC}-L-{nnr:ACPC}-K-{nnr:ACPC}-A-{nnr:APC}{cyc:N-C}{ct:Amid},Peptide 8,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1099,17212422,2007,ACPC-A-APC-K-APC-L-ACPC-K-APC-A-ACPC-A-ACPC-L-ACPC,{nnr:ACPC}-A-{nnr:APC}-K-{nnr:APC}-L-{nnr:ACPC}-K-{nnr:APC}-A-{nnr:ACPC}-A-{nnr:ACPC}-L-{nnr:ACPC}{cyc:N-C}{ct:Amid},Peptide 9,Amidation,Free,Cyclic,L,"APC = APC, ACPC = ACPC",15,Antibacterial,>10% Hemolysis at >400 μg/ml,Human,Synthetic peptide,NA,NA,NA,NA
1145,18186149,2008,KKKKKKAAFAAWAAFDA,KKKKKKAAFAAWAAFDA{cyc:N-C}{ct:Amid},7K-F18-1D17,Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC = 650 µM,Human,Synthetic peptide,random coil,NA,CCGGGGGSSSGGGGGCC,C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
1146,18186149,2008,kkkkkkaafaawaafaa,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}A{d}A{d}{cyc:N-C}{ct:Amid},6k-f17,Amidation,Free,Cyclic,D,None,17,Antimicrobial,MHC = 325 µM,Human,Synthetic peptide,random coil,NA,CGGGGGGSTTCCSCTTC,C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
1147,18186149,2008,KKKKKKAAFALWAAFAA,KKKKKKAAFALWAAFAA{cyc:N-C}{ct:Amid},6K-F17-1L11,Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC = 81 µM,Human,Synthetic peptide,random coil,NA,CCSSSSSSCSSTTTCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
1148,18186149,2008,KKKKKKAAFALWLAFAA,KKKKKKAAFALWLAFAA{cyc:N-C}{ct:Amid},"6K-F17-2L11,13",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <81 µM,Human,Synthetic peptide,random coil,NA,CCCCTTGGGGCSSSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
1149,18186149,2008,KKKKKKAAFLAWALFAA,KKKKKKAAFLAWALFAA{cyc:N-C}{ct:Amid},"6K-F17-2L10,14",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <81 µM,Human,Synthetic peptide,random coil,NA,CCSCTTHHHHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
1150,18186149,2008,kkkkkkaafaawaafll,K{d}K{d}K{d}K{d}K{d}K{d}A{d}A{d}F{d}A{d}A{d}W{d}A{d}A{d}F{d}L{d}L{d}{cyc:N-C}{ct:Amid},"6k-f17-2l16,17",Amidation,Free,Cyclic,D,None,17,Antimicrobial,MHC <81 µM,Human,Synthetic peptide,random coil,NA,CCSGGGTTTTTHHHHTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)O
1151,18186149,2008,KKKKKKALFAAWAAFLA,KKKKKKALFAAWAAFLA{cyc:N-C}{ct:Amid},"6K-F17-2L8,16",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <81 µM,Human,Synthetic peptide,random coil,NA,CGGGGGGTGGGHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
1152,18186149,2008,KKKKKKLLFAAWAAFAA,KKKKKKLLFAAWAAFAA{cyc:N-C}{ct:Amid},"6K-F17-2L7,8",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <81 µM,Human,Synthetic peptide,random coil,NA,CCSSCSSTTHHHHTTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
1153,18186149,2008,KKKKKKALFALWLAFAA,KKKKKKALFALWLAFAA{cyc:N-C}{ct:Amid},"6K-F17-3L8,11,13",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <<81 µM,Human,Synthetic peptide,random coil,NA,CGGGGGGCGGGGTCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O
1154,18186149,2008,KKKKKKAAFALWLAFLA,KKKKKKAAFALWLAFLA{cyc:N-C}{ct:Amid},"6K-F17-3L11,13,16",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <<81 µM,Human,Synthetic peptide,random coil,NA,CCSSTTSSGGGTGGGGC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
1155,18186149,2008,KKKKKKALFALWLAFLA,KKKKKKALFALWLAFLA{cyc:N-C}{ct:Amid},"6K-F17-4L8,11,13,16",Amidation,Free,Cyclic,L,None,17,Antimicrobial,MHC <<81 µM,Human,Synthetic peptide,random coil,NA,CGGGGGGSHHHHHHHHC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O
1265,18972522,2008,PICTRNGLPVCGETCFGGTCNTPGCTCTW,PICTRNGLPVCGETCFGGTCNTPGCTCTW{cyc:N-C},K1 (B2),Free,Free,Cyclic,L,None,29,Uteroactive and antimicrobial,100% Hemolysis at >0.5 mg/ml,Human,Kalata (Oldenlandia affinis DC),β-strands,NA,CCCCCSSCCCCCSTTGGGGCCCSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O
1266,18972522,2008,PVCTRNGLPVCGETCVGGTCNTPGCTCSW,PVCTRNGLPVCGETCVGGTCNTPGCTCSW{cyc:N-C},K2 (B1),Free,Free,Cyclic,L,None,29,Uteroactive and antimicrobial,100% Hemolysis at >0.5 mg/ml,Human,Kalata (Oldenlandia affinis DC),β-strands,NA,CCSSCCSSSSSBSSSSBSSSCCSSCSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
1267,18972522,2008,PICKRNGLPVCGETCTLGTCYTQGCTCSW,PICKRNGLPVCGETCTLGTCYTQGCTCSW{cyc:N-C},K3 (B7),Free,Free,Cyclic,L,None,29,Uteroactive and antimicrobial,100% Hemolysis at >0.5 mg/ml,Human,Kalata (Oldenlandia affinis DC),β-strands,NA,CCGGGSSCCSSSCGGGCCSSCSSCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
1283,19132829,2009,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,HC50 = 21.1(±2.6)µM,Sheep,Gramicidin S (Bacillus brevis),β-sheet structure,NA,NA,NA
1284,19132829,2009,VOL-hpa-PVOL-hpa-P,V{nnr:O}L{nnr:hpa}PV{nnr:O}L{nnr:hpa}P{cyc:NC},GS1,Free,Free,Cyclic,Mix,"O = L-Ornithine, Hpa = homophenylalanine",10,Antimicrobial,HC50 = 7.0(±0.3)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1285,19132829,2009,VOL-1-nal-PVOL-1-nal-P,V{nnr:O}L{nnr:1nal}PV{nnr:O}L{nnr:1nal}P{cyc:NC},GS2,Free,Free,Cyclic,Mix,"O = L-Ornithine, 1-Nal = 1-naphthylalanine",10,Antimicrobial,HC50 = 5.0(±0.1)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1286,19132829,2009,VOL-2-nal-PVOL-2-nal-P,V{nnr:O}L{nnr:2nal}PV{nnr:O}L{nnr:2nal}P{cyc:NC},GS3,Free,Free,Cyclic,Mix,"O = L-Ornithine, 2-Nal = 2-naphthylalanine",10,Antimicrobial,HC50 = 7.1(±3.5)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1287,19132829,2009,VOL-dip-PVOL-dip-P,V{nnr:O}L{nnr:dip}PV{nnr:O}L{nnr:dip}P{cyc:NC},GS4,Free,Free,Cyclic,Mix,"O = L-Ornithine, Dip = β,β-diphenylalanine",10,Antimicrobial,HC50 = 8.6(±1.1)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1288,19132829,2009,VOL-flg-PVOL-flg-P,V{nnr:O}L{nnr:flg}PV{nnr:O}L{nnr:flg}P{cyc:NC},GS5,Free,Free,Cyclic,Mix,"O = L-Ornithine, Flg = fluorenylglycine",10,Antimicrobial,HC50 = 6.2(±0.3)µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1289,19132829,2009,VOL-tic-PVOL-tic-P,V{nnr:O}L{nnr:tic}PV{nnr:O}L{nnr:tic}P{cyc:NC},GS6,Free,Free,Cyclic,Mix,"O = L-Ornithine, Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid",10,Antimicrobial,HC50 >50 µM,Sheep,Gramicidin S analogue (Bacillus brevis),β-sheet structure,NA,NA,NA
1502,20449481,2010,VOLLfPVOLfP,V{nnr:O}LLF{d}PV{nnr:O}LF{d}P{cyc:N-C},2HBr (1),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,100% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1503,20449481,2010,VOLAfPVOLfP,V{nnr:O}LAF{d}PV{nnr:O}LF{d}P{cyc:N-C},2HBr (2),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,50% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1504,20449481,2010,VOLOfPVOLfP,V{nnr:O}L{nnr:O}F{d}PV{nnr:O}LF{d}P{cyc:N-C},3HBr (3),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,10% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1505,20449481,2010,VOLKfPVOLfP,V{nnr:O}LKF{d}PV{nnr:O}LF{d}P{cyc:N-C},3HBr (4),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,10% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1506,20449481,2010,VOLRfPVOLfP,V{nnr:O}LRF{d}PV{nnr:O}LF{d}P{cyc:N-C},3HCl (5),Free,Free,Cyclic,Mix,O = L-Ornithine,11,Antimicrobial,15% Hemolysis at 100 µM,Sheep,Gramacidin S (Bacillus brevis ),antiparallel β-sheet,NA,NA,NA
1516,20564013,2010,GTPCGESCVYIPCISGVIGCSCTDKVCYLN,GTPCGESCVYIPCISGVIGCSCTDKVCYLN{cyc:N-C},Kalata B5,Free,Free,Cyclic,L,None,30,Pesticidal,HD50 = 27.4±1.2 µM,Human,Cyclotides (Oldenlandia affinis),typical bracelet cyclotide fold,NA,CCSSSCSSCCCCSSSSSTTSCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C
1584,15009528,2004,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14KD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 125 μg/ml,Human,Gramicidin S analog,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1585,15009528,2004,VKLlVyPLKVKLyP,VKLL{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14LD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 5 μg/ml,Human,Gramicidin S analog,NA,NA,CCCEEETTEEECCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1586,15009528,2004,VKLfVyPLKVKLyP,VKLF{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14FD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 2 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1587,15009528,2004,VKLyVyPLKVKLyP,VKLY{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14YD4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 5 μg/ml,Human,Gramicidin S analog,NA,NA,CCCSSSSSSCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1588,15009528,2004,VKLnVyPLKVKLyP,VKLN{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14ND4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 62 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSCTTCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
1660,16235231,2006,ZDRRLSYKQRSVTYORGR,{nnr:Z}DRRLSYKQRSVTYORGR{cyc:N-C}{ct:Amid},"cyclo(2-15)[Asp2 Ser6,11, Orn15]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,~10% Hemolysis at 100 µM,Human,Analog of Gomesin (Acanthoscurria gomesiana),α-helical and β-sheet,NA,NA,NA
1661,16235231,2006,ZSRRLDYKQROVTYSRGR,{nnr:Z}SRRLDYKQROVTYSRGR{cyc:N-C}{ct:Amid},"cyclo(6-11)[Ser2,15, Asp6, Orn11]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,~10% Hemolysis at 100 µM,Human,Analog of Gomesin (Acanthoscurria gomesiana),α-helical and β-sheet,NA,NA,NA
1663,16235231,2006,ZCRRLDYKQROVTYCRGR,{nnr:Z}CRRLDYKQROVTYCRGR{cyc:N-C}{ct:Amid},"Bicyclo(2-15, 6-11)[Cys2, 15, Asp6, Orn11]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,>30% Hemolysis at 100 µM,Human,Analog of Gomesin (Acanthoscurria gomesiana),α-helical and β-sheet,NA,NA,NA
1664,16235231,2006,ZCRRLDYKQRBVTYCRGR,{nnr:Z}CRRLDYKQRBVTYCRGR{cyc:N-C}{ct:Amid},"Bicyclo(2-15, 6-11)[Cys2, 15, Asp6, Dap11]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,>30% Hemolysis at 100 µM,Human,Analog of Gomesin (Acanthoscurria gomesiana),α-helical and β-sheet,NA,NA,NA
1666,16235231,2006,ZDRRLCYKQRCVTYORGR,{nnr:Z}DRRLCYKQRCVTYORGR{cyc:N-C}{ct:Amid},"Bicyclo(2-15, 6-11)[Asp2, Cys6, 11, Orn15]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,~15% Hemolysis at 100 µM,Human,Analog of Gomesin (Acanthoscurria gomesiana),α-helical and β-sheet,NA,NA,NA
1667,16235231,2006,ZDRRLCYKQRCVTYBRGR,{nnr:Z}DRRLCYKQRCVTYBRGR{cyc:N-C}{ct:Amid},"Bicyclo(2-15, 6-11)[Asp2, Cys6, Dap15]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,~15% Hemolysis at 100 µM,Human,Analog of Gomesin (Acanthoscurria gomesiana),α-helical and β-sheet,NA,NA,NA
1684,16730857,2006,KFKLKQ,KFKLKQ{cyc:N-C},BPC6L,Free,Free,Cyclic,L,None,6,Hemolytic,11±4.6% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1685,16730857,2006,KLKFKLKQ,KLKFKLKQ{cyc:N-C},BPC8L,Free,Free,Cyclic,L,None,8,Antibacterial,68±7.5% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1686,16730857,2006,KLKLKFKLKQ,KLKLKFKLKQ{cyc:N-C},BPC10L,Free,Free,Cyclic,L,None,10,Antibacterial,81 ± 5.3% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCTTSCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1687,16730857,2006,KLKfKLKQ,KLKF{d}KLKQ{cyc:N-C},BPC8D,Free,Free,Cyclic,Mix,None,8,Hemolytic,37±5.2% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1688,16730857,2006,KLKLKfKLKQ,KLKLKF{d}KLKQ{cyc:N-C},BPC10D,Free,Free,Cyclic,Mix,None,10,Hemolytic,42± 6.8% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCTTSCSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1689,16730857,2006,KLKLKLKQ,KLKLKLKQ{cyc:N-C},BPC8S1,Free,Free,Cyclic,L,None,8,Hemolytic,1±0.1% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1690,16730857,2006,LKLKLKLQ,LKLKLKLQ{cyc:N-C},BPC8S3,Free,Free,Cyclic,L,None,8,Hemolytic,5±0.1% Hemolysis at 360 µM,Human,Synthetic peptide,NA,NA,CCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1864,15003352,2004,RLRLRIGRR,RLRLRIGRR{cyc:N-C}{ct:Amid},9-Fluorenylmethoxycarbonyl (F-moc),Amidation,Free,Cyclic,L,None,9,Antimicrobial,0% Hemolysis at 100 μg/ml (non-hemolytic),Rabbit,Synthetic peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1865,15003352,2004,RLRLRIGRR,RLRLRIGRR{cyc:N-C}{ct:Amid},9-Fluorenylmethoxycarbonyl (F-moc),Amidation,Free,Cyclic,L,None,9,Antimicrobial,0% Hemolysis at 100 μg/ml (non-hemolytic),Rabbit,Synthetic peptide,NA,Non-hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1866,15003352,2004,RLRLRIGRR,RLRLRIGRR{cyc:N-C}{ct:Amid},9-Fluorenylmethoxycarbonyl (F-moc),Amidation,Free,Cyclic,L,None,9,Antimicrobial,0% Hemolysis at 100 μg/ml (non-hemolytic),Rabbit,Synthetic peptide,NA,Non-hemolytic,CCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
1892,15949628,2005,EWGRRCCGWGPGRRYCVRWC,EWGRRCCGWGPGRRYCVRWC{cyc:N-C},Ib-AMP1,Free,Free,Cyclic,L,None,20,Antimicrobial,no Hemolysis upto 100 µM (non-hemolytic),Rabbit,Synthetic peptide (Impatiens balsamina),NA,Non-hemolytic,CCTTCSSCCCSCCCCCCCCC,CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
1893,15949628,2005,EWGRRCCGWGPGRRYCRRWC,EWGRRCCGWGPGRRYCRRWC{cyc:N-C},Ib-AMP4,Free,Free,Cyclic,L,None,20,Antimicrobial,no Hemolysis upto 100 µM (non-hemolytic),Rabbit,Synthetic peptide (Impatiens balsamina),NA,Non-hemolytic,CCSCCCSSSCTTSTTTCSCC,N=C(N)NCCC[C@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
1906,16730857,2006,KFKQ,KFKQ{cyc:N-C},BPC4L,Free,Free,Cyclic,L,None,4,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1907,16730857,2006,KfKQ,KF{d}KQ{cyc:N-C},BPC4D,Free,Free,Cyclic,Mix,None,4,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1908,16730857,2006,KfKLKQ,KF{d}KLKQ{cyc:N-C},BPC6D,Free,Free,Cyclic,Mix,None,6,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
1909,16730857,2006,KLKLKLKE,KLKLKLKE{cyc:N-C},BPC8S2,Free,Free,Cyclic,L,None,8,Antibacterial,0% Hemolysis at 360 µM (non-hemolytic),Human,Synthetic peptide,NA,Non-hemolytic,CCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O
2004,21928440,2011,CGETCVGGTCNTPGCTCSWPVCTRNGLPV,CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,29,Anticancer and Anti-HIV,IC50 = 26 µM,Human,Kalata (Oldenlandia affinis),NA,NA,CCCGGGTTTSSCCCCCSSSCCCTTCSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
2005,21928440,2011,cgetcvggtcntpgctcswpvctrnglnpv,C{d}G{d}E{d}T{d}C{d}V{d}G{d}G{d}T{d}C{d}N{d}T{d}P{d}G{d}C{d}T{d}C{d}S{d}W{d}P{d}V{d}C{d}T{d}R{d}N{d}G{d}L{d}N{d}P{d}V{d}{cyc:N-C},D-Kalata B1,Free,Free,Cyclic,D,None,29,Anticancer and Anti-HIV,IC50 = 77 µM,Human,Kalata analog (Oldenlandia affinis),NA,NA,CCCSSSSCCCCCTTTTCCCCSSSSSCSCCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
2147,11892852,2001,FLPLLAGLAANFLPKIFCKITRKC,FLPLLAGLAANFLPKIFCKITRKC{cyc:N-C},Brevinin 1E (B),Free,Free,Cyclic,L,None,24,Antibacterial,100% Hemolysis at 0.7 µM,Rat,Brevinin 1E from the skin secretions of Rana esculenta,NA,NA,CCHHHHHHHHHHHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)[C@@H](C)CC
2149,11892852,2001,FLPLLAGLCKITRKCAANFLPKIF,FLPLLAGLCKITRKCAANFLPKIF{cyc:N-C},Analog of brevinin 1E (BA),Free,Free,Cyclic,L,None,24,Antibacterial,100% Hemolysis at 7 µM,Rat,Synthetic brevinin 1E variants (Rana esculenta),NA,NA,CCTTTSHHHHHHHHHTTCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
2271,12404639,2002,LRLKYRRFKYRV,LRLKYRRFKYRV{cyc:N-C},Mimetic 1,Free,Free,Cyclic,L,None,12,Antibacterial,27% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2272,12404639,2002,LRLQYRRFQYRV,LRLQYRRFQYRV{cyc:N-C},Mimetic 2,Free,Free,Cyclic,L,None,12,Antibacterial,27% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2273,12404639,2002,LRLEYRRFEYRV,LRLEYRRFEYRV{cyc:N-C},Mimetic 3,Free,Free,Cyclic,L,None,12,Antibacterial,14% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCTTCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2274,12404639,2002,LRLKKRRWKYRV,LRLKKRRWKYRV{cyc:N-C},Mimetic 4,Free,Free,Cyclic,L,None,12,Antibacterial,1% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCSCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2275,12404639,2002,LRLKKRRWKYRV,LRLKKRRWKYRV{cyc:N-C},Mimetic 5,Free,Free,Cyclic,L,None,12,Antibacterial,13% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCSCCSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2276,12404639,2002,LCLKKRRWKYCV,LCLKKRRWKYCV{cyc:N-C},Mimetic 6,Free,Free,Cyclic,L,None,12,Antibacterial,3% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)C(C)C
2277,12404639,2002,LRCKKRRWKCRV,LRCKKRRWKCRV{cyc:N-C},Mimetic 7,Free,Free,Cyclic,L,None,12,Antibacterial,1% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCBTTBCCSSCC,CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C
2281,12569105,2003,FFHLHFH-dcΔDOPA,FFHLHFH-{nnr:dcΔDOPA}{cyc:N-C},Plicatamide,Free,Free,Cyclic,L,"dcΔDOPA = decarboxy-(E)α,β-dehydro3,4-dihydroxyphenylalanine",8,Antibacterial,100% Hemolysis at ~40 µM,Human,Plicatamide (Styela plicata),NA,NA,NA,NA
2282,12569105,2003,FFHLHFH-dcΔDOPA,FFHLHFH-{nnr:dcΔDOPA}{cyc:N-C},Plicatamide,Free,Free,Cyclic,L,"dcΔDOPA = decarboxy-(E)α,β-dehydro3,4-dihydroxyphenylalanine",8,Antibacterial,~10% Hemolysis at 80 µM,Sheep,Plicatamide (Styela plicata),NA,NA,NA,NA
2286,12712499,2003,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,NA,NA
2287,12712499,2003,yPyP,Y{d}PY{d}P{cyc:N-C},GS4,Free,Free,Cyclic,Mix,None,4,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCC,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2288,12712499,2003,KyPKyP,KY{d}PKY{d}P{cyc:N-C},GS6,Free,Free,Cyclic,Mix,None,6,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2289,12712499,2003,VKyPKLyP,VKY{d}PKLY{d}P{cyc:N-C},GS8,Free,Free,Cyclic,Mix,None,8,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2290,12712499,2003,VKLyPVKLyP,VKLY{d}PVKLY{d}P{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antibacterial and Antifungal,100% Hemolysis at 51–100 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2291,12712499,2003,VKLKyPKVKLyP,VKLKY{d}PKVKLY{d}P{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCTTCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2292,12712499,2003,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2293,12712499,2003,vKLKVyPLKVKLyP,V{d}KLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2294,12712499,2003,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2295,12712499,2003,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2296,12712499,2003,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2297,12712499,2003,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2298,12712499,2003,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50µg/m,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2299,12712499,2003,VKLKVyplKVKLyP,VKLKVY{d}P{d}L{d}KVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2300,12712499,2003,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2301,12712499,2003,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 51–100 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2302,12712499,2003,VKLKVyPLKvKLyP,VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at <15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2303,12712499,2003,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2304,12712499,2003,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2305,12712499,2003,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2306,12712499,2003,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2307,12712499,2003,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14 K3L4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 100–150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2308,12712499,2003,LKLkLfPLKLKLfP,LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C},"GS14K4 Y2/F2, V3/L3",Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at < 15 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCCCCTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
2309,12712499,2003,LKLkLyPLKLKLyP,LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C},GS14K4 V3/L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CCBTTBSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2310,12712499,2003,VKLkVfPLKVKLfP,VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C},GS14K4 Y2/F2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 15-50 μg/ml,Human,Gramicidin S analogs,NA,NA,CBCTTTTCCBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2311,12712499,2003,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2312,12712499,2003,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C},GS14K4 V3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2313,12712499,2003,VKAkVyPAKVKAyP,VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C},GS14K4 L3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCSSSCSSCCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2314,12712499,2003,AKAkAyPAKAKAyP,AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C},GS14K4 V3L3/A6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at > 150 μg/ml,Human,Gramicidin S analogs,NA,NA,CCCCCCCTTCCCCC,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2373,15328096,2004,CVKVKVKVGSGVKVKVKVC,CVKVKVKVGSGVKVKVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V1,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 880000 nM,Human,Synthetic peptide,NA,NA,CCCCSSCCSSSSCCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2374,15328096,2004,CVKVSVKVGSGVKVSVKVC,CVKVSVKVGSGVKVSVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V2,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,"EC50 = 5,89,000 nM",Human,Synthetic peptide,NA,NA,CCCCCEECSSSEECCCSCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2375,15328096,2004,CVKVRVKVGSGVKVRVKVC,CVKVRVKVGSGVKVRVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V3,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 590000 nM,Human,Synthetic peptide,NA,NA,CCCCSSCCSSSSCCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2376,15328096,2004,CVKVQVKVGSGVKVQVKVC,CVKVQVKVGSGVKVQVKVC{cyc:N-C}{nt:Acet}{ct:Amid},V4,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 3226000 nM,Human,Synthetic peptide,NA,NA,CCCCSSSSSCCSCCCCCCC,CC(C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C)C(C)C
2377,15328096,2004,CAKAKAKAGSGAKAKAKAC,CAKAKAKAGSGAKAKAKAC{cyc:N-C}{nt:Acet}{ct:Amid},V5,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 1055000 nM,Human,Synthetic peptide,NA,NA,CBTTBCCCCSSCCCTTSCC,C[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O
2378,15328096,2004,CFKFKFKFGSGFKFKFKFC,CFKFKFKFGSGFKFKFKFC{cyc:N-C}{nt:Acet}{ct:Amid},V6,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 35000 nM,Human,Synthetic peptide,NA,NA,CCCTTSSSSSSSCCCCSCC,NCCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O
2379,15328096,2004,CWKWKWKWGSGWKWKWKWC,CWKWKWKWGSGWKWKWKWC{cyc:N-C}{nt:Acet}{ct:Amid},V7,Amidation,Acetylation,Cyclic,L,None,19,Antibacterial,EC50 = 45000 nM,Human,Synthetic peptide,NA,NA,CCCCGGGCCSSSSSCSSCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
2390,15345319,2004,TFRRLKWK,TFRRLKWK{cyc:N-C},LALF-10,Free,Free,Cyclic,L,None,8,Antimicrobial,~5% Hemolysis at 100 μg/ml,Human,Limulus analogs (Limulus polyphemus),NA,NA,CCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
2391,15345319,2004,TFRRLKWK,TFRRLKWK{cyc:N-C},LALF-11,Free,Free,Cyclic,L,None,8,Antimicrobial,~5% Hemolysis at 100 μg/ml,Human,Limulus analogs (Limulus polyphemus),NA,NA,CCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)O
2392,15345319,2004,KPTFRRLKWKYK,KPTFRRLKWKYK{cyc:N-C},LALF-14,Free,Free,Cyclic,L,None,12,Antimicrobial,~5% Hemolysis at 100 μg/ml,Human,Limulus analogs (Limulus polyphemus),NA,NA,CCSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O
2393,15345319,2004,HYRIKPTFRRLKWKYKGKFW,HYRIKPTFRRLKWKYKGKFW{cyc:N-C},LALf-22,Free,Free,Cyclic,L,None,20,Antimicrobial,~20% Hemolysis at 100 μg/ml,Human,Limulus analogs (Limulus polyphemus),NA,NA,CCCCSSSTTGGGGCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O
2413,11846794,2002,RLYRKVYG,RLYRKVYG{cyc:N-C},RLYRKVYG,Free,Free,Cyclic,L,None,17,Antibacterial and Antifungal,EC50 = 3950 µM,Human,Synthetic peptide,NA,NA,CCCCSSCC,CC(C)C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)O)C(C)C
2414,11846794,2002,RLYRKVYGRLYRKVYGK,RLYRKVYGRLYRKVYGK{cyc:N-C},(RLYRKVYG)2-[K],Free,Free,Cyclic,L,None,17,Antibacterial and Antifungal,EC50 = 1420 µM,Human,Synthetic peptide,NA,NA,CTHHHHHHHHGGGGSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
2415,11846794,2002,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKK,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKK{cyc:N-C},(RLYRKVYG)4-[K2K],Free,Free,Cyclic,L,None,35,Antibacterial and Antifungal,EC50 = 610 µM,Human,Synthetic peptide,NA,NA,CTHHHHHHHHHHHHTHHHHHHHHIIIIITHHHHHC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
2416,11846794,2002,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKKKK,RLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGRLYRKVYGKKKKK{cyc:N-C},(RLYRKVYG)8 (K2K)2K,Free,Free,Cyclic,L,None,63,Antibacterial and Antifungal,EC50 = 112 µM,Human,Synthetic peptide,NA,NA,CGGGGTTHHHHHHHHHHHGGGGHHHHHHHHHHHHHGGGGHHHHHHHTHHHHHHHHHHHTHHHHCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
2417,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{cyc:N-C}{ct:Amid},S1,Amidation,Free,Cyclic,L,None,12,Antibacterial,100% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2418,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{cyc:N-C}{ct:Amid},SC1,Amidation,Free,Cyclic,L,None,12,Antibacterial,100% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,CCSCTTTHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2419,10819172,2000,KLLLKLLLKLLK,KLLLKLLLKLLK{cyc:N-C}{ct:Amid},SC2,Amidation,Free,Cyclic,L,None,12,Antibacterial,~90% Hemolysis at 200 μg/ml,Mouse,Synthetic peptide,NA,NA,CCSCTTTHHHHC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O
2420,11606214,2001,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,Strong Hemolysis,Human,Gramicidin S,NA,NA,NA,NA
2421,11606214,2001,VKLyPVKLyP,VKLY{d}PVKLY{d}P{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antimicrobial,Strong Hemolysis,Human,Gramicidin S analogs,NA,NA,CCSSCCSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2422,11606214,2001,VKLKyPKVKLyP,VKLKY{d}PKVKLY{d}P{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antimicrobial,Weak Hemolysis,Human,Gramicidin S analogs,NA,NA,CCTTCSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2423,11606214,2001,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,Very strong Hemolysis,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2424,11606214,2001,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},[D-Lys]4GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,Weak Hemolysis,Human,Gramicidin S analogs,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2425,11682479,2002,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 1.5 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2426,11682479,2002,LKLkLfPLKLKLfP,LKLK{d}LF{d}PLKLKLF{d}P{cyc:N-C},"Y2/F2, V3/L3",Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 12.5 μg/ml,Human,Synthetic peptide,NA,NA,CTTCCCCTTSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O
2427,11682479,2002,LKLkLyPLKLKLyP,LKLK{d}LY{d}PLKLKLY{d}P{cyc:N-C},V3/L3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 25 μg/ml,Human,Synthetic peptide,NA,NA,CCBTTBSSCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2428,11682479,2002,VKLkVfPLKVKLfP,VKLK{d}VF{d}PLKVKLF{d}P{cyc:N-C},Y2/F2,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 40 μg/ml,Human,Synthetic peptide,NA,NA,CBCTTTTCCBCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2429,11682479,2002,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at 200 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2430,11682479,2002,AKLkAyPLKAKLyP,AKLK{d}AY{d}PLKAKLY{d}P{cyc:N-C},V3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,CCCCCCCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2431,11682479,2002,VKAkVyPAKVKAyP,VKAK{d}VY{d}PAKVKAY{d}P{cyc:N-C},L3/A3,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSCSSCCCCCC,CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2432,11682479,2002,AKAkAyPAKAKAyP,AKAK{d}AY{d}PAKAKAY{d}P{cyc:N-C},V3L3/A6,Free,Free,Cyclic,Mix,None,14,Antibacterial and Antifungal,100% Hemolysis at >800 μg/ml,Human,Synthetic peptide,NA,NA,NA,C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2453,10799508,2000,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCSCTTSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2454,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCSCTTSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2455,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,1% Hemolysis at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSSCTTTCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2456,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,8% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSSCTTTCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2457,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,3% Hemolysis at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSSSSSSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2458,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,37% Hemolysis at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCSSSSSSSSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2484,10747913,2000,CGETCVGGTCNTPGCTCSWPVCTRNGLPV,CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,29,Anti-HIV,50% hemolytic at 50 µM,Human,Macrocyclic peptides,NA,NA,CCCGGGTTTSSCCCCCSSSCCCTTCSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
2486,10799508,2000,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 10 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2487,10799508,2000,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 100 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2488,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,1% hemolytic at 10 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2489,10799508,2000,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,8% hemolytic at 100 μg/ml,Human,Synthetic peptide,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2490,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,3% hemolytic at 10 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2491,10799508,2000,VKKLVyPLKVKLyP,VKKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14K3L4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,37% hemolytic at 100 μg/ml,Human,Synthetic peptide,NA,NA,CCCSSCCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
2506,12931994,2003,RGGRLCYCRRRFCVCVGR,RGGRLCYCRRRFCVCVGR{cyc:N-C}{ct:Amid},Protegrin-I (2),Amidation,Free,Cyclic,L,None,18,Antimicrobial,37% hemolytic at 100 μg/ml,Human,Protegrin,NA,NA,CCSCCSCCCCCSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
2507,12931994,2003,LRLKKRRWKYRVp,LRLKKRRWKYRVP{d}{cyc:N-C},5,Free,Free,Cyclic,Mix,None,13,Antimicrobial,1.4% hemolytic at 100 μg/ml,Human,Protegrin,NA,NA,CCSCCCCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C
2532,10821683,2000,CKLLLKWLLKLLKC,CKLLLKWLLKLLKC{cyc:N-C},Cyclic-K4L7W,Free,Free,Cyclic,L,None,14,Cytolytic,50% hemolytic at 50 µM,Human,Synthetic peptide,NA,NA,CTTHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
2534,10821683,2000,cklllkwllkllkc,C{d}K{d}L{d}L{d}L{d}K{d}W{d}L{d}L{d}K{d}L{d}L{d}K{d}C{d}{cyc:N-C},"cyclic-[D]-L3,4,8,10-K4L7W",Free,Free,Cyclic,D,None,14,Cytolytic,90% hemolytic at 50 µM,Human,Synthetic peptide,NA,NA,CTTHHHHHHHHTTC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
2551,10224074,1999,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,NA,NA
2552,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 1.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2553,10224074,1999,VKLKVyPLKvKLyP,VKLKVY{d}PLKV{d}KLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 6.2 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2554,10224074,1999,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2555,10224074,1999,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 6.2 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2556,10224074,1999,VKLKVypLKVKLyP,VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2557,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 40 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2558,10224074,1999,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 25 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2559,10224074,1999,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 150 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2560,10224074,1999,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 12.5 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2561,10224074,1999,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 50 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2562,10224074,1999,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 25 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2563,10224074,1999,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 50 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2564,10224074,1999,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 100 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2565,10224074,1999,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 200 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2566,10224074,1999,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at 150 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2567,10224074,1999,VkLkVyPLKVKLyP,VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K2K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at >200 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2568,10224074,1999,VkLkVyPLkVkLyP,VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C},GS14K2K4K9K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial and Hemolytic,100% hemolytic at >200 μg/ml,Human,Derivative of Gramicidin S,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
2695,22249992,2012,NWCKRGRKQCKTHPH,NWCKRGRKQCKTHPH{cyc:N-C},NWC15c,Free,Free,Cyclic,L,None,15,Antimicrobial,~2% hemolytic at 6 µM,Human,ß-amyloid precursor protein derivative (Homo sapien),NA,NA,CCSTTTTTTCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
2696,22249992,2012,NWCKRGRKQCKTHPH,NWCKRGRKQCKTHPH{cyc:N-C},NWC15c,Free,Free,Cyclic,L,None,15,Antimicrobial,~3% hemolytic at 60 µM,Human,ß-amyloid precursor protein derivative (Homo sapien),NA,NA,CCSTTTTTTCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
2697,22249992,2012,NWCKRGRKQCKTHPHFVIPY,NWCKRGRKQCKTHPHFVIPY{cyc:N-C},NWC20c,Free,Free,Cyclic,L,None,20,Antimicrobial,~4% hemolytic at 6 µM,Human,ß-amyloid precursor protein derivative (Homo sapien),NA,NA,CCSSCSTTTSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
2698,22249992,2012,NWCKRGRKQCKTHPHFVIPY,NWCKRGRKQCKTHPHFVIPY{cyc:N-C},NWC20c,Free,Free,Cyclic,L,None,20,Antimicrobial,~3% hemolytic at 60 µM,Human,ß-amyloid precursor protein derivative (Homo sapien),NA,NA,CCSSCSTTTSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O
2736,22038181,2012,GLPRKILCAIAKKKGKCKGPLKLVCKC,GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C},Lasiocepsin,Free,Free,Cyclic,L,None,27,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCTTSCCGGGGSCCCSSCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2737,22038181,2012,GLPRKILCAIAKKKGKCKGPLKLVCKC,GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C}{ct:Amid},Lasiocepsin-NH2,Amidation,Free,Cyclic,L,None,27,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCTTSCCGGGGSCCCSSCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2738,22038181,2012,GLPRKILCAIAKKKGKCKGPLKLVCKC,GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C},"Las[C8-C27, C17-C25]",Free,Free,Cyclic,L,None,27,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCTTSCCGGGGSCCCSSCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2739,22038181,2012,GLPRKILCAIAKKKGKCKGPLKLVCKC,GLPRKILCAIAKKKGKCKGPLKLVCKC{cyc:N-C},"Las[C8-C17, C25-C27]",Free,Free,Cyclic,L,None,27,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCTTSCCGGGGSCCCSSCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2740,22038181,2012,GLPRKILCAIAKKKGKAKGPLKLVCKA,GLPRKILCAIAKKKGKAKGPLKLVCKA{cyc:N-C},"Las[C8-C25, Ala17,27]",Free,Free,Cyclic,L,None,27,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCTTCCCHHHHTTCCCCCCSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C
2741,22038181,2012,GLPRKILAAIAKKKGKCKGPLKLVAKC,GLPRKILAAIAKKKGKCKGPLKLVAKC{cyc:N-C},"Las[C17-C27, Ala8,25]",Free,Free,Cyclic,L,None,27,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2743,22038181,2012,LCAIAKKKGKCKGPLKLVCKC,LCAIAKKKGKCKGPLKLVCKC{cyc:N-C}{ct:Amid},Las[des1-6]-NH2,Amidation,Free,Cyclic,L,None,21,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCTTTTSCCSSCCSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2744,22038181,2012,AKKKGKCKGPLKLVAKC,AKKKGKCKGPLKLVAKC{cyc:N-C}{ct:Amid},"Las[des1-10, Ala25]-NH2",Amidation,Free,Cyclic,L,None,17,Antimicrobial,<1% hemolytic at 200 µM,Human,"Lasiocepsin analogs (From venom of eusocial bee, Lasioglossum laticeps)",NA,NA,CCSTTTTCCSCCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
2791,20848624,2010,fPVOLfPVOL,F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,HC50 = 17.5±1.07 µM,Human,Gramicidin S,NA,NA,NA,NA
2792,20848624,2010,fPVOLfP-Ada-GOL,F{d}PV{nnr:O}LF{d}P-{nnr:Ada}-G{nnr:O}L{cyc:N-C},GS2,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 10.1±1.11 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2793,20848624,2010,fPVOLfPVO-Ada-A,F{d}PV{nnr:O}LF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C},GS4,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 5.20±1.13 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2794,20848624,2010,fPVO-Ada-AfPVO-Ada-A,F{d}PV{nnr:O}-{nnr:Ada}-AF{d}PV{nnr:O}-{nnr:Ada}-A{cyc:N-C},GS5,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 10.3±1.07 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2795,20848624,2010,fP-Ada-GO-Ada-AfP-Ada-GO-Ada-A,F{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-AF{d}P-{nnr:Ada}-G{nnr:O}-{nnr:Ada}-A{cyc:N-C},GS6,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 7.55±1.10 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2796,20848624,2010,FP-tBuGly-O-tBuAla-fP-tBuGly-O-tBuAla,FP-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}-F{d}P-{nnr:tBuGly}-{nnr:O}-{nnr:tBuAla}{cyc:N-C},GS7,Free,Free,Cyclic,Mix,"O = L-Ornithine, tBuGly = tert-butylglycine, tBuAla = tert-butylalanine",10,Antimicrobial,HC50 = 9.30±1.07 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2797,20848624,2010,fP-Chg-O-Cha-fP-Chg-O-Cha,F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}-F{d}P-{nnr:Chg}-{nnr:O}-{nnr:Cha}{cyc:N-C},GS8,Free,Free,Cyclic,Mix,"O = L-Ornithine, Chg = Cyclohexylglycine, Cha = Cyclohexylalanine",10,Antimicrobial,HC50 = 9.12±1.13 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2798,20848624,2010,fPOVO,F{d}P{nnr:O}V{nnr:O}{cyc:N-C},GS9,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antimicrobial,Non-hemolytic,Human,Gramicidin S analogue,NA,NA,NA,NA
2799,20848624,2010,fPO-AdaGly-OfPO-Ada-Gly-O,F{d}P{nnr:O}-{nnr:Ada}Gly-{nnr:O}F{d}P{nnr:O}-{nnr:Ada}-Gly-{nnr:O}{cyc:N-C},GS10,Free,Free,Cyclic,Mix,"O = L-Ornithine, Ada = Adamantylglycine",10,Antimicrobial,HC50 = 107±1.07 µM,Human,Gramicidin S analogue,NA,NA,NA,NA
2960,21820306,2011,tle-K-tle-A-tle-A-tle-A,{nnr:tle}-K-{nnr:tle}-A-{nnr:tle}-A-{nnr:tle}-A{cyc:N-C},A,Free,Free,Cyclic,Mix,tle = D-Tert-leucine,8,Antimicrobial,HC50 = 17 µM,Human,Synthetic peptides,NA,NA,NA,NA
2961,21820306,2011,Tle-k-Tle-a-Tle-a-Tle-a,{nnr:Tle}-K{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}{cyc:N-C},B,Free,Free,Cyclic,Mix,Tle = Tert-leucine,8,Antimicrobial,HC50 = 17 µM,Human,Synthetic peptides,NA,NA,NA,NA
2962,21820306,2011,tle-k-tle-A-tle-A-tle-A,{nnr:tle}-K{d}-{nnr:tle}-A-{nnr:tle}-A-{nnr:tle}-A{cyc:N-C},C,Free,Free,Cyclic,Mix,tle = D-Tert-leucine,8,Antimicrobial,HC50 = 316 µM,Human,Synthetic peptides,NA,NA,NA,NA
2963,21820306,2011,Tle-K-Tle-a-Tle-a-Tle-a,{nnr:Tle}-K-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}-{nnr:Tle}-A{d}{cyc:N-C},D,Free,Free,Cyclic,Mix,Tle = Tert-leucine,8,Antimicrobial,HC50 = 316 µM,Human,Synthetic peptides,NA,NA,NA,NA
2982,22040603,2011,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C},Crp4-1,Free,Free,Cyclic,L,None,32,Antimicrobial,4.2% hemolytic at 0 μg/ml,Human,Synthetic peptide of Crp4,NA,NA,CCCSSSCCCCCCCCCCCCCCCSCCCTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2983,22040603,2011,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C},Crp4-1,Free,Free,Cyclic,L,None,32,Antimicrobial,5.4% hemolytic at 12.5 μg/ml,Human,Synthetic peptide of Crp4,NA,NA,CCCSSSCCCCCCCCCCCCCCCSCCCTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2984,22040603,2011,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C},Crp4-1,Free,Free,Cyclic,L,None,32,Antimicrobial,5.8% hemolytic at 25 μg/ml,Human,Synthetic peptide of Crp4,NA,NA,CCCSSSCCCCCCCCCCCCCCCSCCCTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2985,22040603,2011,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C},Crp4-1,Free,Free,Cyclic,L,None,32,Antimicrobial,5.9% hemolytic at 50 μg/ml,Human,Synthetic peptide of Crp4,NA,NA,CCCSSSCCCCCCCCCCCCCCCSCCCTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
2986,22040603,2011,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL,CYCRKGHCKRGERVRGTCGIRFLYCCPRRGLL{cyc:N-C},Crp4-1,Free,Free,Cyclic,L,None,32,Antimicrobial,4.9% hemolytic at 100 μ g/mL,Human,Synthetic peptide of Crp4,NA,NA,CCCSSSCCCCCCCCCCCCCCCSCCCTTSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O
3002,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},kB1,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,41.2 ±1.5% hemolytic at 25 µM,Human,Kalata B1 (Oldenlandia affinis),NA,NA,CCCCCSSHHHHCCCCCSSCCCCSSCCSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3003,21576247,2011,GLPKCGETCVGGTCNTPGCTCSWPVCTRN,GLPKCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},V4K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,2.9±0.5% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCCCSSSSSSCCCCCCCCCSSSCCTTSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O
3004,21576247,2011,GLPVCGDTCVGGTCNTPGCTCSWPVCTRN,GLPVCGDTCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},E7D,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,3.8±0.4% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCCCCCCTTTGGGSCSCCTTSCCCCCSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3005,21576247,2011,GLPVCGEKCVGGTCNTPGCTCSWPVCTRN,GLPVCGEKCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},T8K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,3.4±0.7% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCSSSSCCSSSTTSCCSSSSSCCCTTSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(C)C
3006,21576247,2011,GLPVCGETCKGGTCNTPGCTCSWPVCTRN,GLPVCGETCKGGTCNTPGCTCSWPVCTRN{cyc:N-C},V10K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,0±1.7% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,Non-hemolytic,CCSSSSSSSCSSSCCCSSCSSCSGGGTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C
3007,21576247,2011,GLPVCGETCVGGTCKTPGCTCSWPVCTRN,GLPVCGETCVGGTCKTPGCTCSWPVCTRN{cyc:N-C},N15K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,2.1±0.4% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCBSSSBSSSSBSCCCSCCCSCCCSSSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3008,21576247,2011,GLPVCGETCVGGTCNKPGCTCSWPVCTRN,GLPVCGETCVGGTCNKPGCTCSWPVCTRN{cyc:N-C},T16K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,4.3±0.1% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCSSTTSCSHHHHSSSTTCSCCCCGGGGC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3009,21576247,2011,GLPVCGETCVGGTCNTPGCKCSWPVCTRN,GLPVCGETCVGGTCNTPGCKCSWPVCTRN{cyc:N-C},T20K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,51.3±1.6% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCCCCSCTTTTTTCCCSSCCCCCTTCSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3010,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPKCTRN,GLPVCGETCVGGTCNTPGCTCSWPKCTRN{cyc:N-C},V25K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,1.1±1.0% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCSSCSCTTTTTTSCCCCCSSCCSSCCCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3011,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTRK,GLPVCGETCVGGTCNTPGCTCSWPVCTRK{cyc:N-C},N29K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,54.5±0.9% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCSSTTSCSHHHHSCCSCCCCSCSSSSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3012,21576247,2011,GLPVCGETCVGGTCNTPGCTCSKPVCTRN,GLPVCGETCVGGTCNTPGCTCSKPVCTRN{cyc:N-C},W23K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,2.4±0.7% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCSCSSSTTCCCCCSCSSCCSCCCCCCCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3013,21576247,2011,GLPVCGETCVGGTCNTPGCNCSWPVCTRK,GLPVCGETCVGGTCNTPGCNCSWPVCTRK{cyc:N-C},T20N29K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,64.4±2.2% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CBCCSSCTTTBCCCCSTTCCCCSSSTTCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3014,21576247,2011,GLPVCGETCVGGTCNTPGCTCSWPVCTKN,GLPVCGETCVGGTCNTPGCTCSWPVCTKN{cyc:N-C},R28K,Free,Free,Cyclic,L,None,29,Hemolytic and Anti-HIV,12.0±1.8% hemolytic at 25 µM,Human,kalata B1 analog (Oldenlandia affinis),NA,NA,CCCCCCCTTCSSCCCCSSCSSCCSSSCCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3026,19038369,2009,ILPWKWPWWPWRR,ILPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID,Amidation,Free,Cyclic,L,None,13,Antimicrobial,5-10% Hemolysis at 25 μg/ml,Human,Cytoplasmic granules of bovine neutrophils,NA,NA,NA,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3027,19038369,2009,I*LPWKWPWWPWRR,I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID-I,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,5-10% Hemolysis at 25 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3028,19038369,2009,ILPWKWPW*WPWRR,ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-W,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,5-10% Hemolysis at 25 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3029,19038369,2009,I*LPWKWPW*WPWRR,I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-IW,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,5% Hemolysis at 25 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3030,19038369,2009,ILPWKWPWWPWRR,ILPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID,Amidation,Free,Cyclic,L,None,13,Antimicrobial,10% Hemolysis at 50 μg/ml,Human,Cytoplasmic granules of bovine neutrophils,NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3031,19038369,2009,I*LPWKWPWWPWRR,I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID-I,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,10% Hemolysis at 50 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3032,19038369,2009,ILPWKWPW*WPWRR,ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-W,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,10% Hemolysis at 50 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3033,19038369,2009,I*LPWKWPW*WPWRR,I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-IW,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,5% Hemolysis at 50 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3034,19038369,2009,ILPWKWPWWPWRR,ILPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID,Amidation,Free,Cyclic,L,None,13,Antimicrobial,10% Hemolysis at 100 μg/ml,Human,Cytoplasmic granules of bovine neutrophils,NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3035,19038369,2009,I*LPWKWPWWPWRR,I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID-I,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,10-15% Hemolysis at 100 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3036,19038369,2009,ILPWKWPW*WPWRR,ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-W,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,10-15% Hemolysis at 100 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3037,19038369,2009,I*LPWKWPW*WPWRR,I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-IW,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,10% Hemolysis at 100 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3038,19038369,2009,ILPWKWPWWPWRR,ILPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID,Amidation,Free,Cyclic,L,None,13,Antimicrobial,30% Hemolysis at 200 μg/ml,Human,Cytoplasmic granules of bovine neutrophils,NA,NA,CCCCCCSSCSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3039,19038369,2009,I*LPWKWPWWPWRR,I{nnr:*}LPWKWPWWPWRR{cyc:N-C}{ct:Amid},ID-I,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,30% Hemolysis at 200 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3040,19038369,2009,ILPWKWPW*WPWRR,ILPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-W,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,30% Hemolysis at 200 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3041,19038369,2009,I*LPWKWPW*WPWRR,I{nnr:*}LPWKWPW{nnr:*}WPWRR{cyc:N-C}{ct:Amid},ID-IW,Amidation,Free,Cyclic,L,* = Reduced amide bond ψCH2NH,13,Antimicrobial,~10% Hemolysis at 200 μg/ml,Human,Indolicidin analog,NA,NA,NA,NA
3043,19961432,2010,SVSNAATRVCRTGRSRWRDVCRNFMR,SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C},Gr-1C(25-50),Free,Free,Cyclic,L,None,26,Antimicrobial,20-30% Hemolysis at 50 µM,Human,Derivative of granulysin (Synthetic peptide),NA,NA,CCCSSSSSCSCCCSSSSGGGHHHHCC,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3047,19961432,2010,SVSNAATRVCRTGRSRWRDVCRNFMR,SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C},Gr-1C(25-50),Free,Free,Cyclic,L,None,26,Antimicrobial,40-50% Hemolysis at 100 µM,Human,Derivative of granulysin (Synthetic peptide),NA,NA,CCCSSSSSCSCCCSSSSGGGHHHHCC,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3051,19961432,2010,SVSNAATRVCRTGRSRWRDVCRNFMR,SVSNAATRVCRTGRSRWRDVCRNFMR{cyc:N-C},Gr-1C(25-50),Free,Free,Cyclic,L,None,26,Antimicrobial,70% Hemolysis at 200 µM,Human,Derivative of granulysin (Synthetic peptide),NA,NA,CCCSSSSSCSCCCSSSSGGGHHHHCC,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
3134,21664395,2011,WCPPMIPLCSRF,WCPPMIPLCSRF{cyc:N-C}{ct:Amid},Tigerinin-M1,Amidation,Free,Cyclic,L,None,12,Antibacterial,LC50 >500 µM,Human,Derived from skin secretions of Xenopus muelleri,NA,NA,CCCCCCSCSTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
3150,21682682,2011,CVDIHVWDGVC,CVDIHVWDGVC{cyc:N-C},Cyclic C-PIP[59-67]C,Free,Free,Cyclic,L,None,11,Cytotoxic,7.2% Hemolysis at 100 µM,Human,synthetic peptide,NA,NA,CCCSCCCTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
3161,22943778,2012,FLPFLLSALPKVFCFFSKKC,FLPFLLSALPKVFCFFSKKC{cyc:N-C},Brevinin-1ZHa,Free,Free,Cyclic,L,None,20,Antimicrobial,HC50 = 3 µM,Human,Derived from skin of Rana zhenhaiensis,NA,NA,CCCTTTCSSCCSCCCSSCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
3162,22943778,2012,FLPLLLASLPSFLCLVFKKC,FLPLLLASLPSFLCLVFKKC{cyc:N-C},Brevinin-1ZHb,Free,Free,Cyclic,L,None,20,Antimicrobial,HC50 = 5 µM,Human,Derived from skin of Rana zhenhaiensis,NA,NA,CHHHHHHHTTTTTSSGGGCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O)C(C)C
3163,22943778,2012,GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC,GIMRVFKGVLKTAGKSVAKNVAGSFLDRLKCKISGGC{cyc:N-C},Brevinin-2ZHa,Free,Free,Cyclic,L,None,37,Antimicrobial,HC50 = 52 µM,Human,Derived from skin of Rana zhenhaiensis,NA,NA,CTHHHHHHHHHHHCHHHHHHHIIIIIHHHGGGCSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(C)C
3396,10430870,1999,CTCSWPVCTRNGLPVCGETCVGGTCNTPG,CTCSWPVCTRNGLPVCGETCVGGTCNTPG{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,29,Antimicrobial,50% Hemolysis at >400 µM,Human,Kalata (Oldenlandia affinis),NA,NA,NA,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
3397,10430870,1999,CSCKNKVCYRNGIPCGESCVWIPCISAALG,CSCKNKVCYRNGIPCGESCVWIPCISAALG{cyc:N-C},Cir A,Free,Free,Cyclic,L,None,30,Antimicrobial,50% Hemolysis at >400 µM,Human,Circulin A (Chassalia parvifolia),NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O
3398,10430870,1999,CSCKNKVCYRNGVIPCGESCVFIPCISTLLG,CSCKNKVCYRNGVIPCGESCVFIPCISTLLG{cyc:N-C},Cir B,Free,Free,Cyclic,L,None,30,Antimicrobial,50% Hemolysis at >400 µM,Human,Circulin B (Chassalia parvifolia),NA,NA,CCCCCCCSSSSSSSCSSCCSSCCCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)C(C)C)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@@H](C)O
3399,10430870,1999,CSCKSKVCYKNSIPCGESCVFIPCTVTALLG,CSCKSKVCYKNSIPCGESCVFIPCTVTALLG{cyc:N-C},CPT,Free,Free,Cyclic,L,None,30,Antimicrobial,50% Hemolysis at >400 µM,Human,Cyclopsychotride (Psychotria longipes),NA,NA,CCSSSSSSSSSSSCSSSCCCCCSSSSHHHHC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C
3455,10604598,1999,CKLLKTFLSKWIC,CKLLKTFLSKWIC{cyc:N-C},SC,Free,Free,Cyclic,L,None,13,Antibacterial,100% Hemolysis at 40 μg/ml,Rat,Synthetic peptide,NA,NA,CCHHHHTGGGTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
3456,10604598,1999,CKLLKTFLSKWIC,CKLLKTFLSKWIC{cyc:N-C}{ct:Amid},SAC,Amidation,Free,Cyclic,L,None,13,Antibacterial,100% Hemolysis at 5 μg/ml,Rat,Synthetic peptide,NA,NA,CCHHHHTGGGTTC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
3607,22074926,2012,CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP,CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP{cyc:N-C},Parigidin_br1,Free,Free,Cyclic,L,None,32,Antimicrobial,41% Hemolysis at 40 µM,Human,Parigidinbr1 (Palicourea rigida),NA,NA,CCCCCCCCSSSSSSSSSCCCCCCCCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)[C@@H](C)O
3608,22074926,2012,CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP,CGESCVFIPCITSLAGCSCKNKVCYYDGGSVP{cyc:N-C},Parigidin_br1,Free,Free,Cyclic,L,None,32,Antimicrobial,28% Hemolysis at 20 µM,Human,Parigidinbr1 (Palicourea rigida),NA,NA,CCCCCCCCSSSSSSSSSCCCCCCCCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)[C@@H](C)O
3638,17764786,2007,SIITMTKEAKLPQLWKQIACRLYNTC,SIITMTKEAKLPQLWKQIACRLYNTC{cyc:N-C},Pleurain-A1,Free,Free,Cyclic,L,None,26,Antimicrobial,Little Hemolysis at 200mg/ml,Human,Derived from skin secretion of Rana pleuraden,NA,NA,CCSSTTSSSSCHHHHHHHTTTTSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
3639,17764786,2007,SIITMTKEAKLPQSWKQIACRLYNTC,SIITMTKEAKLPQSWKQIACRLYNTC{cyc:N-C},Pleurain-A2,Free,Free,Cyclic,L,None,26,Antimicrobial,Little Hemolysis at 200mg/ml,Human,Derived from skin secretion of Rana pleuraden,NA,NA,CCCCTTSCSCCCCCHHHHGGGTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
3640,17764786,2007,SIITMTREAKLPQLWKQIACRLYNTC,SIITMTREAKLPQLWKQIACRLYNTC{cyc:N-C},Pleurain-A3,Free,Free,Cyclic,L,None,26,Antimicrobial,Little Hemolysis at 200mg/ml,Human,Derived from skin secretion of Rana pleuraden,NA,NA,CCTTTTSCSSCHHHHHHHHHTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
3641,17764786,2007,SIITTTKEAKLPQLWKQIACRLYNTC,SIITTTKEAKLPQLWKQIACRLYNTC{cyc:N-C},Pleurain-A4,Free,Free,Cyclic,L,None,26,Antimicrobial,Little Hemolysis at 200mg/ml,Human,Derived from skin secretion of Rana pleuraden,NA,NA,CCCCTTCCSSCHHHHHHHHHTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
3662,8810288,1996,fPVOLfPVOL,F{d}PV{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,O = L-Ornithine,10,Antibacterial,100% Hemolysis at 39 μg/ml,Human,Gramicidin S (Bacillus brevis),NA,NA,NA,NA
3663,8810288,1996,yPyP,Y{d}PY{d}P{cyc:N-C},GS4,Free,Free,Cyclic,Mix,None,4,Antibacterial,100% Hemolysis at >800 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCC,N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
3664,8810288,1996,yPKyPK,Y{d}PKY{d}PK{cyc:N-C},GS6,Free,Free,Cyclic,Mix,None,6,Antibacterial,100% Hemolysis at >1600 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O
3665,8810288,1996,yPVKyPKL,Y{d}PVKY{d}PKL{cyc:N-C},GS8,Free,Free,Cyclic,Mix,None,8,Antibacterial,100% Hemolysis at >1600 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCSSCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)O
3666,8810288,1996,yPVKLyPVKL,Y{d}PVKLY{d}PVKL{cyc:N-C},GS10,Free,Free,Cyclic,Mix,None,10,Antibacterial,100% Hemolysis at 67 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCSSCCSTTC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
3667,8810288,1996,yPVKLKyPKVKL,Y{d}PVKLKY{d}PKVKL{cyc:N-C},GS12,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 250 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCGGGCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(=O)O
3668,8810288,1996,yPVKLKVyPLKVKL,Y{d}PVKLKVY{d}PLKVKL{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antibacterial,100% Hemolysis at 6 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCCGGGSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(C)C)C(C)C)C(=O)O
3669,8810288,1996,yPLKVKyPKLKV,Y{d}PLKVKY{d}PKLKV{cyc:N-C},GS12LV,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 92 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCCCCCSCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)C(C)C
3670,8810288,1996,fPVKLKfPKVKL,F{d}PVKLKF{d}PKVKL{cyc:N-C},GS12F,Free,Free,Cyclic,Mix,None,12,Antibacterial,100% Hemolysis at 400 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,CCCSSSCTTCCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
3671,8810288,1996,fPVOLOfPOVOL,F{d}PV{nnr:O}L{nnr:O}F{d}P{nnr:O}V{nnr:O}L{cyc:N-C},GS12FO,Free,Free,Cyclic,Mix,O = L-Ornithine,12,Antibacterial,100% Hemolysis at 160 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,NA,NA
3672,8810288,1996,fPLOLOfPOLOL,F{d}PL{nnr:O}L{nnr:O}F{d}P{nnr:O}L{nnr:O}L{cyc:N-C},GS12FO/LL,Free,Free,Cyclic,Mix,O = L-Ornithine,12,Antibacterial,100% Hemolysis at 170 μg/ml,Human,Gramicidin S analog (Bacillus brevis),NA,NA,NA,NA
3695,19540868,2009,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC{cyc:N-C},Bactridine 1,Free,Free,Cyclic,L,None,61,Antibacterial,0.2% Hemolysis at 90 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSSSCCCCCCCCSCSTTSSCCSTTTTTTTTTTCSCCCTTTSCCSCCCCSSCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
3696,19540868,2009,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC,KDGYIIEHRGCKYSCFFGTNSWCNTECTLKKGSSGYCAWPACWCYGLPDNVKIFDSNNLKC{cyc:N-C},Bactridine 1,Free,Free,Cyclic,L,None,61,Antibacterial,1.0% Hemolysis at 180 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSSSCCCCCCCCSCSTTSSCCSTTTTTTTTTTCSCCCTTTSCCSCCCCSSCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
3697,19540868,2009,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR{cyc:N-C},Bactridine 2,Free,Free,Cyclic,L,None,64,Antibacterial,7.6% Hemolysis at 90 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSCCSSSCSSSCCSCSSSSCCCHHHHHHCCCCCSCCCSCGGGCCCCSCCTTSCCCCCCCCTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
3698,19540868,2009,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR,KDGYLVGNDGCKYSCFTRPGTYCANECSRVKGKDGYCYAWMACYCYSMPNWVKTWNRATNRCGR{cyc:N-C},Bactridine 2,Free,Free,Cyclic,L,None,64,Antibacterial,21.0% Hemolysis at 180 µM,Human,Derived from venom of Tityus discrepans,NA,NA,CCSCCSSSCSSSCCSCSSSSCCCHHHHHHCCCCCSCCCSCGGGCCCCSCCTTSCCCCCCCCTTC,CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C
3770,14636071,2003,GALRGCWTKSYPPKPCK,GALRGCWTKSYPPKPCK{cyc:N-C}{ct:Amid},Ranacyclin T,Amidation,Free,Cyclic,L,None,17,Antimicrobial,20% Hemolysis at 100 µM,Human,Derived from skin secretion of Rana temporaria,NA,NA,CCCCSSTTSCSCSSCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)CN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
3771,14636071,2003,SAPRGCWTKSYPPKPCK,SAPRGCWTKSYPPKPCK{cyc:N-C}{ct:Amid},Ranacyclin E,Amidation,Free,Cyclic,L,None,17,Antimicrobial,55% Hemolysis at 100 µM,Human,Derived from skin secretion of Rana esculenta,NA,NA,CCSCCSCCCCCCSSCCC,C[C@H](NC(=O)[C@@H](N)CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
3772,14636071,2003,LVRGCWTKSYPPKPCFVR,LVRGCWTKSYPPKPCFVR{cyc:N-C},pLR,Free,Free,Cyclic,L,None,18,Antimicrobial,85% Hemolysis at 100 µM,Human,Derived from skin of Rana pipiens,NA,NA,CTTSSCSSSSSSSCSCCC,CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)O)C(C)C
3845,10224074,1999,VOLfPVOLfP,VOLF{d}PVOLF{d}P{cyc:N-C},GS,Free,Free,Cyclic,Mix,None,10,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
3846,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 1.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3847,10224074,1999,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14V10,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 6.2 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3848,10224074,1999,VKlKVyPLKVKLyP,VKL{d}KVY{d}PLKVKLY{d}P{cyc:N-C},GS14L3,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3849,10224074,1999,VKLKVyPLKVKLyp,VKLKVY{d}PLKVKLY{d}P{d}{cyc:N-C},GS14P14,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 6.2 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3850,10224074,1999,VKLKVypLKVKLyP,VKLKVY{d}P{d}LKVKLY{d}P{cyc:N-C},GS14P7,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3851,10224074,1999,vKLKVYPLKVKLyP,V{d}KLKVYPLKVKLY{d}P{cyc:N-C},GS14V1,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 40 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3852,10224074,1999,VKLKVyPLKVKlyP,VKLKVY{d}PLKVKL{d}Y{d}P{cyc:N-C},GS14L12,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 25 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3853,10224074,1999,VKLKvyPLKVKLyP,VKLKV{d}Y{d}PLKVKLY{d}P{cyc:N-C},GS14V5,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 150 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3854,10224074,1999,VKLKVyPLKVKLYP,VKLKVY{d}PLKVKLYP{cyc:N-C},GS14Y13,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 12.5 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3855,10224074,1999,VKLKVyPlKVKLyP,VKLKVY{d}PL{d}KVKLY{d}P{cyc:N-C},GS14L8,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 50 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3856,10224074,1999,VKLKVYPLKVKLyP,VKLKVYPLKVKLY{d}P{cyc:N-C},GS14Y6,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 25 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3857,10224074,1999,VkLKVyPLKVKLyP,VK{d}LKVY{d}PLKVKLY{d}P{cyc:N-C},GS14K2,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 50 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3858,10224074,1999,VKLKVyPLkVKLyP,VKLKVY{d}PLK{d}VKLY{d}P{cyc:N-C},GS14K9,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 100 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3859,10224074,1999,VKLkVyPLKVKLyP,VKLK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 200 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3860,10224074,1999,VKLKVyPLKVkLyP,VKLKVY{d}PLKVK{d}LY{d}P{cyc:N-C},GS14K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at 150 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3861,10224074,1999,VkLkVyPLKVKLyP,VK{d}LK{d}VY{d}PLKVKLY{d}P{cyc:N-C},GS14K2K4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at >200 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3862,10224074,1999,VkLkVyPLkVkLyP,VK{d}LK{d}VY{d}PLK{d}VK{d}LY{d}P{cyc:N-C},GS14K2K4K9K11,Free,Free,Cyclic,Mix,None,14,Antimicrobial,100% Hemolysis at >200 μg/ml,Human,Synthetic Peptide,NA,NA,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
3889,11318033,2001,QlLVDlI,QL{d}LVDL{d}I{cyc:N-C},Lichenysin,Free,Free,Cyclic,Mix,None,7,Chelating agent,100% Hemolysis at 15 µM,Human,Bacillus licheniformis,NA,NA,CCSGGGC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(N)=O)C(C)C)C(=O)O
3995,16441062,2005,CAESCVWIPCTVTALLGCSCSNNVCYNGIP,CAESCVWIPCTVTALLGCSCSNNVCYNGIP{cyc:N-C},Cycloviolacin H4,Free,Free,Cyclic,L,None,30,"HIV inhibitory, Antimicrobial, Cytotoxic, Neurotensin antagonistic, Trypsin inhibitory, Insecticide",HD50 = 5.5 µM,Human,Viola hederaceae,NA,NA,CCSSSSCCGGGGGTSBTTBCCCCCSSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)O
3996,16488428,2006,SAISCGETCFKFKCYTPRCSCSYPVCK,SAISCGETCFKFKCYTPRCSCSYPVCK{cyc:N-C},Violacin A,Free,Free,Cyclic,L,None,27,"Uterotonic, Insecticidal, Anti-HIV, Antimicrobial, Anti-neurotensive, Cytotoxic and Hemolytic",30% Hemolysis at 1.5 µM,Human,Synthetic Peptide,NA,NA,CCSCCCSTTCCCTTCCSCCSCSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O
3997,10600388,1999,CAESCVYIPCTVTALLGCSCSNRVCYNGIP,CAESCVYIPCTVTALLGCSCSNRVCYNGIP{cyc:N-C},Cycloviolacin O1,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCSSCCCCTHHHHCSSCCGGGSSCCSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)O
3998,10600388,1999,CGESCVWIPCISSAIGCSCKSKVCYRNGIP,CGESCVWIPCISSAIGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O2,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCSSSCSTTCSSSCSSSSSSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C
3999,10600388,1999,CGESCVWIPCLTSAIGCSCKSKVCYRNGIP,CGESCVWIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O3,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C
4000,10600388,1999,CGESCVWIPCISSAIGCSCKNKVCYRNGIP,CGESCVWIPCISSAIGCSCKNKVCYRNGIP{cyc:N-C},Cycloviolacin O4,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCSCSCTTTTBTTTBCCCCCCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C
4001,10600388,1999,CGESCVWIPCISSAVGCSCKNKVCYKNGTP,CGESCVWIPCISSAVGCSCKNKVCYKNGTP{cyc:N-C},Cycloviolacin O5,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCSSCCCSTTCSSSSCGGGCCSSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)C(C)C
4002,10600388,1999,CGESCVWIPCISAAVGCSCKSKVCYKNGTLP,CGESCVWIPCISAAVGCSCKSKVCYKNGTLP{cyc:N-C},Cycloviolacin O6,Free,Free,Cyclic,L,None,31,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCTTSSSCTTTTTTTTTSCCCCCCCCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)C(C)C
4003,10600388,1999,CGESCVWIPCTITALAGCKCKSKVCYNSIP,CGESCVWIPCTITALAGCKCKSKVCYNSIP{cyc:N-C},Cycloviolacin O7,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCTTSSSCCSHHHHSSSCCCCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C)[C@@H](C)O
4004,10600388,1999,CESCVWIPCISSVVGCSCKSKVCYKNGTLP,CESCVWIPCISSVVGCSCKSKVCYKNGTLP{cyc:N-C},Cycloviolacin O8,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCSSCCCSSSSTTSSSCSSCCCCCSTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C
4005,10600388,1999,CGESCVWIPCLTSAVGCSCKSKVCYRNGIP,CGESCVWIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O9,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCSTTCCSSCCSBSSSBCCCCCCCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)O
4006,10600388,1999,CGESCVYIPCLTSAVGCSCKSKVCYRNGIP,CGESCVYIPCLTSAVGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin O10,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCSCCCCTTCCCCCTTCSSCCCCSSSCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)O
4007,10600388,1999,CGESCVWIPCISAVVGCSCKSKVCYKNGTLP,CGESCVWIPCISAVVGCSCKSKVCYKNGTLP{cyc:N-C},Cycloviolacin O11,Free,Free,Cyclic,L,None,31,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)C(C)C)C(C)C
4008,10600388,1999,CGESCVYIPCLTSAIGCSCKSKVCYRNGIP,CGESCVYIPCLTSAIGCSCKSKVCYRNGIP{cyc:N-C},Cycloviolacin H1,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCSSSSSTTCCSCSCSCSSSSSCCCSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C
4009,10600388,1999,CGESCVYIPCISGVIGCSCTDKVCYLNGTP,CGESCVYIPCISGVIGCSCTDKVCYLNGTP{cyc:N-C},Kalata B5,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCTTCCCGGGCSSSSSBTTBCCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C
4010,10600388,1999,CGESCVWIPCISAALGCSCKNKVCYRNGIP,CGESCVWIPCISAALGCSCKNKVCYRNGIP{cyc:N-C},Circulin A,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCSSSSCTTTSCTTTTTCCCCCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C
4011,10600388,1999,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C},Circulin B,Free,Free,Cyclic,L,None,31,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCSSSSSSTHHHHHTTSCCCCCCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O
4012,10600388,1999,CGESCVFIPCVTALLGCSCKSKVCYKNSIP,CGESCVFIPCVTALLGCSCKSKVCYKNSIP{cyc:N-C},Cyclopsychotride A,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCSSCHHHHHHHTSCCBTTBCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(C)C)C(=O)N1CCC[C@H]1C(=O)O
4013,10600388,1999,VCGETCVGGTCNTPGCSCSRPVCTRNGLP,VCGETCVGGTCNTPGCSCSRPVCTRNGLP{cyc:N-C},Violapeptide I,Free,Free,Cyclic,L,None,29,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCSCGGGTTCSSCCCCCCCCCCCSCCSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)O
4014,10600388,1999,ICGETCVGGTCNTPGCSCSWPVCTRNGLP,ICGETCVGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C},Cycloviolacin O12,Free,Free,Cyclic,L,None,29,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCCCTTTGGGSCCSSCCSCCCCSSSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O
4015,10600388,1999,VCGETCFGGTCNTPGCSCTWPICTRDGLP,VCGETCFGGTCNTPGCSCTWPICTRDGLP{cyc:N-C},Kalata B2,Free,Free,Cyclic,L,None,29,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CBSSSSSSBCSSSCSCBSSSBSSSSCSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
4016,10600388,1999,TCGETCFGGTCNTPGCTCDPWPICTDRGLP,TCGETCFGGTCNTPGCTCDPWPICTDRGLP{cyc:N-C},Kalata B3,Free,Free,Cyclic,L,None,30,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCSSTTSCSSSCCSSCCSSCSTTTTCSSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)O
4017,10600388,1999,VCGETCVGGTCNTPGCTCSWPVCTRDGLP,VCGETCVGGTCNTPGCTCSWPVCTRDGLP{cyc:N-C},Kalata B4,Free,Free,Cyclic,L,None,29,Anti-HIV,50% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCSSSSHHHHTCCSSCTTCCCBSSSBSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)O
4018,10600388,1999,VCGETCEGGTCNTPGCSCSWPVCTRNGLP,VCGETCEGGTCNTPGCSCSWPVCTRNGLP{cyc:N-C},Kalata S,Free,Free,Cyclic,L,None,29,Anti-HIV,51% Hemolysis at ~20 µM,Human,"Cyclic cystine knot (Viola hederaceae, Viola odorata and Oldenlandia afrnis)",NA,NA,CCSSSCCSSSSCSTTCCCCCCCSSSSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)O
4135,10441158,1999,CGETCVGGTCNTPGCTCSWPVCTRNGLPV,CGETCVGGTCNTPGCTCSWPVCTRNGLPV{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,29,Uterotonic,HD50 = 50 µM,Human,O. affinis,NA,NA,CCCGGGTTTSSCCCCCSSSCCCTTCSSCC,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)C(C)C
4136,10441158,1999,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP,CGESCVFIPCISTLLGCSCKNKVCYRNGVIP{cyc:N-C},Circulin B,Free,Free,Cyclic,L,None,30,Uterotonic,HD50 = 30 µM,Human,O. affinis,NA,NA,CCCSSSSSSTHHHHHTTSCCCCCCCCCSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H](N)CS)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O
4158,20564013,2010,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},Kalata B1,Free,Free,Cyclic,L,None,30,Pesticidal,HD50 = 20.0±1.1 µM,Human,Cyclotides (Oldenlandia affinis),NA,NA,CCCCCSSHHHHCCCCCSSCCCCSSCCSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
4159,20564013,2010,GLPVCGETCTLGTVYTQGCTCSWPICKRN,GLPVCGETCTLGTVYTQGCTCSWPICKRN{cyc:N-C},Kalata B7,Free,Free,Cyclic,L,None,30,Pesticidal,HD50 = 55.2±1.3 µM,Human,Cyclotides (Oldenlandia affinis),NA,NA,CCSSCCCSSCCCCCCSSSSCCCCSSSTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O
4160,15009528,2004,VKLKVyPLKVKLyP,VKLKVY{d}PLKVKLY{d}P{cyc:N-C},GS14KL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 2 μg/ml,Human,Gramicidin S analog,NA,NA,CTTCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4161,15009528,2004,VKLLVyPLKVKLyP,VKLLVY{d}PLKVKLY{d}P{cyc:N-C},GS14LL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 3 μg/ml,Human,Gramicidin S analog,NA,NA,CCCEEETTEEECCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4162,15009528,2004,VKLVyPLKVKLyP,VKLVY{d}PLKVKLY{d}P{cyc:N-C},GS14FL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 3 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSSCCCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O
4163,15009528,2004,VKLYyYPLKVKLyP,VKLYY{d}YPLKVKLY{d}P{cyc:N-C},GS14YL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 8 μg/ml,Human,Gramicidin S analog,NA,NA,CCCSSSSSSCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C
4164,15009528,2004,VKLNVyPLKVKLyP,VKLNVY{d}PLKVKLY{d}P{cyc:N-C},GS14NL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 2 μg/ml,Human,Gramicidin S analog,NA,NA,CCCCSCTTCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4165,15009528,2004,VKLNVyPLKVKLyP,VKLNVY{d}PLKVKLY{d}P{cyc:N-C},GS14GL4,Free,Free,Cyclic,Mix,None,14,Antimicrobial,MHC = 3 μg/ml,Human,Gramicidin S analog,NA,NA,CCSTTSSSCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C
4194,16235231,2006,ZCRRLCYKQRCVTYCRGR,{nnr:Z}CRRLCYKQRCVTYCRGR{cyc:N-C}{ct:Amid},Gomesin,Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,~40 % Hemolysis at 100 µM,Human,Gomesin (Acanthoscurria gomesiana),NA,NA,NA,NA
4196,16235231,2006,ZSRRLCYKQRCVTYSRGR,{nnr:Z}SRRLCYKQRCVTYSRGR{cyc:N-C}{ct:Amid},"[Ser2,15]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,<10 % Hemolysis at 100 µM,Human,Gomesin analogs,NA,NA,NA,NA
4197,16235231,2006,ZCRRLSYKQRSVTYCRGR,{nnr:Z}CRRLSYKQRSVTYCRGR{cyc:N-C}{ct:Amid},"[Ser6,11]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,<10 % Hemolysis at 100 µM,Human,Gomesin analogs,NA,NA,NA,NA
4198,16235231,2006,ZDRRLSYKQRSVTYORGR,{nnr:Z}DRRLSYKQRSVTYORGR{cyc:N-C}{ct:Amid},"Cyclo(2–15)[Asp2, Ser6, 11, Orn15]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,<10 % Hemolysis at 100 µM,Human,Gomesin analogs,NA,NA,NA,NA
4199,16235231,2006,ZSRRLOYKQRDVTYSRGR,{nnr:Z}SRRLOYKQRDVTYSRGR{cyc:N-C}{ct:Amid},"Cyclo(6-11)[Ser2,15, Orn6, Asp11]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,<10 % Hemolysis at 100 µM,Human,Gomesin analogs,NA,NA,NA,NA
4200,16235231,2006,ZCRRLEYKQRKVTYCRGR,{nnr:Z}CRRLEYKQRKVTYCRGR{cyc:N-C}{ct:Amid},"Bicyclo(2–15, 6–11)[Cys2, 15, Glu6, Lys11]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,<10 % Hemolysis at 100 µM,Human,Gomesin analogs,NA,NA,NA,NA
4201,16235231,2006,ZERRLCYKQRCVTYKRGR,{nnr:Z}ERRLCYKQRCVTYKRGR{cyc:N-C}{ct:Amid},"Bicyclo(2–15, 6–11)[Glu2, Cys6, 11, Lys15]-Gm",Amidation,Free,Cyclic,L,Z = pyroglutamic acid,18,Antimicrobial,~32 % Hemolysis at 100 µM,Human,Gomesin analogs,NA,NA,NA,NA
5366,25997127,2015,LIAGLAANFLPQILCKIARKC,LIAGLAANFLPQILCKIARKC{cyc:N-C}{ct:Amid},Cyclic B1CTcu5,Amidation,Free,Cyclic,L,None,21,Antibacterial,40 % Hemolysis at 25 μg/ml,Human,"Smmd-B1Ctcu5 Analogs, Skin Secretion Of Frog Clinotarsus Curtipes",α-Helix,NA,CCTTHHHIIIIIIIHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
5519,26318064,2015,LR(NalNal)LR(NalNal)G,LR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},1,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at 215 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5520,26318064,2015,LRWLRWG,LRWLRWG{cyc:N-C},2,Free,Free,Cyclic,L,None,7,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,CCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
5521,26318064,2015,LK(NalNal)LR(NalNal)G,LK{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},3,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5522,26318064,2015,LR(NalNal)LK(NalNal)G,LR{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},4,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5523,26318064,2015,LK(NalNal)LK(NalNal)G,LK{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},5,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5524,26318064,2015,LKWLKWG,LKWLKWG{cyc:N-C},6,Free,Free,Cyclic,L,None,7,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,CCSSSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
5525,26318064,2015,LKFLKFG,LKFLKFG{cyc:N-C},7,Free,Free,Cyclic,L,None,7,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,CCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
5526,26318064,2015,LR(NalNal)LR(NalNal)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{cyc:N-C},8,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Abu = 4-aminobutyric acid",4,Antimicrobial,50 % Hemolysis at 230 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5527,26318064,2015,LR(NalNal)LR(NalNal)(AhxAhxAhxAhxAhxAhx),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:6-Ahx}{cyc:N-C},9,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 6-Ahx = 6-aminohexanoic acid",4,Antimicrobial,50 % Hemolysis at 115 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5528,26318064,2015,LR(NalNal)LR(NalNal)(AocAocAocAocAocAocAocAoc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},10,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 22 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5529,26318064,2015,LR(NalNal)LR(NalNal)(AdcAdcAdcAdcAdcAdcAdcAdcAdcAdc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:10-Adc}{cyc:N-C},11,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 10-Adc = 10-aminodecanoic acid",4,Antimicrobial,50 % Hemolysis at 15 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5530,26318064,2015,LR(NalNal)LR(NalNal)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{cyc:N-C},12,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,50 % Hemolysis at 265 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5531,26318064,2015,LR(NalNal)LR(NalNal)(εK),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:εK}{cyc:N-C},13,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, εK = coupling of 2-Nal6 has occurred on lysine’s ε-amino functionality",4,Antimicrobial,50 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5532,26318064,2015,LR(NalNal)LR(NalNal)(DabDab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},14,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,50 % Hemolysis at >450 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5533,26318064,2015,LR(NalNal)LR(NalNal)(Abu)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{nnr:Dab}{cyc:N-C},15,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,50 % Hemolysis at 420 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5534,26318064,2015,LR(NalNal)LR(NalNal)(Dab)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Abu}{cyc:N-C},16,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,50 % Hemolysis at 255 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5535,26318064,2015,LR(Bip)LR(Bip)G,LR{nnr:Bip}LR{nnr:Bip}G{cyc:N-C},17,Free,Free,Cyclic,Mix,"Bip = 4,4’-biphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 16 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5536,26318064,2015,LR(Dip)LR(Dip)G,LR{nnr:Dip}LR{nnr:Dip}G{cyc:N-C},18,Free,Free,Cyclic,Mix,"Dip = 3,3-diphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 145 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5537,26318064,2015,(AocAoc)R(NalNal)LR(NalNal)G,{nnr:2-Aoc}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},19,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5538,26318064,2015,LR(NalNal)(AocAoc)R(NalNal)G,LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},20,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 33 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5539,26318064,2015,(Cha)R(NalNal)LR(NalNal)G,{nnr:Cha}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},21,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 28 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5540,26318064,2015,LR(NalNal)(Cha)R(NalNal)G,LR{nnr:2-Nal}{nnr:Cha}R{nnr:2-Nal}G{cyc:N-C},22,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 60 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5541,26318064,2015,LR(NalNal)(Nle)R(NalNal)G,LR{nnr:2-Nal}{nnr:Nle}R{nnr:2-Nal}G{cyc:N-C},23,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Nle = norleucine",4,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5542,26318064,2015,PR(NalNal)LR(NalNal)G,PR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},24,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,4,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5543,26318064,2015,LR(NalNal)PR(NalNal)G,LR{nnr:2-Nal}PR{nnr:2-Nal}G{cyc:N-C},25,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5544,26318064,2015,LR(NalNal)LRYG,LR{nnr:2-Nal}LRYG{cyc:N-C},26,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,6,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5545,26318064,2015,TR(NalNal)LR(NalNal)G,TR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},27,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5546,26318064,2015,LR(NalNal)TR(NalNal)G,LR{nnr:2-Nal}TR{nnr:2-Nal}G{cyc:N-C},28,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5547,26318064,2015,QR(NalNal)LR(NalNal)G,QR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},29,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5548,26318064,2015,LR(DNalNal)(AocAoc)R(NalNal)G,LR{nnr:D-2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},30,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5549,26318064,2015,LR(NalNal)(DAocAoc)R(NaINal)G,LR{nnr:2-Nal}{nnr:D-2-Aoc}R{nnr:2-Nal}G{cyc:N-C},31,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5550,26318064,2015,LR(2NalNal)LR(DNalNal)G,LR{nnr:2-Nal}LR{nnr:D-2-Nal}G{cyc:N-C},32,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",5,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5551,26318064,2015,TR(NalNal)IR(NaINal)(AocAocAocAocAocAocAocAoc),TR{nnr:2-Nal}IR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},33,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,50 % Hemolysis at >150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5552,26318064,2015,LR(NalNal)(AocAoc)R(NaINal)(DabDab),LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},34,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,3,Antimicrobial,50 % Hemolysis at 55 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5553,26318064,2015,LR(NalNal)LR(NalNal)G,LR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},1,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,27 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5554,26318064,2015,LRWLRWG,LRWLRWG{cyc:N-C},2,Free,Free,Cyclic,L,None,7,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,CCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
5555,26318064,2015,LK(NalNal)LR(NalNal)G,LK{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},3,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,14 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5556,26318064,2015,LR(NalNaI)LK(NalNal)G,LR{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},4,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,19 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5557,26318064,2015,LK(NalNal)LK(NalNal)G,LK{nnr:2-Nal}LK{nnr:2-Nal}G{cyc:N-C},5,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,13 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5558,26318064,2015,LKWLKWG,LKWLKWG{cyc:N-C},6,Free,Free,Cyclic,L,None,7,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,CCSSSCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)O
5559,26318064,2015,LKFLKFG,LKFLKFG{cyc:N-C},7,Free,Free,Cyclic,L,None,7,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,CCCCCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O
5560,26318064,2015,LR(NalNal)LR(NalNal)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{cyc:N-C},8,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Abu = 4-aminobutyric acid",4,Antimicrobial,22 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5561,26318064,2015,LR(NalNal)LR(NalNal)(AhxAhxAhxAhxAhxAhx),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:6-Ahx}{cyc:N-C},9,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 6-Ahx = 6-aminohexanoic acid",4,Antimicrobial,75 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5562,26318064,2015,LR(NalNal)LR(NalNal)(AocAocAocAocAocAocAocAoc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},10,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5563,26318064,2015,LR(NalNal)LR(NalNal)(AdcAdcAdcAdcAdcAdcAdcAdcAdcAdc),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:10-Adc}{cyc:N-C},11,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 10-Adc = 10-aminodecanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5564,26318064,2015,LR(NalNal)LR(NalNal)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{cyc:N-C},12,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5565,26318064,2015,LR(NalNal)LR(NalNal)(εK),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:εK}{cyc:N-C},13,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, εK = coupling of 2-Nal6 has occurred on lysine’s ε-amino functionality",4,Antimicrobial,51 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5566,26318064,2015,LR(NalNal)LR(NalNal)(DabDab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},14,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5567,26318064,2015,LR(NalNal)LR(NalNal)(Abu)(Dab),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Abu}{nnr:Dab}{cyc:N-C},15,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5568,26318064,2015,LR(NalNal)LR(NalNal)(Dab)(Abu),LR{nnr:2-Nal}LR{nnr:2-Nal}{nnr:Dab}{nnr:Abu}{cyc:N-C},16,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Dab = 2,4-diaminobutyric acid, Abu = 4-aminobutyric acid",4,Antimicrobial,12 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5569,26318064,2015,LR(Bip)LR(Bip)G,LR{nnr:Bip}LR{nnr:Bip}G{cyc:N-C},17,Free,Free,Cyclic,Mix,"Bip = 4,4’-biphenyl-L-alanine",5,Antimicrobial,96 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5570,26318064,2015,LR(Dip)LR(Dip)G,LR{nnr:Dip}LR{nnr:Dip}G{cyc:N-C},18,Free,Free,Cyclic,Mix,"Dip = 3,3-diphenyl-L-alanine",5,Antimicrobial,54 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5571,26318064,2015,(AocAoc)R(NalNal)LR(NalNal)G,{nnr:2-Aoc}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},19,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5572,26318064,2015,LR(NalNal)(AocAoc)R(NalNal)G,LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},20,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5573,26318064,2015,(Cha)R(NalNal)LR(NalNal)G,{nnr:Cha}R{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},21,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,99 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5574,26318064,2015,LR(NalNal)(Cha)R(NalNal)G,LR{nnr:2-Nal}{nnr:Cha}R{nnr:2-Nal}G{cyc:N-C},22,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Cha = 3-cyclohexyl-L-alanine",4,Antimicrobial,96 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5575,26318064,2015,LR(NalNal)(Nle)R(NalNal)G,LR{nnr:2-Nal}{nnr:Nle}R{nnr:2-Nal}G{cyc:N-C},23,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, Nle = norleucine",4,Antimicrobial,35 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5576,26318064,2015,PR(NalNal)LR(NalNal)G,PR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},24,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5577,26318064,2015,LR(NalNal)PR(NalNal)G,LR{nnr:2-Nal}PR{nnr:2-Nal}G{cyc:N-C},25,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5578,26318064,2015,LR(NalNal)LRYG,LR{nnr:2-Nal}LRYG{cyc:N-C},26,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,6,Antimicrobial,19 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5579,26318064,2015,TR(NalNal)LR(NalNal)G,TR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},27,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5580,26318064,2015,LR(NalNal)TR(NalNal)G,LR{nnr:2-Nal}TR{nnr:2-Nal}G{cyc:N-C},28,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5581,26318064,2015,QR(NalNal)LR(NalNal)G,QR{nnr:2-Nal}LR{nnr:2-Nal}G{cyc:N-C},29,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5582,26318064,2015,LR(DNalNal)(AocAoc)R(NalNal)G,LR{nnr:D-2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}G{cyc:N-C},30,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,92 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5583,26318064,2015,LR(NalNal)(DAocAoc)R(NaINal)G,LR{nnr:2-Nal}{nnr:D-2-Aoc}R{nnr:2-Nal}G{cyc:N-C},31,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 2-Aoc = 2-aminooctanoic acid",4,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5584,26318064,2015,LR(NalNal)LR(DNalNal)G,LR{nnr:2-Nal}LR{nnr:D-2-Nal}G{cyc:N-C},32,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,<8 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5585,26318064,2015,TR(NalNal)IR(NaINal)(AocAocAocAocAocAocAocAoc),TR{nnr:2-Nal}IR{nnr:2-Nal}{nnr:8-Aoc}{cyc:N-C},33,Free,Free,Cyclic,Mix,"2-Nal = 3-(2-naphthyl)-L-alanine, 8-Aoc = 8-aminooctanoic acid",4,Antimicrobial,10 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5586,26318064,2015,LR(NalNal)(AocAoc)R(NaINal)(DabDab),LR{nnr:2-Nal}{nnr:2-Aoc}R{nnr:2-Nal}{nnr:Dab}{nnr:Dab}{cyc:N-C},34,Free,Free,Cyclic,Mix,2-Nal = 3-(2-naphthyl)-L-alanine,3,Antimicrobial,100 % Hemolysis at 150 µM,Human,Synthetic Peptide,α-Helix,NA,NA,NA
5588,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 0.67 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5589,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 3.35 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5590,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 6.7 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5591,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,~10 % Hemolysis at 33.5 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5592,26159095,2015,GIVFLDHVESFQVKPKLRKFQLYF,GIVFLDHVESFQVKPKLRKFQLYF{cyc:N-C},cMnALF24,Free,Free,Cyclic,L,None,24,Antibacterial,22 % Hemolysis at 67 µM,Rabbit,Macrobrachium Nipponense,β-Sheets,Low hemolytic,CCSCCCSTTSSSCSSBTTBSSCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)C(C)C)C(C)C
5721,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5722,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5723,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5724,26295533,2015,RLARIVVIRVAR,RLARIVVIRVAR{cyc:N-C}{ct:Amid},Bac2A,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bovine Host Defense Peptide Variant,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5725,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5726,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5727,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5728,26295533,2015,RLRRIVVIRVAR,RLRRIVVIRVAR{cyc:N-C}{ct:Amid},R3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5729,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5730,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5731,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5732,26295533,2015,RLARIVPIRVAR,RLARIVPIRVAR{cyc:N-C}{ct:Amid},P7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C
5733,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",10 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5734,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",5 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5735,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",>5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5736,26295533,2015,VRWRIRVAVIRA,VRWRIRVAVIRA{cyc:N-C}{ct:Amid},W3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCSSSCCSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC)C(C)C)C(C)C
5737,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<10 % Hemolysis at 0.25 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5738,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",10 % Hemolysis at 0.1 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5739,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",5 % Hemolysis at 0.05 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5740,26295533,2015,RRWRIVVIRVRR,RRWRIVVIRVRR{cyc:N-C}{ct:Amid},Sub3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",<5 % Hemolysis at 0.025 mg/ml,Human,Bac2A Derivative,α-Helical,NA,CCCCCCCTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C
5927,25728268,2015,FFWLSRRTK,FFWLSRRTK{cyc:N-C},Pep6,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 5 µM,Human,Derived From Pepa8,NA,NA,CCSSSSCCC,CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O
5928,25728268,2015,FFWSRRTK,FFWSRRTK{cyc:N-C},Pep7,Free,Free,Cyclic,L,None,8,Antibacterial,50 % Hemolysis at 14 µM,Human,Derived From Pepa9,NA,NA,CCSCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5929,25728268,2015,FFWRRTK,FFWRRTK{cyc:N-C},Pep8,Free,Free,Cyclic,L,None,7,Antibacterial,50 % Hemolysis at 160 µM,Human,Derived From Pepa10,NA,NA,CCCCCCC,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)O
5931,25728268,2015,FFWLRR-aza-β3Hyt-K,FFWLRR{nnr:aza-β3Hyt}K{cyc:N-C},Pep10,Free,Free,Cyclic,L,aza-b3 = homohydroxythreonine,8,Antibacterial,50 % Hemolysis at 150 µM,Human,Derived From Pepa12,NA,NA,NA,NA
5932,25728268,2015,FFWRR-aza-β3Hyt-K,FFWRR{nnr:aza-β3Hyt}K{cyc:N-C},Pep11,Free,Free,Cyclic,L,aza-b3 = homohydroxythreonine,7,Antibacterial,50 % Hemolysis at 840 µM,Human,Derived From Pepa13,NA,NA,NA,NA
5950,25495219,2015,R1 -dab-[Dab-Dab-L-f-Dab-Dab-L],{nnr:R1}-{nnr:dab}-[{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L],13,Free,Free,Cyclic,Mix,"R1 = 4-methylhexanoyl, Dab = diaminobutyric acid",3,Antimicrobial,2.02 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,NA,NA,NA,NA
5951,25495219,2015,Fmoc-dab-[Dab-Dab-L-f-Dab-Dab-L],{conj:Fmoc}-{nnr:dab}-[{nnr:Dab}-{nnr:Dab}-L-F{d}-{nnr:Dab}-{nnr:Dab}-L],12,Free,Free,Cyclic,Mix,"Dab = diaminobutyric acid, Fmoc = fluorenylmethyloxycarbonyl",3,Antimicrobial,41 % Hemolysis at 100 µM,Mouse,Synthetic Analogues Of Battacin,NA,NA,NA,NA
5965,25583073,2015,CVDIHVWDGVC,CVDIHVWDGVC{cyc:N-C},Cyclic C-PIP[57-67]C,Free,Free,Cyclic,L,None,11,Antibacterial,30 % Hemolysis at 100 μg/ml,Human,Python Reticulatus Serum Protein,β or Helical,NA,CCSSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)O)C(C)C)C(C)C
6475,27560386,2016,RICTPIPFPMCY,RICTPIPFPMCY{cyc:N-C}{ct:Amid},tigerinin-1O,Amidation,Free,Cyclic,L,None,12,Cytotoxic,0 % Hemolysis at 500 µM,Mouse,African Crowned Bullfrog Hoplobatrachus Occipitalis,NA,Non-hemolytic,CCCCSSCCSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)[C@@H](C)O
6476,27560386,2016,RTCIPIPLVMC,RTCIPIPLVMC{cyc:N-C}{ct:Amid},tigerinin-2O,Amidation,Free,Cyclic,L,None,11,Cytotoxic,0 % Hemolysis at 500 µM,Mouse,African Crowned Bullfrog Hoplobatrachus Occipitalis,NA,Non-hemolytic,CCCCSCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)O)C(C)C)[C@@H](C)CC
6477,27560386,2016,RICTAIPLPMCL,RICTAIPLPMCL{cyc:N-C}{ct:Amid},tigerinin-3O,Amidation,Free,Cyclic,L,None,12,Cytotoxic,0 % Hemolysis at 500 µM,Mouse,African Crowned Bullfrog Hoplobatrachus Occipitalis,NA,Non-hemolytic,CCSCCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)O
6478,27560386,2016,RTCIPIPPVCF,RTCIPIPPVCF{cyc:N-C}{ct:Amid},tigerinin-4O,Amidation,Free,Cyclic,L,None,11,Cytotoxic,0 % Hemolysis at 500 µM,Mouse,African Crowned Bullfrog Hoplobatrachus Occipitalis,NA,Non-hemolytic,CCSSSSSSSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)CC
6666,27008420,2016,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6667,27008420,2016,KKLKK(CO-C7H15)FKKLQ,KKLKK{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC498,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Peptide,NA,Low hemolytic,NA,NA
6668,27008420,2016,KKLKK(CO-C3H7)FKKLQ,KKLKK{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC500,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,28 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6669,27008420,2016,KKLKK(CO-C4H9)FKKLQ,KKLKK{conj:CO-C4H9}FKKLQ{cyc:N-C},BPC526,Free,Free,Cyclic,L,CO-C4H9 = pentanoyl,10,Anti-plant-pathogenic bacteria and fungi,62 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6670,27008420,2016,KKLKK(CO-isoC5H11)FKKLQ,KKLKK{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC504,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,89 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6671,27008420,2016,KKLKK(CO-nC5H11)FKKLQ,KKLKK{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC528,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,98 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6672,27008420,2016,KKLKK(LK-CO-nC5H11)FKKLQ,KKLKKLK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC596,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,93 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6673,27008420,2016,KKLKK(CO-C6H13)FKKLQ,KKLKK{conj:CO-C6H13}FKKLQ{cyc:N-C},BPC592,Free,Free,Cyclic,L,CO-C6H13 = 2-methylhexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6674,27008420,2016,KKLKK(CO-C8H17)FKKLQ,KKLKK{conj:CO-C8H17}FKKLQ{cyc:N-C},BPC594,Free,Free,Cyclic,L,CO-C8H17 = 4-methyloctanoyl,10,Anti-plant-pathogenic bacteria and fungi,93 ± 11 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6675,27008420,2016,KKLKK(CO-C11H23)FKKLQ,KKLKK{conj:CO-C11H23}FKKLQ{cyc:N-C},BPC530,Free,Free,Cyclic,L,CO-C11H23 = lauroyl,10,Anti-plant-pathogenic bacteria and fungi,89 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6676,27008420,2016,KKLKK(CO-C11H22OH)FKKLQ,KKLKK{conj:CO-C11H22OH}FKKLQ{cyc:N-C},BPC524,Free,Free,Cyclic,L,CO-C11H22OH = 12-hydroxylauroyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 8 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6677,27008420,2016,KKLKK(CO-C15H31)FKKLQ,KKLKK{conj:CO-C15H31}FKKLQ{cyc:N-C},BPC502,Free,Free,Cyclic,L,CO-C15H31 = palmitoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6678,27008420,2016,KKLKK(CO-C17H33)FKKLQ,KKLKK{conj:CO-C17H33}FKKLQ{cyc:N-C},BPC622,Free,Free,Cyclic,L,CO-C17H33 = oleoyl,10,Anti-plant-pathogenic bacteria and fungi,91 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6679,27008420,2016,KKLKKFKK(CO-nC5H11)LQ,KKLKKFKK{conj:CO-nC5H11}LQ{cyc:N-C},BPC582,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6680,27008420,2016,KKLKKFK(CO-nC5H11)KLQ,KKLKKFK{conj:CO-nC5H11}KLQ{cyc:N-C},BPC584,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,72 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6681,27008420,2016,KKLK(CO-nC5H11)KFKKLQ,KKLK{conj:CO-nC5H11}KFKKLQ{cyc:N-C},BPC586,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 9 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6682,27008420,2016,KK(CO-nC5H11)LKKFKKLQ,KK{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC588,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,95 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6683,27008420,2016,KK(CO-C3H7)LKKFKKLQ,KK{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC708,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6684,27008420,2016,K(CO-nC5H11)KLKKFKKLQ,K{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC590,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 9 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6685,27008420,2016,K(CO-C3H7)KLKKFKKLQ,K{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC710,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6686,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,30 ± 4 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6687,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,0 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6688,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,53 ± 5 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6689,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,51 ± 7 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6690,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,51 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6691,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{conj:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6692,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{conj:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6693,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{conj:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,77 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6694,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{conj:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,2 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6695,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{conj:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,10 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6696,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6697,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6698,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,19 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6699,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6700,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6701,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,61 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6702,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,68 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6703,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,9 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6704,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,8 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6705,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,35 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6706,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,21 ± 13 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6707,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,Mix,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6708,27008420,2016,KKLKK(CO-C3H7)HKKLQ,KKLKK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC718,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6709,27008420,2016,KKLKK(LK-CO-C3H7)HKKLQ,KKLKKLK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC728,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,12,Anti-plant-pathogenic bacteria and fungi,0 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Non-hemolytic,NA,NA
6710,27008420,2016,KKLKK(CO-nC5H11)HKKLQ,KKLKK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC636,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,5 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6711,27008420,2016,KKLKK(CO-isoC5H11)HKKLQ,KKLKK{conj:CO-isoC5H11}HKKLQ{cyc:N-C},BPC638,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,6 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6712,27008420,2016,KKLKK(LK-CO-nC5H11)HKKLQ,KKLKKLK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC676,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6713,27008420,2016,KKLKK(CO-C7H15)HKKLQ,KKLKK{conj:CO-C7H15}HKKLQ{cyc:N-C},BPC670,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,34 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6714,27008420,2016,KK(CO-nC5H11)LKKHKKLQ,KK{conj:CO-nC5H11}LKKHKKLQ{cyc:N-C},BPC682,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,20 ± 3 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6715,27008420,2016,KK(CO-C3H7)LKKHKKLQ,KK{conj:CO-C3H7}LKKHKKLQ{cyc:N-C},BPC720,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6716,27008420,2016,K(CO-nC5H11)KLKKHKKLQ,K{conj:CO-nC5H11}KLKKHKKLQ{cyc:N-C},BPC688,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,1 ± 2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6717,27008420,2016,K(CO-C3H7)KLKKHKKLQ,K{conj:CO-C3H7}KLKKHKKLQ{cyc:N-C},BPC722,Free,Free,Cyclic,L,CO-C3H7= butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.2 % Hemolysis at 150 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6718,27008420,2016,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Anti-plant-pathogenic bacteria and fungi,6 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
6719,27008420,2016,KKLKK(CO-C7H15)FKKLQ,KKLKK{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC498,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6720,27008420,2016,KKLKK(CO-C3H7)FKKLQ,KKLKK{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC500,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,38 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6721,27008420,2016,KKLKK(CO-C4H9)FKKLQ,KKLKK{conj:CO-C4H9}FKKLQ{cyc:N-C},BPC526,Free,Free,Cyclic,L,CO-C4H9 = pentanoyl,10,Anti-plant-pathogenic bacteria and fungi,78 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6722,27008420,2016,KKLKK(CO-isoC5H11)FKKLQ,KKLKK{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC504,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,93 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6723,27008420,2016,KKLKK(CO-nC5H11)FKKLQ,KKLKK{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC528,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6724,27008420,2016,KKLKK(LK-CO-nC5H11)FKKLQ,KKLKKLK{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC596,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,100 ± 11 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6725,27008420,2016,KKLKK(CO-C6H13)FKKLQ,KKLKK{conj:CO-C6H13}FKKLQ{cyc:N-C},BPC592,Free,Free,Cyclic,L,CO-C6H13 = 2-methylhexanoyl,10,Anti-plant-pathogenic bacteria and fungi,98 ± 6 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6726,27008420,2016,KKLKK(CO-C8H17)FKKLQ,KKLKK{conj:CO-C8H17}FKKLQ{cyc:N-C},BPC594,Free,Free,Cyclic,L,CO-C8H17 = 4-methyloctanoyl,10,Anti-plant-pathogenic bacteria and fungi,96 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6727,27008420,2016,KKLKK(CO-C11H23)FKKLQ,KKLKK{conj:CO-C11H23}FKKLQ{cyc:N-C},BPC530,Free,Free,Cyclic,L,CO-C11H23 = lauroyl,10,Anti-plant-pathogenic bacteria and fungi,91 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6728,27008420,2016,KKLKK(CO-C11H22OH)FKKLQ,KKLKK{conj:CO-C11H22OH}FKKLQ{cyc:N-C},BPC524,Free,Free,Cyclic,L,CO-C11H22OH = 12-hydroxylauroyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 6 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6729,27008420,2016,KKLKK(CO-C15H31)FKKLQ,KKLKK{conj:CO-C15H31}FKKLQ{cyc:N-C},BPC502,Free,Free,Cyclic,L,CO-C15H31 = palmitoyl,10,Anti-plant-pathogenic bacteria and fungi,99 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6730,27008420,2016,KKLKK(CO-C17H33)FKKLQ,KKLKK{conj:CO-C17H33}FKKLQ{cyc:N-C},BPC622,Free,Free,Cyclic,L,CO-C17H33 = oleoyl,10,Anti-plant-pathogenic bacteria and fungi,97 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6731,27008420,2016,KKLKKFKK(CO-nC5H11)LQ,KKLKKFKK{conj:CO-nC5H11}LQ{cyc:N-C},BPC582,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,96 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6732,27008420,2016,KKLKKFK(CO-nC5H11)KLQ,KKLKKFK{conj:CO-nC5H11}KLQ{cyc:N-C},BPC584,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,97 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6733,27008420,2016,KKLK(CO-nC5H11)KFKKLQ,KKLK{conj:CO-nC5H11}KFKKLQ{cyc:N-C},BPC586,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,95 ± 20 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6734,27008420,2016,KK(CO-nC5H11)LKKFKKLQ,KK{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC588,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,92 ± 12 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6735,27008420,2016,KK(CO-C3H7)LKKFKKLQ,KK{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC708,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6736,27008420,2016,K(CO-nC5H11)KLKKFKKLQ,K{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC590,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,100 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6737,27008420,2016,K(CO-C3H7)KLKKFKKLQ,K{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC710,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,13 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6738,27008420,2016,KKLKK(CO-C3H7)fKKLQ,KKLKK{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC712,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,38 ± 7 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6739,27008420,2016,KKLKK(LK-CO-C3H7)fKKLQ,KKLKKLK-{conj:CO-C3H7}F{d}KKLQ{cyc:N-C},BPC726,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,4 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6740,27008420,2016,KKLKK(CO-nC5H11)fKKLQ,KKLKK{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC624,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,64 ± 9 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6741,27008420,2016,KKLKK(CO-isoC5H11)fKKLQ,KKLKK{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC626,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,54 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6742,27008420,2016,KKLKK(LK-CO-nC5H11)fKKLQ,KKLKKLK-{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC674,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",12,Anti-plant-pathogenic bacteria and fungi,56 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6743,27008420,2016,KKLKK(CO-C7H15)fKKLQ,KKLKK{conj:CO-C7H15}F{d}KKLQ{cyc:N-C},BPC668,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,79 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6744,27008420,2016,KK(CO-C3H7)LKKfKKLQ,KK{conj:CO-C3H7}LKKF{d}KKLQ{cyc:N-C},BPC714,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6745,27008420,2016,KK(CO-nC5H11)LKKfKKLQ,KK{conj:CO-nC5H11}LKKF{d}KKLQ{cyc:N-C},BPC680,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,81 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6746,27008420,2016,K(CO-C3H7)KLKKfKKLQ,K{conj:CO-C3H7}KLKKF{d}KKLQ{cyc:N-C},BPC716,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,4 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6747,27008420,2016,K(CO-nC5H11)KLKKfKKLQ,K{conj:CO-nC5H11}KLKKF{d}KKLQ{cyc:N-C},BPC686,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine",10,Anti-plant-pathogenic bacteria and fungi,14 ± 0.4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6748,27008420,2016,KKLKk(CO-C3H7)FKKLQ,KKLKK{d}{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC702,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,2 ± 0.3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6749,27008420,2016,KKLKk(LK-CO-C3H7)FKKLQ,KKLKK{d}LK-{conj:CO-C3H7}FKKLQ{cyc:N-C},BPC724,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,3 ± 0.5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6750,27008420,2016,KKLKk(CO-nC5H11)FKKLQ,KKLKK{d}{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC628,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,34 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6751,27008420,2016,KKLKk(CO-isoC5H11)FKKLQ,KKLKK{d}{conj:CO-isoC5H11}FKKLQ{cyc:N-C},BPC630,Free,Free,Cyclic,Mix,"CO-isoC5H11 = 4-methylpentanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,28 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6752,27008420,2016,KKLKk(LK-CO-nC5H11)FKKLQ,KKLKK{d}LK-{conj:CO-nC5H11}FKKLQ{cyc:N-C},BPC672,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",12,Anti-plant-pathogenic bacteria and fungi,33 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6753,27008420,2016,KKLKk(CO-C7H15)FKKLQ,KKLKK{d}{conj:CO-C7H15}FKKLQ{cyc:N-C},BPC666,Free,Free,Cyclic,Mix,"CO-C7H15 = octanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6754,27008420,2016,Kk(CO-nC5H11)LKKFKKLQ,KK{d}{conj:CO-nC5H11}LKKFKKLQ{cyc:N-C},BPC678,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,73 ± 4 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6755,27008420,2016,Kk(CO-C3H7)LKKFKKLQ,KK{d}{conj:CO-C3H7}LKKFKKLQ{cyc:N-C},BPC704,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,16 ± 2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6756,27008420,2016,k(CO-nC5H11)KLKKFKKLQ,K{d}{conj:CO-nC5H11}KLKKFKKLQ{cyc:N-C},BPC684,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,13 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6757,27008420,2016,k(CO-C3H7)KLKKFKKLQ,K{d}{conj:CO-C3H7}KLKKFKKLQ{cyc:N-C},BPC706,Free,Free,Cyclic,Mix,"CO-C3H7 = butanoyl, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,46 ± 3 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6758,27008420,2016,KKLKk(CO-nC5H11)fKKLQ,KKLKK{d}{conj:CO-nC5H11}F{d}KKLQ{cyc:N-C},BPC632,Free,Free,Cyclic,Mix,"CO-nC5H11 = hexanoyl, f = D-phenylalanine, k = D-Lys",10,Anti-plant-pathogenic bacteria and fungi,22 ± 10 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6759,27008420,2016,KKLKk(CO-isoC5H11)fKKLQ,KKLKK{d}{conj:CO-isoC5H11}F{d}KKLQ{cyc:N-C},BPC634,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,17 ± 8 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6760,27008420,2016,KKLKK(CO-C3H7)HKKLQ,KKLKK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC718,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6761,27008420,2016,KKLKK(LK-CO-C3H7)HKKLQ,KKLKKLK{conj:CO-C3H7}HKKLQ{cyc:N-C},BPC728,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,12,Anti-plant-pathogenic bacteria and fungi,7 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6762,27008420,2016,KKLKK(CO-nC5H11)HKKLQ,KKLKK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC636,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,16 ± 5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6763,27008420,2016,KKLKK(CO-isoC5H11)HKKLQ,KKLKK{conj:CO-isoC5H11}HKKLQ{cyc:N-C},BPC638,Free,Free,Cyclic,L,CO-isoC5H11 = 4-methylpentanoyl,10,Anti-plant-pathogenic bacteria and fungi,8 ± 5 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6764,27008420,2016,KKLKK(LK-CO-nC5H11)HKKLQ,KKLKKLK{conj:CO-nC5H11}HKKLQ{cyc:N-C},BPC676,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,12,Anti-plant-pathogenic bacteria and fungi,3 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6765,27008420,2016,KKLKK(CO-C7H15)HKKLQ,KKLKK{conj:CO-C7H15}HKKLQ{cyc:N-C},BPC670,Free,Free,Cyclic,L,CO-C7H15 = octanoyl,10,Anti-plant-pathogenic bacteria and fungi,40 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6766,27008420,2016,KK(CO-nC5H11)LKKHKKLQ,KK{conj:CO-nC5H11}LKKHKKLQ{cyc:N-C},BPC682,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,27 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6767,27008420,2016,KK(CO-C3H7)LKKHKKLQ,KK{conj:CO-C3H7}LKKHKKLQ{cyc:N-C},BPC720,Free,Free,Cyclic,L,CO-C3H7 = butanoyl,10,Anti-plant-pathogenic bacteria and fungi,4 ± 1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6768,27008420,2016,K(CO-nC5H11)KLKKHKKLQ,K{conj:CO-nC5H11}KLKKHKKLQ{cyc:N-C},BPC688,Free,Free,Cyclic,L,CO-nC5H11 = hexanoyl,10,Anti-plant-pathogenic bacteria and fungi,1 ± 0.2 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Non-hemolytic,NA,NA
6769,27008420,2016,K(CO-C3H7)KLKKHKKLQ,K{conj:CO-C3H7}KLKKHKKLQ{cyc:N-C},BPC722,Free,Free,Cyclic,L,CO-C3H7= butanoyl,10,Anti-plant-pathogenic bacteria and fungi,3 ± 0.1 % Hemolysis at 250 µM,Horse,Synthetic Cyclolipopeptides,NA,Low hemolytic,NA,NA
6822,27487329,2017,GLPVCGETCVGGTCNTPGCTCSWPVCTRN,GLPVCGETCVGGTCNTPGCTCSWPVCTRN{cyc:N-C},kB1,Free,Free,Cyclic,L,None,29,cytotoxic,<60 % Hemolysis at 50 µM,Human,Möbius Family,Loop,NA,CCCCCSCSTTTTTSCCSSSSCSCSSCTTC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
6823,27487329,2017,GLPVCGETCVGGTCPGACTCSWPVCTRN,GLPVCGETCVGGTCPGACTCSWPVCTRN{cyc:N-C},kL3,Free,Free,Cyclic,L,None,28,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Chimeric Cyclotides,Loop,Non-hemolytic,CCCCCCCTTTSCCCCSSSCCCCSSSSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
6824,27487329,2017,GLPVCGETCVGGTCNTPGCICSWPVCTRN,GLPVCGETCVGGTCNTPGCICSWPVCTRN{cyc:N-C},kL4,Free,Free,Cyclic,L,None,29,cytotoxic,<60 % Hemolysis at 50 µM,Human,Chimeric Cyclotides,Loop,NA,CCCCCSBSSTTBTSCGGGCCCCCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C
6825,27487329,2017,GLPVCGETCVGGTCNTPGCTCRGNGYCTRN,GLPVCGETCVGGTCNTPGCTCRGNGYCTRN{cyc:N-C},kL5,Free,Free,Cyclic,L,None,30,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Chimeric Cyclotides,Loop,Non-hemolytic,CCCCCSCCTHHHHBCCSSCSSCCSSSSCCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
6826,27487329,2017,GGVCGETCRRDSDCPGACICRGNGYCGSGSD,GGVCGETCRRDSDCPGACICRGNGYCGSGSD{cyc:N-C},ML1,Free,Free,Cyclic,L,None,31,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Chimeric Cyclotides,Loop,Non-hemolytic,CEETTEECCCCCCCTTCCSSCSSSSCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
6827,27487329,2017,GGVCPKILKKCVGGTCPGACICRGNGYCGSGSD,GGVCPKILKKCVGGTCPGACICRGNGYCGSGSD{cyc:N-C},ML2,Free,Free,Cyclic,L,None,33,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Chimeric Cyclotides,Loop,Non-hemolytic,CTTCHHHHHHHTTSCCCSCCCCCCTTTTCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
6828,27487329,2017,GGVCPKILKKCRRDSDCNTPGCICRGNGYCGSGSD,GGVCPKILKKCRRDSDCNTPGCICRGNGYCGSGSD{cyc:N-C},ML3,Free,Free,Cyclic,L,None,35,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Chimeric Cyclotides,Loop,Non-hemolytic,CTTSHHHHTTSSBCSSCBCSSCCCEETBEESSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
6829,27487329,2017,GGVCPKILKKCRRDSDCPGACTCRGNGYCGSGSD,GGVCPKILKKCRRDSDCPGACTCRGNGYCGSGSD{cyc:N-C},ML4,Free,Free,Cyclic,L,None,34,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Chimeric Cyclotides,Loop,Non-hemolytic,CCSSHHHHTTTTCCCCCSCCBTTTBSCCTTTSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O
6830,27487329,2017,GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD,GGVCPKILKKCRRDSDCPGACICRGNGYCGSGSD{cyc:N-C},MCoTI-II,Free,Free,Cyclic,L,None,34,cytotoxic,0 % Hemolysis at 10-50 µM,Human,Momordica Cochinchinensis,Loop,Non-hemolytic,CTTSHHHHHHHSCSCCCGGGCCCCSSSSSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O
7017,28165293,2017,FKCRRWQWRMKKLGAPSITCVRRAF,FKCRRWQWRMKKLGAPSITCVRRAF{cyc:N-C},LFcinB,Free,Free,Cyclic,L,None,25,Anticancer,<2 % Hemolysis at 10 µM,Human,Bovine Lf (Blf),β-Hairpin,NA,CCSCCSSTTTTTSSCCSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)C(C)C)[C@@H](C)O
7022,28165293,2017,GRRRRSVQWCA,GRRRRSVQWCA{cyc:N-C},Cyclo-hLF11,Free,Free,Cyclic,L,None,11,Anticancer,<2 % Hemolysis at 10 µM,Human,Human-Derived,β-Hairpin,NA,CCCCCCCSSCC,CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O
7023,28165293,2017,GRRRRSVQWCA,GRRRRSVQWCA{cyc:N-C},Cyclo-hLF11C10S,Free,Free,Cyclic,L,None,11,Anticancer,<2 % Hemolysis at 10 µM,Human,Human-Derived,β-Hairpin,NA,CCCCCCCSSCC,CC(C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)O
7027,28165293,2017,APRKNVRWCT,APRKNVRWCT{cyc:N-C},Cyclo-bLF10,Free,Free,Cyclic,L,None,10,Anticancer,<2 % Hemolysis at 10 µM,Human,Bovine Derived,β-Hairpin,NA,CCCCCCSSCC,CC(C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)O)[C@@H](C)O
7165,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 8 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7166,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 15.6 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7167,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 31.2 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7168,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 62.5 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7169,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 125 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7170,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 250 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7171,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",0 % Hemolysis at 500 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7172,28533236,2017,DaplWknr,{nnr:Dap}L{d}WK{d}N{d}R{d}{cyc:N-C},CLP-4,Free,Free,Cyclic,Mix,"Dap = 2,3-diaminopropionic acid, l = D-leucine, k = D-lysine, n = D-asparagine, r = D-arginine",5,"Antibacterial, Antibiofilm",<10 % Hemolysis at 1000 μg/ml,Human,Fusaricidin,NA,Non-hemolytic,NA,NA
7481,29163899,2017,cWkKkC,C{d}WK{d}KK{d}C{cyc:N-C}{ct:Amid},RH1,Amidation,Free,Cyclic,Mix,None,6,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,CCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7482,29163899,2017,CwWkKkC,CW{d}WK{d}KK{d}C{cyc:N-C}{ct:Amid},RH2,Amidation,Free,Cyclic,Mix,None,7,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7483,29163899,2017,cWwKkKkC,C{d}WW{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH3,Amidation,Free,Cyclic,Mix,None,8,Antimicrobial,MHC at 500 μg/ml,Human,Camp,β-Sheet,NA,CCSSCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7484,29163899,2017,CwWwKkKkC,CW{d}WW{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH4,Amidation,Free,Cyclic,Mix,None,9,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCSSCSSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7485,29163899,2017,CwWwKkKkKC,CW{d}WW{d}KK{d}KK{d}KC{cyc:N-C}{ct:Amid},RH5,Amidation,Free,Cyclic,Mix,None,10,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,CCSTTSCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7486,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,CEEETTTEEEC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7487,29163899,2017,cWwWwKkKkKkC,C{d}WW{d}WW{d}KK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH7,Amidation,Free,Cyclic,Mix,None,12,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,CCSSCTTSCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7488,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6m,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-meta-xylene",11,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7489,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6o,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-ortho-xylene.",11,Antimicrobial,MHC at 31 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7490,29163899,2017,CwWwWkKkKkC,CW{d}WW{d}WK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH6ss,Amidation,Free,Cyclic,Mix,Cyclized with disulfide bridge,11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,NA,NA
7491,29163899,2017,CfFfFkKkKkC,CF{d}FF{d}FK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH8,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 500 μg/ml,Human,Camp,β-Sheet,NA,CCCSSSSSCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7492,29163899,2017,ClLlLkKkKkC,CL{d}LL{d}LK{d}KK{d}KK{d}C{cyc:N-C}{ct:Amid},RH9,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at >2000 μg/ml,Human,Camp,β-Sheet,NA,CCSSSSSCCCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O
7493,29163899,2017,CkKkWwWwKkC,CK{d}KK{d}WW{d}WW{d}KK{d}C{cyc:N-C}{ct:Amid},RH10,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 250 μg/ml,Human,Camp,β-Sheet,NA,CTTCCCCCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7494,29163899,2017,CwWkKkKkWwC,CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH11,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7495,29163899,2017,cWwKkKkKwWc,C{d}WW{d}KK{d}KK{d}KW{d}WC{d}{cyc:N-C}{ct:Amid},dRH11,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,CCSCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7496,29163899,2017,CwWkKkKkWwC,CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH11m,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-meta-xylene",11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,NA,NA
7497,29163899,2017,CwWkKkKkWwC,CW{d}WK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH11o,Amidation,Free,Cyclic,Mix,"Cyclized with α,α′-dichloro-ortho-xylene.",11,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,NA,NA
7498,29163899,2017,CkWkWkWkWkC,CK{d}WK{d}WK{d}WK{d}WK{d}C{cyc:N-C}{ct:Amid},RH12,Amidation,Free,Cyclic,Mix,None,10,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCSSCC,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7499,29163899,2017,CWwKkKkKwWwC,CWW{d}KK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid},RH13,Amidation,Free,Cyclic,Mix,None,12,Antimicrobial,MHC at 125 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCSCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7500,29163899,2017,cwWkKkKkWwWc,C{d}W{d}WK{d}KK{d}KK{d}WW{d}WC{d}{cyc:N-C}{ct:Amid},dRH13,Amidation,Free,Cyclic,Mix,None,12,Antimicrobial,Minimum Hemolytic Concentration,Human,Camp,β-Sheet,NA,CCSCCCCSCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7501,29163899,2017,CwWkKkKwWwC,CW{d}WK{d}KK{d}KW{d}WW{d}C{cyc:N-C}{ct:Amid},RH14,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 8 μg/ml,Human,Camp,β-Sheet,NA,CCSCSCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7502,29163899,2017,CwKkKkKkWwC,CW{d}KK{d}KK{d}KK{d}WW{d}C{cyc:N-C}{ct:Amid},RH15,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 250 μg/ml,Human,Camp,β-Sheet,NA,CCCCCCCCSCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7503,29163899,2017,ClLkKkKkLlC,CL{d}LK{d}KK{d}KK{d}LL{d}C{cyc:N-C}{ct:Amid},RH16,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at >2000 μg/ml,Human,Camp,β-Sheet,NA,CCCCCBTTBCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CS)C(=O)O
7504,29163899,2017,CWWKKKKKWWC,CWWKKKKKWWC{cyc:N-C}{ct:Amid},RH17,Amidation,Free,Cyclic,Mix,None,11,Antimicrobial,MHC at 250 μg/ml,Human,Camp,β-Sheet,NA,CCSCCCCCCCC,NCCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O
7505,29163899,2017,C(Me)wWkKkKkW(Me)wC,C{nnr:Me}W{d}WK{d}KK{d}KK{d}W{nnr:Me}W{d}C{cyc:N-C}{ct:Amid},RH18,Amidation,Free,Cyclic,Mix,Me = N-methylation of the peptide bond.,11,Antimicrobial,MHC at 8 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7506,29163899,2017,Cw(Me)WkKkKkW(Me)wC,CW{d}{nnr:Me}WK{d}KK{d}KK{d}W{nnr:Me}W{d}C{cyc:N-C}{ct:Amid},RH19,Amidation,Free,Cyclic,Mix,Me = N-methylation of the peptide bond.,11,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7507,29163899,2017,CwW(Me)kKkK(Me)kWwC,CW{d}W{nnr:Me}K{d}KK{d}K{nnr:Me}K{d}WW{d}C{cyc:N-C}{ct:Amid},RH20,Amidation,Free,Cyclic,Mix,Me = N-methylation of the peptide bond.,11,Antimicrobial,MHC at 1000 μg/ml,Human,Camp,β-Sheet,NA,NA,NA
7857,28026016,2017,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Antimicrobial,3 ± 0.6 % Hemolysis at 150 µM,Horse,Synthetic Peptidotriazoles,NA,NA,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
7858,28026016,2017,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Antimicrobial,3 ± 0.6 % Hemolysis at 250 µM,Horse,Synthetic Peptidotriazoles,NA,NA,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
7859,28026016,2017,KKLKKFKKLQ,KKLKKFKKLQ{cyc:N-C},BPC194,Free,Free,Cyclic,L,None,10,Antimicrobial,4 ± 0.7 % Hemolysis at 375 µM,Horse,Synthetic Peptidotriazoles,NA,NA,CCCTTSSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)O
7860,28026016,2017,AAA(TrBn),AAA{nnr:Tr-Bn}{cyc:N-C},BPC458,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,3,Antimicrobial,2 ± 0.3 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7861,28026016,2017,AAA(TrBn),AAA{nnr:Tr-Bn}{cyc:N-C},BPC458,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,3,Antimicrobial,3 ± 0.5 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7862,28026016,2017,AAA(TrBn),AAA{nnr:Tr-Bn}{cyc:N-C},BPC458,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,3,Antimicrobial,5 ± 0.2 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7863,28026016,2017,AAA(TrNle),AAA{nnr:Tr-Nle}{cyc:N-C},BPC460,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.3 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7864,28026016,2017,AAA(TrNle),AAA{nnr:Tr-Nle}{cyc:N-C},BPC460,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7865,28026016,2017,AAA(TrNle),AAA{nnr:Tr-Nle}{cyc:N-C},BPC460,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7866,28026016,2017,AAA(TrPhNH2),AAA{nnr:TrPhNH2}{cyc:N-C},BPC518,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.1 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7867,28026016,2017,AAA(TrPhNH2),AAA{nnr:TrPhNH2}{cyc:N-C},BPC518,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.1 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7868,28026016,2017,AAA(TrPhNH2),AAA{nnr:TrPhNH2}{cyc:N-C},BPC518,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7869,28026016,2017,AAA(TrPhMe),AAA{nnr:TrPhMe}{cyc:N-C},BPC540,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,2 ± 0.5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7870,28026016,2017,AAA(TrPhMe),AAA{nnr:TrPhMe}{cyc:N-C},BPC540,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,4 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7871,28026016,2017,AAA(TrPhMe),AAA{nnr:TrPhMe}{cyc:N-C},BPC540,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,6 ± 1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7872,28026016,2017,AAA(TrPhOMe),AAA{nnr:TrPhOMe}{cyc:N-C},BPC542,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,1 ± 0.6 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7873,28026016,2017,AAA(TrPhOMe),AAA{nnr:TrPhOMe}{cyc:N-C},BPC542,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,2 ± 0.2 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7874,28026016,2017,AAA(TrPhOMe),AAA{nnr:TrPhOMe}{cyc:N-C},BPC542,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,4 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7875,28026016,2017,AAA(TrPh),AAA{nnr:TrPh}{cyc:N-C},BPC544,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,1 ± 0.4 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7876,28026016,2017,AAA(TrPh),AAA{nnr:TrPh}{cyc:N-C},BPC544,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,1 ± 0.3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7877,28026016,2017,AAA(TrPh),AAA{nnr:TrPh}{cyc:N-C},BPC544,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,2 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7878,28026016,2017,NleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC516,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,5 ± 0.2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7879,28026016,2017,NleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC516,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,6 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7880,28026016,2017,NleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC516,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph = triazole bearing a phenyl group",3,Antimicrobial,8 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7881,28026016,2017,NleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC538,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.8 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7882,28026016,2017,NleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC538,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,1 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7883,28026016,2017,NleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC538,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",3,Antimicrobial,2 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7884,28026016,2017,NleNleNle(TrPhMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C},BPC548,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,12 ± 0.3 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7885,28026016,2017,NleNleNle(TrPhMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C},BPC548,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,24 ± 1 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7886,28026016,2017,NleNleNle(TrPhMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhMe}{cyc:N-C},BPC548,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-Me = triazole bearing a tolyl group",3,Antimicrobial,26 ± 4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7887,28026016,2017,NleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC550,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,7 ± 0.8 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7888,28026016,2017,NleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC550,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,10 ± 0.8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7889,28026016,2017,NleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC550,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-PhOMe = triazole bearing an anisole moiety",3,Antimicrobial,19 ± 5 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7890,28026016,2017,KKK(COTr),KKK{nnr:COTr}{cyc:N-C},BPC692,Free,Free,Cyclic,L,Tr = unsubsituted triazole,3,Antimicrobial,5 ± 0.7 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7891,28026016,2017,KKK(COTr),KKK{nnr:COTr}{cyc:N-C},BPC692,Free,Free,Cyclic,L,Tr = unsubsituted triazole,3,Antimicrobial,5 ± 0.8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7892,28026016,2017,KKK(COTr),KKK{nnr:COTr}{cyc:N-C},BPC692,Free,Free,Cyclic,L,Tr = unsubsituted triazole,3,Antimicrobial,7 ± 0.2 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7893,28026016,2017,KKK(COTrBn),KKK{nnr:COTrBn}{cyc:N-C},BPC696,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",3,Antimicrobial,19 ± 4 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7894,28026016,2017,KKK(COTrBn),KKK{nnr:COTrBn}{cyc:N-C},BPC696,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",3,Antimicrobial,20 ± 5 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7895,28026016,2017,KKK(COTrBn),KKK{nnr:COTrBn}{cyc:N-C},BPC696,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",3,Antimicrobial,30 ± 4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7896,28026016,2017,KKK(COTrNle),KKK{nnr:COTrNle}{cyc:N-C},BPC700,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7897,28026016,2017,KKK(COTrNle),KKK{nnr:COTrNle}{cyc:N-C},BPC700,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.4 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7898,28026016,2017,KKK(COTrNle),KKK{nnr:COTrNle}{cyc:N-C},BPC700,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",3,Antimicrobial,0 ± 0.1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7899,28026016,2017,AAAAA(TrBn),AAAAA{nnr:TrBn}{cyc:N-C},BPC510,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",5,Antimicrobial,32 ± 2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7900,28026016,2017,AAAAA(TrBn),AAAAA{nnr:TrBn}{cyc:N-C},BPC510,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",5,Antimicrobial,35 ± 3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7901,28026016,2017,AAAAA(TrBn),AAAAA{nnr:TrBn}{cyc:N-C},BPC510,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Bn = triazole bearing a benzyl group",5,Antimicrobial,40 ± 4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7902,28026016,2017,AAAAA(TrNle),AAAAA{nnr:Tr-Nle}{cyc:N-C},BPC512,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",5,Antimicrobial,2 ± 0.1 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7903,28026016,2017,AAAAA(TrNle),AAAAA{nnr:Tr-Nle}{cyc:N-C},BPC512,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",5,Antimicrobial,2 ± 0.2 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7904,28026016,2017,AAAAA(TrNle),AAAAA{nnr:Tr-Nle}{cyc:N-C},BPC512,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Nle = triazole bearing a 2-aminohexanoic acid",5,Antimicrobial,3 ± 0.4 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7905,28026016,2017,AAAAA(TrPhNH2),AAAAA{nnr:TrPhNH2}{cyc:N-C},BPC514,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",5,Antimicrobial,16 ± 0.9 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7906,28026016,2017,AAAAA(TrPhNH2),AAAAA{nnr:TrPhNH2}{cyc:N-C},BPC514,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",5,Antimicrobial,19 ± 0.8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7907,28026016,2017,AAAAA(TrPhNH2),AAAAA{nnr:TrPhNH2}{cyc:N-C},BPC514,Free,Free,Cyclic,L,"Tr = unsubsituted triazole, Tr-Ph-NH2 = triazole bearing an aniline moiety",5,Antimicrobial,23 ± 2 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7908,28026016,2017,NleNleNleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC562,Free,Free,Cyclic,L,Tr-Ph = triazole bearing a phenyl group,5,Antimicrobial,42 ± 5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7909,28026016,2017,NleNleNleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC562,Free,Free,Cyclic,L,Tr-Ph = triazole bearing a phenyl group,5,Antimicrobial,51 ± 3 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7910,28026016,2017,NleNleNleNleNle(TrPh),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPh}{cyc:N-C},BPC562,Free,Free,Cyclic,L,Tr-Ph = triazole bearing a phenyl group,5,Antimicrobial,58 ± 1 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7911,28026016,2017,NleNleNleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC572,Free,Free,Cyclic,L,Tr-Ph-NH2 = triazole bearing an aniline moiety,5,Antimicrobial,8 ± 0.2 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7912,28026016,2017,NleNleNleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC572,Free,Free,Cyclic,L,Tr-Ph-NH2 = triazole bearing an aniline moiety,5,Antimicrobial,13 ± 0.2 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7913,28026016,2017,NleNleNleNleNle(TrPhNH2),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhNH2}{cyc:N-C},BPC572,Free,Free,Cyclic,L,Tr-Ph-NH2 = triazole bearing an aniline moiety,5,Antimicrobial,25 ± 5 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7914,28026016,2017,NleNleNleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC558,Free,Free,Cyclic,L,Tr-PhOMe = triazole bearing an anisole moiety,5,Antimicrobial,54 ± 4 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7915,28026016,2017,NleNleNleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC558,Free,Free,Cyclic,L,Tr-PhOMe = triazole bearing an anisole moiety,5,Antimicrobial,76 ± 8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7916,28026016,2017,NleNleNleNleNle(TrPhOMe),{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:Nle}{nnr:TrPhOMe}{cyc:N-C},BPC558,Free,Free,Cyclic,L,Tr-PhOMe = triazole bearing an anisole moiety,5,Antimicrobial,90 ± 8 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7917,28026016,2017,KKKKK(COTr),KKKKK{nnr:COTr}{cyc:N-C},BPC690,Free,Free,Cyclic,L,Tr = unsubsituted triazole,5,Antimicrobial,47 ± 7 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7918,28026016,2017,KKKKK(COTr),KKKKK{nnr:COTr}{cyc:N-C},BPC690,Free,Free,Cyclic,L,Tr = unsubsituted triazole,5,Antimicrobial,67 ± 8 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7919,28026016,2017,KKKKK(COTr),KKKKK{nnr:COTr}{cyc:N-C},BPC690,Free,Free,Cyclic,L,Tr = unsubsituted triazole,5,Antimicrobial,75 ± 7 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7920,28026016,2017,KKKKK(COTrBn),KKKKK{nnr:COTrBn}{cyc:N-C},BPC694,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,57 ± 5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7921,28026016,2017,KKKKK(COTrBn),KKKKK{nnr:COTrBn}{cyc:N-C},BPC694,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,74 ± 15 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7922,28026016,2017,KKKKK(COTrBn),KKKKK{nnr:COTrBn}{cyc:N-C},BPC694,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,93 ± 15 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7923,28026016,2017,KKKKK(COTrNle),KKKKK{nnr:COTrNle}{cyc:N-C},BPC698,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,3 ± 0.5 % Hemolysis at 150 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7924,28026016,2017,KKKKK(COTrNle),KKKKK{nnr:COTrNle}{cyc:N-C},BPC698,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,4 ± 1 % Hemolysis at 250 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7925,28026016,2017,KKKKK(COTrNle),KKKKK{nnr:COTrNle}{cyc:N-C},BPC698,Free,Free,Cyclic,L,Tr-Bn = triazole bearing a benzyl group,5,Antimicrobial,5 ± 0.7 % Hemolysis at 375 µM,Horse,Bpc194 Analog,NA,NA,NA,NA
7928,28833783,2017,IDWKKLLKAAKPraIL,IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid},C-MPI-1,Amidation,Acetylation,Cyclic,Mix,Pra = L-propargylglycine,16,Antimicrobial,30 % Hemolysis at 50 µM,Human,Mpi Analogs,α-Helical,NA,NA,NA
7929,28833783,2017,IDWKKLLKAAKPraIL,IDWKKLLKAAK{nnr:Pra}IL{cyc:N-C}{nt:Acet}{ct:Amid},C-MPI-1,Amidation,Acetylation,Cyclic,Mix,Pra = L-propargylglycine,16,Antimicrobial,35 % Hemolysis at 150 µM,Human,Mpi Analogs,α-Helical,NA,NA,NA
8381,38663759,2024,RRRW-Dip-Dip,RRRW-{nnr:Dip}-{nnr:Dip}{cyc:N-C},1a,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 50 μg/ml,Human,Synthetic,NA,NA,NA,NA
8382,38663759,2024,RRR-Dip-W-Dip,RRR-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C},1b,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 75 μg/ml,Human,Synthetic,NA,NA,NA,NA
8383,38663759,2024,RRR-Dip-Dip-W,RRR-{nnr:Dip}-{nnr:Dip}-W{cyc:N-C},1c,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 65 μg/ml,Human,Synthetic,NA,NA,NA,NA
8384,38663759,2024,RRRW-Nal-Nal,RRRW-{nnr:Nal}-{nnr:Nal}{cyc:N-C},2a,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,4,Antimicrobial,50 % Hemolysis at 60 μg/ml,Human,Synthetic,NA,NA,NA,NA
8385,38663759,2024,RRR-Nal-W-Nal,RRR-{nnr:Nal}-W-{nnr:Nal}{cyc:N-C},2b,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,4,Antimicrobial,50 % Hemolysis at 55 μg/ml,Human,Synthetic,NA,NA,NA,NA
8386,38663759,2024,RRR-Nal-Nal-W,RRR-{nnr:Nal}-{nnr:Nal}-W{cyc:N-C},2c,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,4,Antimicrobial,50 % Hemolysis at 45 μg/ml,Human,Synthetic,NA,NA,NA,NA
8387,38663759,2024,RRRRW-Dip-Dip,RRRRW-{nnr:Dip}-{nnr:Dip}{cyc:N-C},3a,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",5,Antimicrobial,50 % Hemolysis at 85 μg/ml,Human,Synthetic,NA,NA,NA,NA
8388,38663759,2024,RRRR-Dip-W-Dip,RRRR-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C},3b,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",5,Antimicrobial,50 % Hemolysis at 230 μg/ml,Human,Synthetic,NA,NA,NA,NA
8389,38663759,2024,RRRR-Dip-Dip-W,RRRR-{nnr:Dip}-{nnr:Dip}-W{cyc:N-C},3c,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",5,Antimicrobial,50 % Hemolysis at 100 μg/ml,Human,Synthetic,NA,NA,NA,NA
8390,38663759,2024,RRRRW-Nal-Nal,RRRRW-{nnr:Nal}-{nnr:Nal}{cyc:N-C},4a,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at 150 μg/ml,Human,Synthetic,NA,NA,NA,NA
8391,38663759,2024,RRRR-Nal-W-Nal,RRRR-{nnr:Nal}-W-{nnr:Nal}{cyc:N-C},4b,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at 175 μg/ml,Human,Synthetic,NA,NA,NA,NA
8392,38663759,2024,RRRR-Nal-Nal-W,RRRR-{nnr:Nal}-{nnr:Nal}-W{cyc:N-C},4c,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at 105 μg/ml,Human,Synthetic,NA,NA,NA,NA
8393,38663759,2024,RRRRW-Dip-W,RRRRW-{nnr:Dip}-W{cyc:N-C},5a,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",6,Antimicrobial,50 % Hemolysis at 220 μg/ml,Human,Synthetic,NA,NA,NA,NA
8394,38663759,2024,RRRRW-Nal-W,RRRRW-{nnr:Nal}-W{cyc:N-C},5b,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antimicrobial,50 % Hemolysis at 200 μg/ml,Human,Synthetic,NA,NA,NA,NA
8395,38663759,2024,RRRR-Dip-L-Dip,RRRR-{nnr:Dip}-L-{nnr:Dip}{cyc:N-C},6a,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",5,Antimicrobial,50 % Hemolysis at 155 μg/ml,Human,Synthetic,NA,NA,NA,NA
8396,38663759,2024,RRRR-Nal-L-Nal,RRRR-{nnr:Nal}-L-{nnr:Nal}{cyc:N-C},6b,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,5,Antimicrobial,50 % Hemolysis at 170 μg/ml,Human,Synthetic,NA,NA,NA,NA
8397,38663759,2024,Agp-Agp-Agp-Agp-Dip-W-Dip,{nnr:Agp}-{nnr:Agp}-{nnr:Agp}-{nnr:Agp}-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C},7a,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine, Agp = (S)−2-amino-3-guanidinopropionic acid",1,Antimicrobial,50 % Hemolysis at 240 μg/ml,Human,Synthetic,NA,NA,NA,NA
8398,38663759,2024,Agb-Agb-Agb-Agb-Dip-W-Dip,{nnr:Agb}-{nnr:Agb}-{nnr:Agb}-{nnr:Agb}-{nnr:Dip}-W-{nnr:Dip}{cyc:N-C},7b,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine, Agb = (S)−2-amino-4-guanidinobutyric acid",1,Antimicrobial,50 % Hemolysis at 190 μg/ml,Human,Synthetic,NA,NA,NA,NA
8399,38663759,2024,hArg-R-hArg-R-Dip-W-Dip,{nnr:hArg}R{nnr:hArg}R{nnr:Dip}W{nnr:Dip}{cyc:N-C},7c,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine, hArg = homo-arginine (S)−2-amino-6-guanidino-hexanoic acid",7,Antimicrobial,50 % Hemolysis at 160 μg/ml,Human,Synthetic,NA,NA,NA,NA
8400,38663759,2024,RRRR-Dip-Dip-Dip,RRRR-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},8a,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",4,Antimicrobial,50 % Hemolysis at 70 μg/ml,Human,Synthetic,NA,NA,NA,NA
8401,38663759,2024,RRRR-Nal-Nal-Nal,RRRR-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},8b,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,4,Antimicrobial,50 % Hemolysis at 80 μg/ml,Human,Synthetic,NA,NA,NA,NA
8672,29077406,2017,fPVOL-fPVOL,F{d}PV{nnr:O}L-F{d}PV{nnr:O}L{cyc:N-C},GS,Free,Free,Cyclic,Mix,"O = Ornithine, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 12 μg/ml,Human,Aneurinibacillus Migulanus,C2-symmetric antiparallel β-Sheet,NA,NA,NA
8673,29077406,2017,f(Dyp)VOLfPVOL,F{d}{nnr:Dyp}V{nnr:O}LF{d}PV{nnr:O}L{cyc:N-C},GS mimetic 15,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 85 μg/ml,Human,Gs Derivative Synthesized,β-Turn,NA,NA,NA
8674,29077406,2017,D-Hot═Tap-V-O-L-f-P-V-O-L,{nnr:D-Hot═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C},dimethylketal modified GS analogue,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",9,Antimicrobial,90 % Hemolysis at >200 μg/ml,Human,Dihydroxylated Dipeptide D-Hot═Tap (D-Hydroxythreonine═Thiaproline With The “═” Representing The Two Covalent Ring Connections),twisted β-Sheet structure,NA,NA,NA
8675,29077406,2017,"D-Hot[(7S,8S)-O-(2(S)-decyliden)]═Tap-V-O-L-f-P-V-O-L","{nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-decyliden)]═Tap}-V-{nnr:O}-L-F{d}-P-V-{nnr:O}-L{cyc:N-C}",GS mimetic 17,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 38 μg/ml,Human,Gs Analogue Modified With A C8- Alkyl Chain,twisted β-Sheet structure,NA,NA,NA
8676,29077406,2017,"D-Hot[(7S,8S)-O-(2(S)-pentadecyliden)]═Tap-V-O-L- f-P-V-O-L","{nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-pentadecyliden)]═Tap}-V-{nnr:O}-L- F{d}-P-V-{nnr:O}-L{cyc:N-C}",GS mimetic 18,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 6 μg/ml,Human,Gs Analogue 18 Modified With A C13-Alkyl Chain,twisted β-Sheet structure,NA,NA,NA
8677,29077406,2017,"D-Hot[(7S,8S)-O-(2(S)-8-pentadecyliden)]═Tap-V-O L-f-P-V-O-L","{nnr:D-Hot[(7S,8S)-{nnr:O}-(2(S)-8-pentadecyliden)]═Tap}-V-{nnr:O}L-F{d}-P-V-{nnr:O}-L{cyc:N-C}",GS mimetic 19,Free,Free,Cyclic,Mix,"O = Ornithine, Dyp = cis-dihydroxyproline, D-Hot═Tap = D-Hot═Tap, f = D-Phenylalanine",10,Antimicrobial,90 % Hemolysis at 5 μg/ml,Human,Gs Analogue Modified With Two C7-Alkyl Chains,twisted β-Sheet structure,NA,NA,NA
8712,29568446,2017,ACLLQSLLCPYSTHRCG,ACLLQSLLCPYSTHRCG{cyc:N-C},P8-d-C10,Free,Free,Bicyclic,L,None,17,Antibacterial,6 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Low hemolytic,CGGGGTGGGTCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8713,29568446,2017,ACLLQSLLCPYSTHACG,ACLLQSLLCPYSTHACG{cyc:N-C},P8-d-(R15A)-C10,Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCCCCCGGGTTCCCSCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8714,29568446,2017,ACLLQSLLCPYSTARCG,ACLLQSLLCPYSTARCG{cyc:N-C},"P8-d-(H14R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,2 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Low hemolytic,CCTTCCHHHHSCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8715,29568446,2017,ACLLQSLLCAYSTHRCG,ACLLQSLLCAYSTHRCG{cyc:N-C},"P8-d-(P10R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCCHHHHTTSCCCTTCC,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8716,29568446,2017,ACLLQALLCPYSTHRCG,ACLLQALLCPYSTHRCG{cyc:N-C},"P8-d-(S6R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCTHHHHHHHTTTCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8717,29568446,2017,ACLLQALLCPYSTHRCG,ACLLQALLCPYSTHRCG{cyc:N-C},"P8-L-(S6R, R15A)-C10",Free,Free,Bicyclic,L,None,17,Antibacterial,0 % Hemolysis at 32 μg/ml,Sheep,Peptide Phage,NA,Non-hemolytic,CCSCCSCSSSSSCCCCC,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C)O
8821,29140694,2017,fPFfNQYVOL,F{d}PFF{d}NQYV{nnr:O}L{cyc:N-C},Tyrocidine A,Free,Free,Cyclic,Mix,"BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine",10,Antimicrobial,100 % Hemolysis at 5 μg/ml,Mouse,Bacillus Brevis,β-Hairpin,NA,NA,NA
8822,29140694,2017,fBE2FfNQYVOL,F{d}{nnr:BE2}FF{d}NQYV{nnr:O}L{cyc:N-C},Tyrocidine A analogue AC3.27,Free,Free,Cyclic,Mix,"BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine",10,Antifungal,~60 % Hemolysis at 38 μg/ml,Mouse,Synthetic Analogue Of Tyrocidine A,β-Hairpin,NA,NA,NA
8823,29140694,2017,fBE2FfNKYVOL,F{d}{nnr:BE2}FF{d}NKYV{nnr:O}L{cyc:N-C},Tyrocidine A analogue AC3.28,Free,Free,Cyclic,Mix,"BE2 = 2-AMINOBENZOIC ACID, f = D-Phenylalanine, O = L-Ornithine",10,Antifungal,~60 % Hemolysis at 38 μg/ml,Mouse,Synthetic Analogue Of Tyrocidine A,β-Hairpin,NA,NA,NA
8824,29188836,2017,fPVRLfPVRL,F{d}PVRLF{d}PVRL{cyc:N-C},GS-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 10.03±0.49 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,CTTSCCCCCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8825,29188836,2017,aPVRLfPVRL,A{d}PVRLF{d}PVRL{cyc:N-C},MGR-1,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 67.18±2.94 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,CCGGGTSTTSSCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
8826,29188836,2017,fAVRLfPVRL,F{d}AVRLF{d}PVRL{cyc:N-C},MGR-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 55.03±1.77 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,CHHHHHHHHTTCC,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8827,29188836,2017,fPARLfPVRL,F{d}PARLF{d}PVRL{cyc:N-C},MGR-3,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 30.56±1.80 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)O
8828,29188836,2017,fPVALfPVRL,F{d}PVALF{d}PVRL{cyc:N-C},MGR-4,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 14.41±0.51 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8829,29188836,2017,fPVRAfPVRL,F{d}PVRAF{d}PVRL{cyc:N-C},MGR-5,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 36.33±1.98 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8830,29188836,2017,aPVRLaPVRL,A{d}PVRLA{d}PVRL{cyc:N-C},DGR-1,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 137.40±6.20 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N)C(C)C)C(C)C)C(=O)O
8831,29188836,2017,fAVRLfAVRL,F{d}AVRLF{d}AVRL{cyc:N-C},DGR-2,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 199.90±9.80 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8832,29188836,2017,fPARLfPARL,F{d}PARLF{d}PARL{cyc:N-C},DGR-3,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at 88.95±7.51 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(=O)O
8833,29188836,2017,fPVALfPVAL,F{d}PVALF{d}PVAL{cyc:N-C},DGR-4,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at >200 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(=O)O
8834,29188836,2017,fPVRAfPVRA,F{d}PVRAF{d}PVRA{cyc:N-C},DGR-5,Free,Free,Cyclic,Mix,None,10,Antibiotic,"50 % Hemolysis at >200 (mean±SD, µM)",Human,Bacillus Brevis (Gramicidin S (Gs)),NA,Low hemolytic,NA,CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O
8900,29038271,2018,NPYNQTSX,NPYNQTS{nnr:X}{cyc:N-C},AF3,Xaa - β-amino fatty acid variant,Free,Cyclic,L,X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17,8,Antifungal,10 % Hemolysis at 8 μg/ml,Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8901,29038271,2018,NPYNQTSX,NPYNQTS{nnr:X}{cyc:N-C},AF3,Xaa - β-amino fatty acid variant,Free,Cyclic,L,X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17,8,Antifungal,50 % Hemolysis at 16.4 μg/ml,Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8902,29038271,2018,NPYNQTSX,NPYNQTS{nnr:X}{cyc:N-C},AF4,Xaa - β-amino fatty acid variant,Free,Cyclic,L,X = Xaa is a β-amino fatty acid variant for AF4-iso-C17,8,Antifungal,∼5.6 % Hemolysis at 8 μg/ml,Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8903,29038271,2018,NPYNQTSX,NPYNQTS{nnr:X}{cyc:N-C},AF4,Xaa - β-amino fatty acid variant,Free,Cyclic,L,X = Xaa is a β-amino fatty acid variant for AF4-iso-C17,8,Antifungal,50 % Hemolysis at 17.7 μg/ml,Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8904,29038271,2018,NPYNQTSX,NPYNQTS{nnr:X}{cyc:N-C},AF5,Xaa - β-amino fatty acid variant,Free,Cyclic,L,X = Xaa is a β-amino fatty acid variant for AF5-iso-C18,8,Antifungal,50 % Hemolysis at 8 μg/ml,Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8905,29038271,2018,NPYNQTSXNPYNQTSX,NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C},"AF3, AF4","Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant",Free,Cyclic,L,"X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17, X = Xaa is a β-amino fatty acid variant for AF4-iso-C17",16,"Antifungal, Antifungal","3.87±3.7 % Hemolysis at 4,4 μg/ml",Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8906,29038271,2018,NPYNQTSXNPYNQTSX,NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C},"AF3, AF5","Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant",Free,Cyclic,L,"X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18",16,"Antifungal, Antifungal","3.43±3.1 % Hemolysis at 4,4 μg/ml",Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8907,29038271,2018,NPYNQTSXNPYNQTSX,NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C},"AF3, AF5","Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant",Free,Cyclic,L,"X = Xaa is a β-amino fatty acid variant for AF3-anteiso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18",16,"Antifungal, Antifungal","4.11±5.9 % Hemolysis at 2,4 μg/ml",Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8908,29038271,2018,NPYNQTSXNPYNQTSX,NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C},"AF4, AF5","Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant",Free,Cyclic,L,"X = Xaa is a β-amino fatty acid variant for AF4-iso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18",16,"Antifungal, Antifungal","3.12±3.4 % Hemolysis at 4,4 μg/ml",Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8909,29038271,2018,NPYNQTSXNPYNQTSX,NPYNQTS{nnr:X}NPYNQTS{nnr:X}{cyc:N-C},"AF4, AF5","Xaa - β-amino fatty acid variant, Xaa - β-amino fatty acid variant",Free,Cyclic,L,"X = Xaa is a β-amino fatty acid variant for AF4-iso-C17, X = Xaa is a β-amino fatty acid variant for AF5-iso-C18",16,"Antifungal, Antifungal","2.96±4.1 % Hemolysis at 2,4 μg/ml",Human,Bacillus Subtilis Rlid 12.1,NA,NA,NA,NA
8976,29360748,2018,RVCSAIPLPICH,RVCSAIPLPICH{cyc:3-11}{ct:Amid},tigerinin-1R,Amidation,Free,Cyclic,L,C–C in parentheses means that the two Cys residues in the sequences form intermolecular disulfide bond,12,Non-toxic insulin-releasing peptide,<2 % Hemolysis at 250 µM,Human,Frog (Hoplobatrachus Ugulosus),"Random coils (48), and type I reverse βTurns (12) in 50 aqueous TFE",Non-hemolytic,CCCHHHHHHHTTTC,NA
8977,29360748,2018,RVCSLLPLPLCH,RVCSLLPLPLCH{cyc:3-11}{ct:Amid},tigerinin-1R-L4,Amidation,Free,Cyclic,L,C–C in parentheses means that the two Cys residues in the sequences form intermolecular disulfide bond,12,Non-toxic insulin-releasing peptide,<3 % Hemolysis at 250 µM,Human,Tigerinin-1R Analogs,Random coil,Low hemolytic,CCCHHHHHHHTTTC,NA
8978,29360748,2018,CSAIPLPIC,CSAIPLPIC{cyc:1-9}{ct:Amid},tigerinin-cyclic,Amidation,Free,Cyclic,L,C–C in parentheses means that the two Cys residues in the sequences form intermolecular disulfide bond,9,Non-toxic insulin-releasing peptide,<2 % Hemolysis at 250 µM,Human,Tigerinin-1R Analogs,Random coil,Non-hemolytic,CCCHHHHHHHTTTC,NA
9041,29277569,2018,VYPFCWGGAYAFCKAKLV,VYPFCWGGAYAFCKAKLV{cyc:N-C}{ct:Amid},cVT18-CAKKLV,Amidation,Free,Cyclic,L,None,18,Antibacterial,1.8 % Hemolysis at 100 μg/ml,Human,Vt18-Cakklv Cyclized Between Cys88 And Cys96,Double Strand β-Sheet,Low hemolytic,NA,CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@H](C(=O)O)C(C)C
9139,29411917,2018,aza-β3Lys-K-aza-β3-1Nal-K-aza-β3-1Nal-L,{nnr:aza-β3Lys}-K-{nnr:aza-β3-1Nal}-K-{nnr:aza-β3-1Nal}-L{cyc:N-C},ACPP20,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),1.5 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,Low hemolytic,NA,NA
9140,29411917,2018,aza-β3Lys-K-aza-β3-2Nal-L-aza-β3-2Nal-L,{nnr:aza-β3Lys}-K-{nnr:aza-β3-2Nal}-L-{nnr:aza-β3-2Nal}-L{cyc:N-C},ACPP21,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),8 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9141,29411917,2018,aza-β3Lys-K-aza-β3-1Nal-L-aza-β3-4Fluo-1Nal-L,{nnr:aza-β3Lys}-K-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-4Fluo-1Nal}-L{cyc:N-C},ACPP22,Free,Free,Cyclic,L,"aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-4Fluo-1Nal = aza-β3-4Fluoro-1-Nahphtylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),5 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,Low hemolytic,NA,NA
9142,29411917,2018,K-aza-β3Lys-L-aza-β3-1Nal-aza-β3Leu-aza-β3-1Nal,K-{nnr:aza-β3Lys}-L-{nnr:aza-β3-1Nal}-aza-β3Leu-{nnr:aza-β3-1Nal}{cyc:N-C},ACPP23,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-1Nal = aza-β3-1-Naphthylalanine, aza-β3-Leu = aza-β3-Leucine, aza-β3-1Nal = aza-β3-1-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),6 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9143,29411917,2018,aza-β3Arg-R-aza-β3-1Nal-L-aza-β3-1Nal-L,aza-β3Arg-R-{nnr:aza-β3-1Nal}-L-{nnr:aza-β3-1Nal}-L{cyc:N-C},ACPP24,Free,Free,Cyclic,L,"aza-β3-Arg = aza-β3-Arginine, aza-β3-1Nal = aza-β3-1-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),12 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9144,29411917,2018,aza-β3Lys-R-aza-β3-2Nal-F-aza-β3-2Nal-F,{nnr:aza-β3Lys}-R-{nnr:aza-β3-2Nal}-F-{nnr:aza-β3-2Nal}-F{cyc:N-C},ACPP25,Free,Free,Cyclic,L,"aza-β3-Lys = aza-β3-Lysine, aza-β3-2Nal = aza-β3-2-Naphthylalanine",6,Antimicrobial cyclic pseudopeptides (ACPPs),50 % Hemolysis at 100 µM,Sheep,Synthesis Of Mixed Aza-Β3-Pseudopeptides,NA,NA,NA,NA
9150,29904274,2018,CLNLKALLAVAKKILC,CLNLKALLAVAKKILC{cyc:N-C}{ct:Amid},cMP-C,Amidation,Free,Cyclic,L,None,16,Antimicrobial,50 % Hemolysis at 9.19 µM,Horse,Modifcation In Mp-C A Skeleton-Based Cyclization By Two Cysteine Residues,"α-Helical at aq, α-Helical at membrane mimic solution",NA,NA,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
9256,29621496,2018,NapNpmNapNpmNapNpm,{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C},C1,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine",6,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9257,29621496,2018,NapNdmbNapNdmbNapNdmb,{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{nnr:Nap}{nnr:Ndmb}{cyc:N-C},C2,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Ndmb = N-(3,5-dimethylbenzyl)glycine",6,Antibacterial,10 % Hemolysis at 125 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9258,29621496,2018,NapNsneNapNsneNapNsne,{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{nnr:Nap}{nnr:Nsne}{cyc:N-C},C3,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Nsne = (S)-N-(1-naphthylethyl)glycine",6,Antibacterial,10 % Hemolysis,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9259,29621496,2018,NapNdpNapNdpNapNdp,{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{nnr:Nap}{nnr:Ndp}{cyc:N-C},C4,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Ndp = N-(2,2-diphenylethyl)glycine",6,Antibacterial,10 % Hemolysis at 31.3 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9260,29621496,2018,NapNbtfmbNapNbtfmbNapNbtfmb,{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{nnr:Nap}{nnr:Nbtfmb}{cyc:N-C},C5,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Nbtfmb = N-(3,5-bis-trifluoromethylbenzyl)glycine",6,Antibacterial,10 % Hemolysis at 31.3 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9261,29621496,2018,NapNpmNapNpmNapNpmNapNpmNapNpm,{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{nnr:Nap}{nnr:Npm}{cyc:N-C},C1dec,Free,Free,Cyclic,Mix,"Nap = N-(3-aminopropyl)glycine, Npm = N-(1-phenylmethyl)glycine",10,Antibacterial,10 % Hemolysis at 250 μg/ml,Human,Synthetic Peptoids Mimic Antimicrobial Peptides,NA,NA,NA,NA
9262,29621496,2018,VOLfPVOLfP,V{nnr:O}LF{d}PV{nnr:O}LF{d}P{cyc:N-C},CGS (gramicidin S),Free,Free,Cyclic,Mix,"O = L-Ornithine, f = D-phenylalanine",10,Antibacterial,10 % Hemolysis at >15.6 μg/ml,Human,Gram-Positive Bacterium Brevibacillus Brevis,NA,NA,NA,NA
9398,29750913,2018,Cyclo(1‑4)‑cILC-KKLFKKILKYL,C{d}ILC-KKLFKKILKYL{cyc:1‑4},Cyclo (1‑4)‑cILC-BP100,Free,Free,Cyclic,Mix,disulfide bond between D-Cys1 and Cys4 at N-Terminal,11,Antimicrobial,50 % Hemolysis at 8.7 µM,Human,Synthesized Analog Of Bp100,membrane =Partly α-Helical and partly β-Turn,NA,NA,NA
9433,29760411,2018,A{d}-L/I-L/I-L/I-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-S{d}-K-K,A{d}-L/I-L/I-L/I-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-S{d}-K-K{cyc},Paenialvin-A,Free,Free,Bicyclic,Mix,None,23,"Antibacterial,Antitumor",3.61 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9434,29760411,2018,L/I-A{d}-L/I-L/I-I/L-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-A{d}-K-K,L/I-A{d}-L/I-L/I-I/L-R{d}-L/I-L/I-V{d}-K-L/I-T-L/I-A{d}-K-K{cyc},Paenialvin-B,Free,Free,Bicyclic,Mix,None,23,Antibacterial,1.93 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9435,29760411,2018,L-A{d}-L-L-V{d}-R{d}-L-L-V{d}-K-L-T-L-S{d}-K-K,L-A{d}-L-L-V{d}-R{d}-L-L-V{d}-K-L-T-L-S{d}-K-K{cyc},Paenialvin-C,Free,Free,Bicyclic,D,None,23,Antibacterial,0 % Hemolysis at 50 μg/ml,Rabbit,Bacteria Paenibacillus Alvei Dsm 29,NA,Non-hemolytic,NA,NA
9493,30112781,2018,KβcfKK,K{nnr:β}{nnr:cf}KK{cyc:N-C},5a,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9494,30112781,2018,KβcfGK,K{nnr:β}{nnr:cf}GK{cyc:N-C},5b,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9495,30112781,2018,KβcfAK,K{nnr:β}{nnr:cf}AK{cyc:N-C},5c,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at >500 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9496,30112781,2018,KβcfFK,K{nnr:β}{nnr:cf}FK{cyc:N-C},5d,Free,Free,Cyclic,Mix,"β = lipophilic β2,2‐amino acid, cf = 4-CF3 (β-phenylalanine derivative has a trifluoromethyl CF3 )",4,Antibacterial,50 % Hemolysis at 88 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9497,30112781,2018,KβdicfKK,K{nnr:β}{nnr:dicf}KK{cyc:N-C},6a,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 216 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9498,30112781,2018,KβdicfGK,K{nnr:β}{nnr:dicf}GK{cyc:N-C},6b,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 100 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9499,30112781,2018,KβdicfAK,K{nnr:β}{nnr:dicf}AK{cyc:N-C},6c,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 67 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9500,30112781,2018,KβdicfFK,K{nnr:β}{nnr:dicf}FK{cyc:N-C},6d,Free,Free,Cyclic,Mix,"β = β^(2,2), dicf = 3,5diCF3(β-phenylalanine derivative has trifluoromethyl CF3 groups)",4,Antibacterial,50 % Hemolysis at 84 μg/ml,Human,Synthetic Cyclic Amps,NA,NA,NA,NA
9582,30135470,2018,R-dabVdabFLdabVLS,{nnr:R}-{nnr:dab}V{nnr:dab}FL{nnr:dab}VLS{cyc:N-C},PGP-E,Free,Free,Cyclic,Mix,"Dab = Diaminobutyric acid, R = CH2CH2CH3(propyl group)",9,Antimicrobial,<50 % Hemolysis at 200 µM,Human,Bacteria Paenibacillus Elgii Bc34-6,NA,NA,NA,NA
9592,30325566,2018,ELlVDlL,ELL{d}VDL{d}L{cyc:N-C}{nt:Amid},surfactin,Free,Amidation,Cyclic,Mix,l = D-Leucine,7,Antimicrobial,high % Hemolysis at 100 µM,Human,Bacteria Bacillus Subtilis,NA,NA,NA,NA
9635,30387611,2018,GLPICGETCVFGKCNTPGCSCRRPICYKN,GLPICGETCVFGKCNTPGCSCRRPICYKN{cyc:N-C},Rivi1,Free,Free,Cyclic,L,None,29,Anticancer,50 % Hemolysis at ≫10 µM,Human,Plant Rinorea Virgata,Loop,NA,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)O
9636,30387611,2018,GSYLCGETCVQGKCYTPGCTCSWPICKKN,GSYLCGETCVQGKCYTPGCTCSWPICKKN{cyc:N-C},Rivi2,Free,Free,Cyclic,L,None,29,Anticancer,50 % Hemolysis at ≫10 µM,Human,Plant Rinorea Virgata,Loop,NA,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
9637,30387611,2018,GLPICGETCLLGKCYTPGCSCRRPVCYKN,GLPICGETCLLGKCYTPGCSCRRPVCYKN{cyc:N-C},Rivi3,Free,Free,Cyclic,L,None,29,Anticancer,50 % Hemolysis at ≫10 µM,Human,Plant Rinorea Virgata,Loop,NA,CHHHHHHHHHTTTTSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)[C@@H](C)O
9917,30973929,2019,EVlADlV,EVL{d}ADL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP1,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,7,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",40 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CHHHHHHHHHHHHHHHTTHHHHHHC,NA
9918,30973929,2019,EVlDlV,EVL{d}DL{d}V{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP2,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,6,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",100 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCHHHHHHHHTTTCC,NA
9919,30973929,2019,EVlDl,EVL{d}DL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP3,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",80 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCHHHHHHHHTTTCC,NA
9920,30973929,2019,EVll,EVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP4,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,4,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",5 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,Low hemolytic,CHHHHHHSSCC,NA
9922,30973929,2019,KVlKl,KVL{d}KL{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP6,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",90 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCTHHHHHHHTC,NA
9923,30973929,2019,EVLDL,EVLDL{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP7,Amidation,Palmityl,Cyclic,L,None,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",30 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCSSSSSSCCSSSSSSSCCCCCC,NA
9924,30973929,2019,EVllD,EVL{d}L{d}D{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP8,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",100 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCSSSSSSCCSSSSSSSCCCCCC,NA
9925,30973929,2019,EDVll,EDVL{d}L{d}{cyc:N-C}{nt:Palmityl}{ct:Amid},SLP9,Amidation,Palmityl,Cyclic,Mix,nter = Palmityl,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",50 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCCCCCCSSCCGGGTCCCGGGTTTTTCCCCCSSTTTTGGGCCTTCC,NA
9926,30973929,2019,EVlDl,EVlDl{cyc:N-C}{nt:Heptaalkyl-biphenyl-acid}{ct:Amid},SLP10,Amidation,Heptaalkyl-biphenyl-acid,Cyclic,Mix,Heptaalkyl-biphenyl-acid,5,"Anti-viral, Anti-PEDV(Porcine epidemic diarrhea virus)",55 % Hemolysis at 10 μg/ml,Porcine,Synthetic Surfactin Lipopeptide Analogues,NA,NA,CCSCCCCTTSTTCCSTTCCCSTTHHHHCCTTTCCCCSSTTTCCSSSSSSCCTHHHHHHHHHTTSSCC,NA
10401,32641937,2019,cyclo(CGAGHVPC)-Yy(GABA)fYG,CGAGHVPC-YY{d}{nnr:GABA}F{d}YG{cyc:1-8},MccJ25-derived peptide,Free,Free,Cyclic,Mix,GABA = gamma amino butyric acid,14,Antibacterial,0.26 ± 0.01 % Hemolysis at 200 µM,Human,Bacteria Enterobacteriacea Mccj25- Derived Peptide,β-Sheet,Non-hemolytic,NA,NA
10684,31775224,2019,IRPIRP,IRPIRP{cyc:N-C},OIR1,Free,Free,Cyclic,L,None,6,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic Cyclic Amps,"aqueous = unordered, β-Hairpin",Low hemolytic,CCSSSCSTTSCCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC
10685,31775224,2019,IRIRPIRIRP,IRIRPIRIRP{cyc:N-C},OIR2,Free,Free,Cyclic,L,None,10,Antibacterial,≥5 % Hemolysis at >128 µM,Human,Synthetic Cyclic Amps,"aqueous = unordered, β-Hairpin",Low hemolytic,CCSSSSTTSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10686,31775224,2019,IRIRIRPIRIRIRP,IRIRIRPIRIRIRP{cyc:N-C},OIR3,Free,Free,Cyclic,L,None,14,"Antibacterial, Anti-Inflammatory",≥5 % Hemolysis at >128 µM,Human,Synthetic Cyclic Amps,"aqueous = unordered, β-Hairpin",Low hemolytic,CCSSTTSCSSSCC,CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
10951,32153522,2020,AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG,AGGKRIVQRIKDFLRGAGGKRIVQRIKDFLRG{cyc:N-C},cd4,Free,Free,Cyclic,L,None,32,Antimicrobial,50 % Hemolysis at >40 µM,Human,Cyclized Kr-12 Dimer,"SDS = α-Helical, Tris-buffer = Random coil",NA,CCCCHHHHHHHHHHHHSSCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
10952,32153522,2020,AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG,AGGKRIVKRIKKFLRGAGGKRIVKRIKKFLRG{cyc:N-C},"cd4(Q5K,D9K)",Free,Free,Cyclic,L,None,32,Antimicrobial,50 % Hemolysis at 10 µM,Human,Cyclized Kr-12 Dimer,"SDS = α-Helical, Tris-buffer = Random coil",NA,CCCCHHHHHHHHHHTTSCCTTSSSCSSSCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)CNC(=O)[C@H](C)N)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O
11098,32437150,2020,GIPCGESCVYIPCITAALGCSCKSKVCYRN,GIPCGESCVYIPCITAALGCSCKSKVCYRN{cyc:N-C},viar 1,Free,Free,Cyclic,L,None,30,Anti-cancer,50 % Hemolysis at 11.1 ± 0.02 µM,Human,Plant Viola Arcuata,α-Helical,Low hemolytic,CCCSCCSSSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O
11099,32437150,2020,GIPCGESCVWIPCISAAIGCSCKSKVCYRN,GIPCGESCVWIPCISAAIGCSCKSKVCYRN{cyc:N-C},cO13,Free,Free,Cyclic,L,None,30,Anti-cancer,50 % Hemolysis at 14.9 ± 0.01 µM,Human,Plant Viola Arcuata,α-Helical,Low hemolytic,NA,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
11100,32437150,2020,GLPVCGETCVGGTCNTPGCSCSWPVCTRN,GLPVCGETCVGGTCNTPGCSCSWPVCTRN{cyc:N-C},kalata S,Free,Free,Cyclic,L,None,29,Anti-cancer,50 % Hemolysis at ≥50 µM,Human,Plant Viola Arcuata,NA,NA,NA,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C
11104,32629881,2020,KNalKKBip-O2Oc-NalKN,K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C},BSI-9,Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,33 % Hemolysis at 150 µM,Human,Synthetic Cyclic Amp,NA,NA,NA,NA
11105,32629881,2020,KNalKKBip-O2Oc-NalNK,K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}NK{cyc:N-C},BSI-9 stage-1 (1),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11106,32629881,2020,KNalKNBip-O2Oc-NalKK,K{nnr:Nal}KN{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C},BSI-9 stage-1 (2),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11107,32629881,2020,KNalNKBip-O2Oc-NalKK,K{nnr:Nal}NK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C},BSI-9 stage-1 (3),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11108,32629881,2020,NNalKKBip-O2Oc-NalKK,N{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KK{cyc:N-C},BSI-9 stage-1 (4),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11109,32629881,2020,KFKKBip-O2Oc-NalKN,KFKK{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C},BSI-9 stage-2 (5),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,4 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11110,32629881,2020,KNalKKF-O2Oc-NalKN,K{nnr:Nal}KKF-{nnr:O2Oc}-{nnr:Nal}KN{cyc:N-C},BSI-9 stage-2 (6),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,6 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11111,32629881,2020,KNalKKBip-O2Oc-FKN,K{nnr:Nal}KK{nnr:Bip}-{nnr:O2Oc}-FKN{cyc:N-C},BSI-9 stage-2 (7),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,7 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11112,32629881,2020,KFKKF-O2Oc-FKN,KFKKF-{nnr:O2Oc}-FKN{cyc:N-C},BSI-9 stage-2 (8),Free,Free,Cyclic,L,"O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,3 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11113,32629881,2020,DabNalDabDabBip-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-2 (9),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,76 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11114,32629881,2020,RNalDabDabBip-O2Oc-NalDabN,R{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-3 (10),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,66 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11115,32629881,2020,DabNalRDabBip-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}R{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-3 (11),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,36 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11116,32629881,2020,DabNalDabRBip-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}{nnr:Dab}R{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-3 (12),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,98 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11117,32629881,2020,DabNalDabDabBip-O2Oc-NalRN,{nnr:Dab}{nnr:Nal}{nnr:Dab}{nnr:Dab}{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}RN{cyc:N-C},BSI-9 stage-3 (13),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,80 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11118,32629881,2020,RNalRRBip-O2Oc-NalRN,R{nnr:Nal}RR{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}RN{cyc:N-C},BSI-9 stage-3 (14),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid",9,Antibacterial,68 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11119,32629881,2020,RNalRDapBip-O2Oc-NalDabN,R{nnr:Nal}RDap{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (15),Free,Free,Cyclic,L,"Bip = L‐biphenylalanine, Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11120,32629881,2020,RNalRDabF-O2Oc-NalDabN,R{nnr:Nal}R{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (16),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,16 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11121,32629881,2020,RNalDabDabF-O2Oc-NalDabN,R{nnr:Nal}{nnr:Dab}{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (17),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,3 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,Non-hemolytic,NA,NA
11122,32629881,2020,DabNalRDabF-O2Oc-NalDabN,{nnr:Dab}{nnr:Nal}R{nnr:Dab}F-{nnr:O2Oc}-{nnr:Nal}{nnr:Dab}N{cyc:N-C},BSI-9 stage-4 (18),Free,Free,Cyclic,L,"Nal = 3‐(2‐Naphthyl)‐L‐alanine, O2Oc = 8‐amino‐3,6‐dioxaoctanoic acid, Dab = L‐2,4‐diaminobutyric acid",9,Antibacterial,30 % Hemolysis at 150 µM,Human,Analogues Of Bsi-9,NA,NA,NA,NA
11272,32126228,2020,CVRRFPWWYPFLRRC,CVRRFPWWYPFLRRC{cyc:N-C}{ct:Amid},Tritrp-DiSu*,Amidation,Free,Cyclic,L,None,15,Anticancer,50 % Hemolysis at 20.9 µM,Human,Modification Tritrpticin,NA,NA,CCCCCCSCCCTTC,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O
11307,32171739,2020,GIINTLQKYYCRVRGGRSAVLSSLPKEEQIGKSSTRGRKCSRRKK,GIINTLQKYYCRVRGGRSAVLSSLPKEEQIGKSSTRGRKCSRRKK{cyc:N-C},hBD-3-c,Free,Free,Cyclic,L,None,45,Antibacterial,>15 % Hemolysis at 250 μg/ml,Human,Hbd-3 Cyclic Variant With One Disulfide Bond,LPS aggregates = α-Helical,Low hemolytic,CHHHHHHHHHHHHHHHHHSSSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C)C(C)C)[C@@H](C)O)[C@@H](C)CC
11468,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},S3(B),Free,Free,Cyclic,L,"Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,77 % Hemolysis at 150 µM,Human,Cyclic Antimicrobial Peptide S3(B),NA,NA,NA,NA
11469,32823798,2020,Dab(C10)-Nal-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab(C10)}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)1,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11470,32823798,2020,Dab-Dab(C10)-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Dab(C10)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)2,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11471,32823798,2020,Dab-Dab(C12)-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Dab(C12)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C12)2,Free,Free,Cyclic,L,"Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11472,32823798,2020,Dab-Dab(C14)-R-Dab-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Dab(C14)}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C14)2,Free,Free,Cyclic,L,"Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11473,32823798,2020,Dab-Nal-R-Dab(C10)-Bip-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab(C10)}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)4,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11474,32823798,2020,Dab-Nal-R-Dab-Dab(C4)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C4)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C4)5,Free,Free,Cyclic,L,"Dab(C4) = Dab(C4), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,5 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,Low hemolytic,NA,NA
11475,32823798,2020,Dab-Nal-R-Dab-Dab(C6)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C6)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C6)5,Free,Free,Cyclic,L,"Dab(C6) = Dab(C6), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,13 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11476,32823798,2020,Dab-Nal-R-Dab-Dab(C8)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C8)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C8)5,Free,Free,Cyclic,L,"Dab(C8) = Dab(C8), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,42 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11477,32823798,2020,Dab-Nal-R-Dab-Dab(C10)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C10)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C10)5,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11478,32823798,2020,Dab-Nal-R-Dab-Dab(C12)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C12)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C12)5,Free,Free,Cyclic,L,"Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11479,32823798,2020,Dab-Nal-R-Dab-Dab(C14)-O2Oc-Nal-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Dab(C14)}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab}-N{cyc:N-C},(C14)5,Free,Free,Cyclic,L,"Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11480,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C4)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C4)}-{nnr:Dab}-N{cyc:N-C},(C4)7,Free,Free,Cyclic,L,"Dab(C4) = Dab(C4), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,4 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,Low hemolytic,NA,NA
11481,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C6)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C6)}-{nnr:Dab}-N{cyc:N-C},(C6)7,Free,Free,Cyclic,L,"Dab(C6) = Dab(C6), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,8 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11482,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C8)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C8)}-{nnr:Dab}-N{cyc:N-C},(C8)7,Free,Free,Cyclic,L,"Dab(C8) = Dab(C8), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,56 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11483,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C10)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C10)}-{nnr:Dab}-N{cyc:N-C},(C10)7,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11484,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C12)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C12)}-{nnr:Dab}-N{cyc:N-C},(C12)7,Free,Free,Cyclic,L,"Dab(C12) = Dab(C12), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,96 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11485,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Dab(C14)-Dab-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Dab(C14)}-{nnr:Dab}-N{cyc:N-C},(C14)7,Free,Free,Cyclic,L,"Dab(C14) = Dab(C14), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,98 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
11486,32823798,2020,Dab-Nal-R-Dab-Bip-O2Oc-Nal-Dab(C10)-N,{nnr:Dab}-{nnr:Nal}-R-{nnr:Dab}-{nnr:Bip}-{nnr:O2Oc}-{nnr:Nal}-{nnr:Dab(C10)}-N{cyc:N-C},(C10)8,Free,Free,Cyclic,L,"Dab(C10) = Dab(C10), Dab = l-2,4-diaminobutyric acid, Nal = 3-(2-Naphthyl)-l-alanine, Bip = l-biphenylalanine, O2Oc = 8-amino-3,6-dioxaoctanoic acid",9,Antibacterial,100 % Hemolysis at 150 µM,Human,Lipidated Analogues Of S3(B),NA,NA,NA,NA
12167,34159664,2021,GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSGGRLCYCRRRFCVCVGRR,GGVCPKILQRCRRDSDCPGACICRGNGYCGSGSGGRLCYCRRRFCVCVGRR{cyc:N-C},MCo-PG2,Free,Free,Cyclic,L,None,51,Antibacterial,50 % Hemolysis at 88± 5 µM,Human,Cyclotide Mcoti-I Modified From Pg-1,NA,NA,CCCSTTTHHHHHHHHHHHHHHCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C)C(C)C
12219,34635758,2021,CTKTDVHFC,CTKTDVHFC{cyc:N-C},CP2,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 µM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic,CCTHHHHHHTTC,CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)O
12220,34635758,2021,CIHSSTRAC,CIHSSTRAC{cyc:N-C},CP4,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 µM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCHHHHHHHC,CC[C@H](C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O
12221,34635758,2021,CTYENHRTC,CTYENHRTC{cyc:N-C},CP12,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 µM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic,NA,C[C@@H](O)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@@H](N)CS)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)O
12222,34635758,2021,CLAQSHPLC,CLAQSHPLC{cyc:N-C},CP16,Free,Free,Cyclic,L,None,9,Antiviral against WNV (West Nile virus),0.2 % Hemolysis at 6 µM,Sheep,Synthetic Cyclic Peptide,NA,Low hemolytic,CTTSGGGSGGGCC,CC(C)C[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O
12370,34977576,2021,BKKLLKCLKCL,{nnr:B}KKLLKCLKCL{cyc:7-10},bp3,Free,Free,Bicyclic,L,"B = 3,5-bis(methylene)toluoyl",11,Antibacterial,MHC at 500 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12371,34977576,2021,BKKLLKCLKCLL,{nnr:B}KKLLKCLKCLL{cyc:7-10},bp65,Free,Free,Bicyclic,L,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12372,34977576,2021,BkKlLkClKcLl,{nnr:B}K{d}KL{d}LK{d}CL{d}KC{d}LL{d}{cyc:7-10},bp67,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at >2000 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,Low hemolytic,NA,NA
12373,34977576,2021,BKKLLKcLKcLL,{nnr:B}KKLLKC{d}LKC{d}LL{cyc:7-10},bp68,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12374,34977576,2021,BkkLLkCLkCLL,{nnr:B}K{d}K{d}LLK{d}CLK{d}CLL{cyc:7-10},bp69,Free,Free,Bicyclic,Mix,"B = 3,5-bis(methylene)toluoyl",12,Antibacterial,MHC at 16.6 μg/ml,Human,Synthetic Peptide,5 mM DPC = α-Helical,NA,NA,NA
12452,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,0.47 ± 0.61 % Hemolysis at 50 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12466,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,1.19 ± 0.05 % Hemolysis at 100 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,Low hemolytic,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12480,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,17.23 ± 3.08 % Hemolysis at 150 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CTTHHHHTTTC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12494,35145500,2022,RRLFRRILRWL,RRLFRRILRWL{cyc:N-C}{ct:Amid},RW-BP100-cycle,Amidation,Free,Cyclic,L,None,11,Antibacterial,48.67 ± 2.17 % Hemolysis at 300 μg/ml,Sheep,Rw-Bp-100 Analogue,NA,NA,CCSSEETTEECCCCCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)O
12526,34978443,2022,R-R-R-Bip-Bip-Bip,R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C},1C,Free,Free,Cyclic,L,"Bip = 4,4′-biphenyl-L-alanine",6,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12527,34978443,2022,R-R-R-Dip-Dip-Dip,R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},2C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",6,Antibacterial,50 % Hemolysis at 45 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12528,34978443,2022,R-R-R-Nal-Nal-Nal,R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},3C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antibacterial,50 % Hemolysis at 50 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12529,34978443,2022,R-R-R-R-Bip-Bip-Bip-Bip,R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C},4C,Free,Free,Cyclic,L,"Bip = 4,4′-biphenyl-L-alanine",8,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12530,34978443,2022,R-R-R-R-Dip-Dip-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},5C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 40 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12531,34978443,2022,R-R-R-R-Nal-Nal-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},6C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,8,Antibacterial,50 % Hemolysis at 30 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12532,34978443,2022,R-R-R-R-Bip-Bip-Bip,R-R-R-R-{nnr:Bip}-{nnr:Bip}-{nnr:Bip}{cyc:N-C},7C,Free,Free,Cyclic,L,"Bip = 4,4′-biphenyl-L-alanine",7,Antibacterial,50 % Hemolysis,Human,Synthetic Peptide,NA,NA,NA,NA
12533,34978443,2022,R-R-R-R-Dip-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},8C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 70 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12534,34978443,2022,R-R-R-R-Nal-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},9C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 80 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12535,34978443,2022,R-R-R-R-Dip-Dip,R-R-R-R-{nnr:Dip}-{nnr:Dip}{cyc:N-C},10C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",6,Antibacterial,50 % Hemolysis at 110 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12536,34978443,2022,R-R-R-R-Nal-Nal,R-R-R-R-{nnr:Nal}-{nnr:Nal}{cyc:N-C},11C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,6,Antibacterial,50 % Hemolysis at 125 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12537,34978443,2022,R-R-R-R-R-Dip-Dip-Dip,R-R-R-R-R-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},12C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 100 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12538,34978443,2022,R-R-R-R-R-Nal-Nal-Nal,R-R-R-R-R-{nnr:Nal}-{nnr:Nal}-{nnr:Nal}{cyc:N-C},13C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,8,Antibacterial,50 % Hemolysis at 90 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12539,34978443,2022,K-K-K-K-Dip-Dip-Dip,K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},14C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 165 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12540,34978443,2022,K-K-K-K-K-Dip-Dip-Dip,K-K-K-K-K-{nnr:Dip}-{nnr:Dip}-{nnr:Dip}{cyc:N-C},15C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",8,Antibacterial,50 % Hemolysis at 180 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12541,34978443,2022,R-Dip-R-R-Dip-Dip-R,R-{nnr:Dip}-R-R-{nnr:Dip}-{nnr:Dip}-R{cyc:N-C},16C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 130 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12542,34978443,2022,R-R-Dip-Dip-R-R-Dip,R-R-{nnr:Dip}-{nnr:Dip}-R-R-{nnr:Dip}{cyc:N-C},17C,Free,Free,Cyclic,L,"Dip = 3,3-diphenyl-L-alanine",7,Antibacterial,50 % Hemolysis at 145 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12543,34978443,2022,R-Nal-R-R-Nal-Nal-R,R-{nnr:Nal}-R-R-{nnr:Nal}-{nnr:Nal}-R{cyc:N-C},18C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 105 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12544,34978443,2022,R-R-Nal-Nal-R-R-Nal,R-R-{nnr:Nal}-{nnr:Nal}-R-R-{nnr:Nal}{cyc:N-C},19C,Free,Free,Cyclic,L,Nal = 3-(2-naphthyl)-L-alanine,7,Antibacterial,50 % Hemolysis at 110 µM,Human,Synthetic Peptide,NA,NA,NA,NA
12581,36430320,2022,CGKKWWGWKCKL,CGKKWWGWKCKL{cyc:1-10}{ct:Amid},cTurg-2,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >1045 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12582,36430320,2022,CGKKWGWWKCKL,CGKKWGWWKCKL{cyc:1-10}{ct:Amid},cTurg-3,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 849 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTCCSSCCSCC,NA
12583,36430320,2022,CGKKPWWWKCKL,CGKKPWWWKCKL{cyc:1-10}{ct:Amid},cTurg-4,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >1065 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTCCSSCCSCC,NA
12584,36430320,2022,CGRRWWGWRCRL,CGRRWWGWRCRL{cyc:1-10}{ct:Amid},cTurg-5,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >1101 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTCCSSCCSCC,NA
12585,36430320,2022,CGRRWGWWRCRL,CGRRWGWWRCRL{cyc:1-10}{ct:Amid},cTurg-6,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 1101 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,CTTSCCSCCCCC,NA
12586,36430320,2022,CGRRPWWWRCRL,CGRRPWWWRCRL{cyc:1-10}{ct:Amid},cTurg-7,Amidation,Free,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 197 μg/ml,Human,Synthetic Peptide,NA,NA,CTTSCCSCCCCC,NA
12596,36430320,2022,(CGKKPGGWKC)KL,CGKKPGGWKCKL{cyc:N-C}{nt:C8}{ct:Amid},C8-cTurg-1,Amidation,C8,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >942 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12597,36430320,2022,(CGKKPGGWKC)KL,CGKKPGGWKCKL{cyc:N-C}{nt:C10}{ct:Amid},C10-cTurg-1,Amidation,C10,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at >956 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12598,36430320,2022,(CGKKPGGWKC)KL,CGKKPGGWKCKL{cyc:N-C}{nt:C12}{ct:Amid},C12-cTurg-1,Amidation,C12,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 219 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
12599,36430320,2022,(CGKKWWGWKC)KL,CGKKWWGWKCKL{cyc:N-C}{nt:C8}{ct:Amid},C8-cTurg-2,Amidation,C8,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 439 μg/ml,Human,Synthetic Peptide,NA,Non-hemolytic,NA,NA
12600,36430320,2022,(CGKKWWGWKC)KL,CGKKWWGWKCKL{cyc:N-C}{nt:C10}{ct:Amid},C10-cTurg-2,Amidation,C10,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 106 μg/ml,Human,Synthetic Peptide,NA,NA,CGGGGHHHHHHHHTTTCCC,NA
12601,36430320,2022,(CGKKWWGWKC)KL,CGKKWWGWKCKL{cyc:N-C}{nt:C12}{ct:Amid},C12-cTurg-2,Amidation,C12,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 32 μg/ml,Human,Synthetic Peptide,NA,NA,CHHHHHHTTHHHHSSSCC,NA
12602,36430320,2022,(CGRRWGWWRC)RL,CGRRWGWWRCRL{cyc:N-C}{nt:C8}{ct:Amid},C8-cTurg-6,Amidation,C8,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 30 μg/ml,Human,Synthetic Peptide,NA,NA,CHHHHTTTTCCSCCCC,NA
12603,36430320,2022,(CGRRWGWWRC)RL,CGRRWGWWRCRL{cyc:N-C}{nt:C10}{ct:Amid},C10-cTurg-6,Amidation,C10,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 16 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
12604,36430320,2022,(CGRRWGWWRC)RL,CGRRWGWWRCRL{cyc:N-C}{nt:C12}{ct:Amid},C12-cTurg-6,Amidation,C12,Cyclic,L,None,12,"Antibacterial, Antifungal",50 % Hemolysis at 9 μg/ml,Human,Synthetic Peptide,NA,NA,NA,NA
12626,36442155,2022,RRRRWWWW,RRRRWWWW{cyc:N-C},1,Free,Free,Cyclic,L,None,8,Antibacterial,50 % Hemolysis at 175 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12627,36442155,2022,RRWWW,RRWWW{cyc:N-C},2a,Free,Free,Cyclic,L,None,5,Antibacterial,50 % Hemolysis at 120 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCSSCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12628,36442155,2022,RRWWWW,RRWWWW{cyc:N-C},2b,Free,Free,Cyclic,L,None,6,Antibacterial,50 % Hemolysis at 85 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12629,36442155,2022,RRRWWW,RRRWWW{cyc:N-C},3a,Free,Free,Cyclic,L,None,6,Antibacterial,50 % Hemolysis at 155 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12630,36442155,2022,RRRWWWW,RRRWWWW{cyc:N-C},3b,Free,Free,Cyclic,L,None,7,Antibacterial,50 % Hemolysis at 105 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12631,36442155,2022,RRRWWWWW,RRRWWWWW{cyc:N-C},3c,Free,Free,Cyclic,L,None,8,Antibacterial,50 % Hemolysis at 80 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12632,36442155,2022,RRRWWWWWW,RRRWWWWWW{cyc:N-C},3d,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 65 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12633,36442155,2022,RRRWWWWWWW,RRRWWWWWWW{cyc:N-C},3e,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 60 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12634,36442155,2022,rrrrWWWW,R{d}R{d}R{d}R{d}WWWW{cyc:N-C},4a,Free,Free,Cyclic,Mix,r = D-Arginine,8,Antibacterial,50 % Hemolysis at 110 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSCC,NA
12635,36442155,2022,RRRRWWWWW,RRRRWWWWW{cyc:N-C},4b,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 100 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12636,36442155,2022,RRRRWWWWWW,RRRRWWWWWW{cyc:N-C},4c,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 75 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12637,36442155,2022,RRRRWWWWWWW,RRRRWWWWWWW{cyc:N-C},4d,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 60 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCSCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12638,36442155,2022,RRRRRWWWW,RRRRRWWWW{cyc:N-C},5a,Free,Free,Cyclic,L,None,9,Antibacterial,50 % Hemolysis at 340 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12639,36442155,2022,RRRRRWWWWW,RRRRRWWWWW{cyc:N-C},5b,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 230 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12640,36442155,2022,RRRRRWWWWWW,RRRRRWWWWWW{cyc:N-C},5c,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 140 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12641,36442155,2022,RRRRRWWWWWWW,RRRRRWWWWWWW{cyc:N-C},5d,Free,Free,Cyclic,L,None,12,Antibacterial,50 % Hemolysis at 115 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCSSCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12642,36442155,2022,RRRRRRWWWW,RRRRRRWWWW{cyc:N-C},6a,Free,Free,Cyclic,L,None,10,Antibacterial,50 % Hemolysis at 265 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12643,36442155,2022,RRRRRRWWWWW,RRRRRRWWWWW{cyc:N-C},6b,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 255 μg/ml,Human,Synthetic Cyclic Peptide,NA,Low hemolytic,CCCCCCCCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12644,36442155,2022,RRRRRRWWWWWW,RRRRRRWWWWWW{cyc:N-C},6c,Free,Free,Cyclic,L,None,12,Antibacterial,50 % Hemolysis at 170 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCCCSSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12645,36442155,2022,RRRRRRWWWWWWW,RRRRRRWWWWWWW{cyc:N-C},6d,Free,Free,Cyclic,L,None,13,Antibacterial,50 % Hemolysis at 85 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCSCCSSSSCCCCCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12646,36442155,2022,RRRRRRRWWWW,RRRRRRRWWWW{cyc:N-C},7a,Free,Free,Cyclic,L,None,11,Antibacterial,50 % Hemolysis at 190 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CHHHHHHHHTTTTTC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12647,36442155,2022,RRRRRRRWWWWW,RRRRRRRWWWWW{cyc:N-C},7b,Free,Free,Cyclic,L,None,12,Antibacterial,50 % Hemolysis at 175 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCHHHHHHHTTSCHHHHTTTTTTSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12648,36442155,2022,RRRRRRRWWWWWW,RRRRRRRWWWWWW{cyc:N-C},7c,Free,Free,Cyclic,L,None,13,Antibacterial,50 % Hemolysis at 170 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12649,36442155,2022,RRRRRRRWWWWWWW,RRRRRRRWWWWWWW{cyc:N-C},7d,Free,Free,Cyclic,L,None,14,Antibacterial,50 % Hemolysis at 140 μg/ml,Human,Synthetic Cyclic Peptide,NA,NA,CCCCCCCSSCC,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12882,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C2},PE-2C-C2-DH,Free,C2,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12883,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C3},PE-2C-C3-DH,Free,C3,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12884,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C4},PE-2C-C4-DH,Free,C4,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12885,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C5},PE-2C-C5-DH,Free,C5,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12886,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C6},PE-2C-C6-DH,Free,C6,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12887,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C7},PE-2C-C7-DH,Free,C7,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12888,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:C8},PE-2C-C8-DH,Free,C8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12889,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC7},PE-2C-6-MC7-DH,Free,6-MC7,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12890,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:6-MC8},PE-2C-6-MC8-DH,Free,6-MC8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at >1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12891,36941353,2023,Dab-T-Dab-[C-Dab-l-L-Dab-Dab-C],{nnr:Dab}-T-{nnr:Dab}-[C-{nnr:Dab}-L{d}-L-{nnr:Dab}-{nnr:Dab}-C]{cyc:4-10}{nt:LB-8},PE-2C-LB-8-DH),Free,LB-8,Cyclic,Mix,"Dab = L-2,4-diaminobutyric acid",10,Antibacterial,0 % Hemolysis at 1500 μg/ml,Rabbit,Synthetic Cyclic Peptide,NA,Non-hemolytic,NA,NA
12961,35326879,2022,RRRRWWWW,RRRRWWWW{cyc:N-C},[R4W4],Free,Free,Cyclic,L,None,8,"Antibacterial, Cytotoxic",80 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
12964,35326879,2022,[Levo-C10-KRRRWWWW],{conj:Levo}{conj:C10}KRRRWWWW{cyc:N-C},[Levo-C10-KR3W4],Free,Free,Cyclic,L,"Levo = Levofloxacin covalent conjugates, C10 = 10-hydroxy decanoic acid(linker)",8,"Antibacterial, Cytotoxic",∼30 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
12966,35326879,2022,Levo + [RRRRWWWW],{conj:Levo}[RRRRWWWW{cyc:N-C},Levo + [R4W4],Free,Free,Cyclic,L,"Levo = Levofloxacin, physical mixture of Levofloxacin and peptides (500 µg/mL (1:1; w/w))",8,"Antibacterial, Cytotoxic",∼22 % Hemolysis at 500 μg/ml,Human,Synthetic,NA,NA,NA,NA
13475,35978681,2022,CKWKLFKKIGAVLKVL,CKWKLFKKIGAVLKVL{cyc:N-C}{ct:Amid},Cyc-CAM,Amidation,Free,Cyclic,L,None,16,Antibacterial,50 % Hemolysis at >1000 μg/ml,Sheep,Synthetic; Analog Of The Pentadecapeptide Ca(1-7)M(2-9),NA,NA,CCCCCCTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)C(C)C
13765,36044031,2022,GSVPCGESCVWIPCISGILGCSCSNKVCYYN,GSVPCGESCVWIPCISGILGCSCSNKVCYYN{cyc:N-C},anpy A,Free,Free,Cyclic,L,None,32,Cytotoxic,50 % Hemolysis at 22 µM,Human,Anchietea Pyrifolia,NA,NA,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13766,36044031,2022,SIPCGESCVWIPCTVTALAGCSCKNKVCYKN,SIPCGESCVWIPCTVTALAGCSCKNKVCYKN{cyc:N-C},anpy B,Free,Free,Cyclic,L,None,31,Cytotoxic,50 % Hemolysis at 78 µM,Human,Anchietea Pyrifolia,NA,Low hemolytic,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CO)[C@@H](C)CC)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O
13767,36044031,2022,GIPCGESCVWIPCISSAIGCSCKNKVCYRN,GIPCGESCVWIPCISSAIGCSCKNKVCYRN{cyc:N-C},cy04,Free,Free,Cyclic,L,None,31,Cytotoxic,50 % Hemolysis at >156 µM,Human,Anchietea Pyrifolia,NA,Non-hemolytic,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13768,36044031,2022,GIPCGESCVWIPCISAAIGCSCKNKVCYRN,GIPCGESCVWIPCISAAIGCSCKNKVCYRN{cyc:N-C},cy017,Free,Free,Cyclic,L,None,31,Cytotoxic,50 % Hemolysis at >156 µM,Human,Anchietea Pyrifolia,NA,Non-hemolytic,CCTHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13832,16207177,2006,GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD,GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD{cyc:N-C},Kalata B8,Free,Free,Cyclic,L,None,31,"Antiviral, Anti-HIV, Hemolytic",0 % Hemolysis at 370 µM,Human,"Plant African Herb, Oldenlandia Affinis",Beta,Non-hemolytic,CCSSCTTCGGGSSSSCCCCSSSSTTSSCC,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)C(C)C)[C@@H](C)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
13836,16872274,2006,GLPTCGETCFGGTCNTPGCTCDPWPVCTHN,GLPTCGETCFGGTCNTPGCTCDPWPVCTHN{cyc:N-C},Cycloviolacin O24,Free,Free,Cyclic,L,None,30,"Antiviral, Anti-HIV, Hemolytic",75 % Hemolytic at 25 μg/ml,Human,Plant Viola Odorata,Bridge,NA,CHHHHHHTTSCSSSSSSSSCC,CC(C)C[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
13857,21596752,2011,GIPCGESCVFIPCITGAIGCSCKSKVCYRN,GIPCGESCVFIPCITGAIGCSCKSKVCYRN{cyc:N-C},Cliotide T1,Free,Free,Cyclic,L,None,30,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 7.1 µM,Human,Plant Clitoria Ternatea,NA,NA,CCHHHHTTTCTTCCTHHHHTCCCCCTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13858,21596752,2011,GLPTCGETCTLGTCYVPDCSCSWPICMKN,GLPTCGETCTLGTCYVPDCSCSWPICMKN{cyc:N-C},Cliotide T3,Free,Free,Cyclic,L,None,29,"Hemolytic, Anticancer",50 % Hemolytic at 13.1 µM,Human,Plant Clitoria Ternatea,NA,NA,CCTHHHHHHHHHSSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
13859,21596752,2011,GIPCGESCVFIPCITAAIGCSCKSKVCYRN,GIPCGESCVFIPCITAAIGCSCKSKVCYRN{cyc:N-C},Cliotide T4,Free,Free,Cyclic,L,None,30,"Antibacterial, Hemolytic, Anticancer",50 % Hemolytic at 8.4 µM,Human,Plant Clitoria Ternatea,NA,NA,CCCHHHHHHHSCCCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
13860,22074926,2012,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD{cyc:N-C},Parigidin-br1,Free,Free,Cyclic,L,None,32,"Insecticidal, Hemolytic",28 % Hemolytic at 20 µM,Human,Plant Palicourea Rigida (Rubiaceae),Bridge,NA,CCCHHHHTHHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O
13861,22074926,2012,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD,GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD{cyc:N-C},Parigidin-br1,Free,Free,Cyclic,L,None,32,"Insecticidal, Hemolytic",41 % Hemolytic at 40 µM,Human,Plant Palicourea Rigida (Rubiaceae),Bridge,NA,CCCHHHHTHHHHHHHHHCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O)C(C)C)[C@@H](C)O
13869,22467870,2012,GDACGETCFTGICFTAGCSCNPWPTCTRN,GDACGETCFTGICFTAGCSCNPWPTCTRN{cyc:N-C},ChaC1 (chassatide C1),Free,Free,Cyclic,L,None,29,"Hemolytic, Anticancer",Hemolytic,Human,Hybrid Peptide,Bridge,NA,CTTTTHHHHHHHHHHHSCGGGTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
13870,22467870,2012,GASCGETCFTGICFTAGCSCNPWPTCTRN,GASCGETCFTGICFTAGCSCNPWPTCTRN{cyc:N-C},ChaC4 (chassatide C4),Free,Free,Cyclic,L,None,29,"Hemolytic, Anticancer",Hemolytic,Human,Plant Chassalia Chartacea (Or Chassalia Curviflora),Bridge,NA,CTTTTHHHHHHHHHHHSCGGGTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
14110,16872274,2006,GIPCGESCVWIPCISSAIGCSCKSKVCYRN,GIPCGESCVWIPCISSAIGCSCKSKVCYRN{cyc:N-C},Cycloviolacin-O2,Free,Free,Cyclic,L,None,30,Antimicrobial,HD50 % Hemolytic at 36 µM,Human,Viola Odorata (Sweet Violet),NA,NA,CCHHHHHHHHHHHHHHTCCCGGGGGTSSSCHHHHHHHSCTTTSSCCBSCCCCBTTBCCCCBCCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
14111,16872274,2006,GIPCGESCVWIPCISAAIGCSCKSKVCYRN,GIPCGESCVWIPCISAAIGCSCKSKVCYRN{cyc:N-C},Cycloviolacin-O13 (Cyclotide c3),Free,Free,Cyclic,L,None,30,Antimicrobial,HD50 % Hemolytic at 11 µM,Human,Viola Odorata (Sweet Violet),NA,NA,CCSCCCCSCC,CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C
14136,26322745,2015,GKYTCGETCFKGKCYTPGCTCSYPICKKD,GKYTCGETCFKGKCYTPGCTCSYPICKKD{cyc:N-C},Cyclotide mela-1,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCCCCSSSSSSTTSSCSBCCSSSCBCCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14137,26322745,2015,GKPTCGETCFKGKCYTPGCTCSYPLCKKD,GKPTCGETCFKGKCYTPGCTCSYPLCKKD{cyc:N-C},Cyclotide mela-2,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCHHHHHHHTTCSCCCCHHHHHHCCC,CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14138,26322745,2015,GLPTCGETCFKGKCYTPGCSCSYPICKKD,GLPTCGETCFKGKCYTPGCSCSYPICKKD{cyc:N-C},Cyclotide mela-6,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCTTTSCCCCCCSSSSSCCSSCTTTSCCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14139,26322745,2015,GLPTCGETCFKGKCYTPGCSCSYPICKKN,GLPTCGETCFKGKCYTPGCSCSYPICKKN{cyc:N-C},Cyclotide mela-7,Free,Free,Cyclic,L,None,29,Antibacterial,50 % Hemolytic at >64 µM,Human,Melicytus Latifolius (Norfolk Island Mahoe) (Hymenanthera Latifolia),NA,Non-hemolytic,CCCCCCSSCSTHHHHHTTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
14140,26322745,2015,GLPTCGETCTLGKCNTPKCTCNWPICYKD,GLPTCGETCTLGKCNTPKCTCNWPICYKD{cyc:N-C},Cyclotide mech-2,Free,Free,Cyclic,L,None,29,cytotoxicity,50 % Hemolytic at >64 µM,Human,Melicytus Chathamicus (Chatham Island Mahoe) (Hymenanthera Latifolia Var. Chathamica),NA,Non-hemolytic,CCSSCCTTSGGGTHHHHTC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O
14141,26322745,2015,GLPTCGETCTLGKCNTPKCTCNWPICYKN,GLPTCGETCTLGKCNTPKCTCNWPICYKN{cyc:N-C},Cyclotide mech-3,Free,Free,Cyclic,L,None,29,cytotoxicity,50 % Hemolytic at >64 µM,Human,Melicytus Chathamicus (Chatham Island Mahoe) (Hymenanthera Latifolia Var. Chathamica),NA,Non-hemolytic,CCCSSCSHHHHHTTSCC,CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O
14143,22467870,2012,GEYCGESCYLIPCFTPGCYCVSRQCVNKN,GEYCGESCYLIPCFTPGCYCVSRQCVNKN{cyc:N-C},Chassatide C10 (Cyclotide chaC10),Free,Free,Cyclic,L,None,29,NA,50 % Hemolytic at >25 µM,Human,Chassalia Chartacea,NA,Non-hemolytic,CHHHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)C(C)C)[C@@H](C)O
14150,32414842,2020,GVPCGESCVYIPCFTGIINCSCRDKVCYNN,GVPCGESCVYIPCFTGIINCSCRDKVCYNN{cyc:N-C},Cyclotide hyen-E,Free,Free,Cyclic,L,None,30,cytotoxicity,50 % Hemolytic at >50 µM,Human,Pigea Enneasperma (Spade Flower) (Hybanthus Enneaspermus),NA,NA,CCGGGHHHHHHHHHHHHHHHTTCC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CN)C(C)C)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC
14151,32414842,2020,GIPCAESCVYIPCTVTALLGCSCSDKVCYN,GIPCAESCVYIPCTVTALLGCSCSDKVCYN{cyc:N-C},Cyclotide hyen-L,Free,Free,Cyclic,L,None,30,cytotoxicity,50 % Hemolytic at >50 µM,Human,Pigea Enneasperma (Spade Flower) (Hybanthus Enneaspermus),NA,NA,CCCCHHHHHHHHTTTTHHHHHHGGGCCCCSCCC,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)[C@@H](C)CC)C(C)C
14165,15893660,2005,SLETKDVITRAAYENLVNSGAIQGITMTKTIISNPILEEALVSHFNRKLG,SLETKDVITRAAYENLVNSGAIQGITMTKTIISNPILEEALVSHFNRKLG{cyc:N-C},Tricyclon-A,Free,Free,Cyclic,L,None,50,Plant defense,2 % Hemolytic at 500 µM,Human,Viola Arvensis (European Field Pansy) (Field Violet),Helix and Extended,NA,CCCCSCCTHHHHHHHTTTGGGGGTTTHHHHTTHHHHHHHHHHHHGGGSSCSSCCCCCCTTTTHHHHCSSHHHHSCCCCCTTTTSTTC,CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)[C@@H](C)O)C(C)C)[C@@H](C)CC)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O